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1.1 Framework
Historical context
The global burden of work-related disease and mortality resulting from exposure to 
hazardous chemicals is substantial. About 1.65 million of the estimated 2 million 
people that die each year due to work-related illnesses and injuries suffer from 
occupational diseases (Driscoll et al., 2005; Fingerhut et al., 2005). Roughly half of these 
occupational diseases result from chemical exposures at the workplace. Occupational 
carcinogens, leukaemogens, particulates and fibres (asbestos) contribute most to 
this number (Pruss-Ustun et al., 2011). 
 Work related exposure to chemicals is not a new phenomenon. It has been 
recognized as a serious health threat since the Romans. Pliny the Elder (23 – 79 AD) 
may have been an occupational hygienist avant la lettre, based on his efforts to provide 
slaves with facemasks made from animal bladder to protect them from exposure to 
dust and lead fumes (Gochfeld, 2005). Although the link between chemical exposure 
at the workplace and the onset of occupational disease was already made in the old 
days, the introduction of the dose concept by Paracelsus around 1500 AD can be 
seen as an important benchmark in assessing the risk of chemical exposures (Ragas, 
2011).  According to this concept, the level of exposure to a chemical substance 
together with its capacity to cause adverse health effects determines the probability 
of the occurrence of these effects: the actual risk. Nowadays, risk assessment is 
often depicted as a multistep process. The number and naming of the different steps 
varies depending on the regulatory context, but two steps are always present, i.e. (1) 
exposure assessment: the estimation of the actual concentration or dose to which 
an individual or population is exposed, and (2) effect assessment: the analysis of the 
relation between dose and response, where the latter refers to an health effect that is 
considered adverse (Van Leeuwen and Vermeire, 2007). 
Exposure assessment
Exposure to chemicals at the workplace can be assessed by means of quantification 
of external (ambient air) or internal (e.g. blood) concentrations of chemicals and/or 
their metabolites. The introduction of portable sampling equipment for personal air 
monitoring of chemicals in the late 1950s has boosted the development of quantitative 
exposure assessment methods (Cherrie, 2003). As a result, personal air monitoring 
of chemical exposure at the workplace has been introduced in most industrialized 
countries in the past decades. Personal air monitoring typically focuses on the 
quantification of inhalation exposure to gasses, vapours or particles during a workday. 
The applied personal air monitors are typically tested in different working situations, 
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for example in low air movements environments (Kenny et al., 1999), and for different 
agents, such as aerosols, volatile organic and biological compounds  (Macher and 
First, 1984; Whitaker et al., 1995). 
 Along with the development of sampling devices, sampling procedures and 
standards were developed to support adequate quantitative assessment of exposure 
and to develop reliable measurement strategies. Examples are the American NIOSH 
standards and the European NEN-EN standards (NEN-EN, 1995; NIOSH, 1995). 
Standardisation of measurement procedures and strategies gave rise to initiatives 
that supported the harmonization and exchange of information from collected 
measurement data from the workplace as well as the assessment of these data (Ogden 
and Lavoue, 2012; Rajan et al., 1997; Tielemans et al., 2002).  
 The quantification of actual exposure levels for an individual worker or 
a group of workers during application of chemicals at the workplace is nowadays 
also referred to as ‘post-registration’ assessment. In the past few decades, there 
has been an increasing emphasis on exposure assessment in the so-called ‘pre-
registration phase’, thus before the actual application and use of chemicals in 
practice. The introduction of the European chemical substance legislation EU-REACH 
– Registration, Evaluation and Authorisation of Chemicals – in 2007 has accelerated 
these ‘pre-registration’ assessments. Within REACH, safe use must be demonstrated 
for all possible exposure scenarios in which a chemical may be used, from production 
to waste, before its introduction to the market. In addition, REACH also puts more 
emphasis on task-based assessments other than the traditional perspective of 
workplace assessment that focuses mainly on 8-h time weighted average (TWA) 
exposures (Marquart H, 2007). As a result, collecting exposure measurements for all 
relevant exposure scenarios has become infeasible due to the number and variety of 
the exposure scenarios and the condition that assessments must be carried out prior 
to the practical application of chemicals. 
 The introduction of REACH and other pre-registration regulations has 
stimulated the development and use of quantitative exposure models for chemicals. 
However, the first steps in exposure modelling were already made in the 1980-ies 
and 1990-ies with the development of statistical regression models that make use 
of the power of collected exposure data(Eisen et al., 1984; Kromhout et al., 1994; 
Lemasters et al., 1985). Other exposure models describe processes in  a more 
mechanistic approach. Mechanistic models rely on a good understanding of the 
physical processes underlying exposure. Subsequently, measured exposure data can 
be used to calibrate and validate these models. The development of the conceptual 
source-receptor model by Cherrie and Schneider, that characterizes emissions from 
sources in the work environment and subsequent interactions between workers and 
the dispersed pollutant, can be considered a significant step in mechanistic modelling 
of occupational exposure, since a number of recently developed exposure models are 
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based on the same principles (Cherrie and Schneider, 1999).
To facilitate the implementation of the REACH legislation, a so-called tiered approach 
for risk assessment was introduced in which a number of newly developed inhalation 
exposure prediction models play a prominent role. In the first tier, relatively simple 
exposure models are used to assess worker exposures. First tier models, such as the 
ECETOC-tra model (ECETOC, 2009) and the EMKG-expo tool (BAuA), are intended 
to provide simple, yet conservative estimates of (inhalation and dermal) exposure 
sufficient for a user to determine whether a more detailed (Tier 2) exposure assessment 
may be required or not (Money et al., 2014; Money et al., 2007). Second tier models 
are more advanced and intended to produce more realistic exposure estimates, but 
generally require more input data. A good example of a robust second tier model is 
the mechanistic Advanced REACH tool (Fransman et al., 2011; Schinkel et al., 2014). 
In situations where reliable exposure models do not fit or do not provide sufficient 
insight in the exposure and risks, exposure measurements are used as fall back option 
in Tier 3.
Effect assessment
In occupational hygiene, the outcome of the health effect assessment is a ‘safe dose’ 
for chemical substances at the workplace expressed as an occupational exposure limit 
(OEL). The derivation of the first OELs started around 1900 and took further shape 
from the 1930s onwards in countries like Germany and Russia. In the US, the first 
list of Maximum Allowable Concentrations, later renamed to Threshold Limit Values 
(TLVs) and nowadays considered as one of the most reputable OELs, was published 
in the late 1940s (Ripple, 2010). 
At present, many countries have developed their own system for derivation and 
enforcement of OELs to control health risks from chemical exposure in occupational 
settings. Ideally, OELs are based on health-based endpoints resulting from 
epidemiological studies. However, in practice this is only possible for a limited number 
of chemicals since human epidemiological data are scarce. For this reason, OELs are 
often derived from the results of toxicological studies with laboratory animals. OELs 
for substances with threshold effects are generally derived from no-observed-adverse-
effect-levels (NOAELs). It is assumed that the internal exposure level that corresponds 
with the NOAEL is so low that the most sensitive toxicological reaction (critical effect) 
is not triggered. This is a point of departure for extrapolation to the OEL. Alternatively, 
the benchmark dose (BMD), which is a predetermined level of adverse effect, may 
be used.  Depending on the origin of the NOAEL or BMD, multiple extrapolation (or 
uncertainty) factors may be applied, for example for interspecies extrapolation and 
variation within the human population. These approaches are based on health-related 
considerations and are intended to protect the majority of the working population 
(Nielsen and Ovrebo, 2008).  Besides health-based approaches, some countries 
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include socio-economic and technological considerations in the derivation of their 
OELs (Nielsen and Ovrebo, 2008; Stouten et al., 2008). 
1.2 External versus internal exposure 
assessment
Chemical exposure in occupational settings has traditionally been assessed through 
personal air monitoring or by the use of models that estimate concentrations 
of chemical substances in the workplace environment. As inhalation exposure 
is regarded to be the dominant route of exposure for most chemicals in most 
occupational settings, many OELs are expressed as air concentrations. Despite the 
practical advantages of measuring concentrations in the workplace environment, it 
is only indirectly related to adverse health effects since these are being triggered by 
internal exposure, i.e. the internal concentration at the site of toxic action. From the 
perspective of (health) risk assessment, biological measures of internal exposure are 
preferable to external exposure data, as they are closer to the target organ dose and 
provide greater precision in risk estimates (Manno et al., 2009). Biological measures 
also reflect other exposure routes that may contribute to the overall exposure to a 
chemical as well as exposure to chemical mixtures with similar components. 
Over the past decades, human biomonitoring (HBM) is increasingly used as a tool 
to complement external exposure monitoring. HBM differentiates between chemical 
dose monitoring and (biochemical and biological) effect monitoring. Dose monitoring 
is the determination of hazardous substances or their metabolites in body fluids, 
whereas effect monitoring quantifies reaction products with biological molecules 
or early biological effects (Angerer et al., 2007). In an occupational setting, human 
biomonitoring is mostly applied as a method for dose monitoring, i.e., as a reflection 
of the actually absorbed dose of a chemical in the human body after exposure in the 
working environment. 
Tissue concentrations are generally considered proportional to blood concentrations 
(Andersen and Dennison, 2002). Therefore, blood or plasma concentrations of the 
parent chemical or a relevant metabolite are in many cases chosen as a starting point 
to relate measures of dose to adverse toxicological responses within the body. Urinary 
concentrations are also used frequently, as they reflect the internal concentration 
for many chemicals and are easy to measure. Reference values for biological media, 
such as blood and urine, have been derived to support the application of human 
biomonitoring. Biological limit values (BLVs), such as biological exposure indices 
(BEI) and Biologische Arbeitsstoff-Toleranzwerten (BAT), are typically derived from 
OELs, based on an empirical relationship between external exposure levels and 
corresponding internal concentrations (ACGIH, 2001; Angerer et al., 2011). BLVs are 
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established for specific biological media at predefined points in time and applicable 
for the parent compound or a specific metabolite. Nowadays, BLVs are available for 
over 50 industrial chemicals.
Besides taking samples of relevant body fluids such as blood or urine, as is common 
practice for the purpose of HBM, target tissue dose metrics can also be predicted with 
computer models. Mathematical descriptions for relationships between measures of 
dose and response within the body has been the starting point for pharmacokinetic 
and toxicokinetic modeling (Andersen and Dennison, 2002). Physiologically based 
pharmacokinetic (PBPK) or toxicokinetic (PBTK) models consist of a series of 
mathematical representations of biological tissues and the physiological processes 
in the body that simulate the absorption, distribution, metabolism and excretion of 
chemicals that enter the body. PBPK models are designed to estimate an internal dose 
or appropriate surrogate dose metric for a target tissue (EPA, 2006). This includes 
the estimation of the time course of the parent chemical or metabolite concentrations 
or amounts in biological fluids, tissues, and excreta (Wagner, 1981). PBPK models 
describe the movement of a chemical throughout the body by sets of mass-balance 
differential equations that account for the disposition of chemical entering the various 
components of the model (Ramsey and Andersen, 1984).  According to Anderssen and 
Dennison (2002), the  potential of PBPK modelling approaches – or more often referred 
to as PBTK when dealing with industrial chemicals instead of pharmaceuticals – is only 
used to a limited extent in occupational health and industrial hygiene (Andersen and 
Dennison, 2002). One of the reasons is that PBTK models are traditionally designed 
specifically for a single substance of interest and require extensive input information. 
1.3 Dealing with variability and uncertainty 
The application of human biomonitoring as a method to assess the internal exposure 
to chemicals in addition to the conventional external exposure assessment methods 
has great potential for risk assessment. However, it is important to know what 
considerations need to be made in the decision to apply this method, in particular 
for modelling purposes. In this thesis, uncertainty and variability in relevant model 
parameters and exposure scenarios are discussed in this context. It has been 
demonstrated that daily air exposure levels within a group of workers performing the 
same job in a specific location vary on average 30-fold. Individual mean exposures were 
on average 4-fold apart and daily averages for an individual worker varied on average 
15-fold (Kromhout, 2002; Kromhout et al., 1993; Rappaport et al., 1993). Variation can 
be observed in both external (ambient air) and internal (biological media) exposure 
media; both measured and predicted by models. It originates from different types of 
uncertainty and variability that have been described in detail by various researchers. 
The most relevant types of variation are discussed from the perspective of chemical 
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exposure assessment for the workplace. 
Uncertainty
Two dominant sources of uncertainty are model uncertainty and parameter uncertainty. 
Model uncertainty results from discrepancies between how processes are simulated 
in a model and the occurrence of these processes in reality. Model assumptions and 
simplifications are examples of model uncertainty (Knol et al., 2009; Ragas et al., 
2009; Schinkel, 2013). Parameter uncertainty relates to the input parameters of a 
model. It is a reflection of a lack of knowledge about the true value of a parameter 
which can be caused by factors such as random and systematic errors in input data 
(Cullen, 1998; EPA, 2011; Morgan, 1990). In principle, uncertainty can be reduced, 
such as by more precise measurements (Nestorov, 2001; Ragas, 2009; Ragas et al., 
2009).    
Variability
Variability can be divided in interindividual variability, intra-individual variability and 
interspecies variability. The latter is not described in this context, since only human 
exposure is considered. Variability can be described, but not reduced (Nestorov, 
2001).Interindividual (or between worker) variability is mainly caused by physiological 
differences between individuals, which has a physiological foundation and is found in 
any population. Individual behaviour, such as an individual’s activity pattern, will also 
influence interindividual variation in external exposure concentrations. Interindividual 
variation in biomarker levels is influenced by the external exposure and intake of a 
substance. Physiological factors related to uptake, distribution, metabolism and 
elimination may also influence interindividual variation. Additional factors such 
as age, ethnicity and gender, anthropometric and genetic differences and life-style 
factors also play a role (EPA, 2011; Spaan et al., 2010). Intra-individual variability (also 
referred to as within-worker variability) is in particular of interest when variation in 
exposure due to fluctuations in working conditions, production characteristics or 
behaviour for a given individual is the subject of study. Spatial or temporal factors, 
such as closer proximity to an emission source or day-to-day variation, may affect both 
interindividual variability and intra-individual variability (EPA, 2011; Kromhout, 2002; 
Ragas et al., 2009). Environmental and production factors have been shown to have a 
distinct influence on the intra-individual variability (Kromhout, 2002; Kromhout et al., 
1993; Rappaport et al., 1993).
Chapter 1
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Table 1 - Types of uncertainty and variability that are identified in this thesis.
Separate quantification of uncertainty and variability
Nowadays, estimating the uncertainty in model predictions by means of probabilistic 
simulations is widely implemented (Barton, 2007; Loizou et al., 2008). Monte Carlo 
simulation, a statistical method that consists of repeatedly random sampling from 
predefined input distributions to obtain a probability distribution of the output 
parameter, is often used to propagate uncertainty in input parameters to model 
outcomes (Huijbregts et al., 2000). Introduction of this type of modelling techniques 
in exposure assessment dramatically improved the understanding of the influence 
of parameter uncertainties on model outcomes. This has lead to a shift from a 
conservative approach with unrealistically high estimates of exposures to an informed 
approach quantifying a distribution of more realistic estimates (Paustenbach, 2000).
 Despite several initiatives to define the different sources of variation in 
measured and modelled data, only occasionally an explicit distinction has been made 
between variation caused by variability or by uncertainty components. Typical sources 
of variability are physiological differences between individuals or working conditions, 
whereas sources of uncertainty may concern parameter values in applied models. 
Consequently, there is need for a better understanding of the separate impacts of 
uncertainty and variability on estimates from exposure models to be able to interpret 
model outcomes for risk assessment purposes (WHO, 2008).
Types of uncertainty Sources Examples 
model uncertainty model structure, assumptions, 
approximations, equations
QSARs (for partitioning)
parameter uncertainty measurement errors, analytical 
errors, misclassification
determination of vapour pressure
Types of variability Sources  Examples 
interindividual variability 
(between worker, within group)
human physiology, behaviour, 
susceptibility 
body weight, metabolic capacity, 
gender, activity pattern, genetic 
predisposition
worker exposure factors (spatial) work organisation, workplace 
design , workstyle
intraindividual variability (within 
worker)
production exposure factors 
(temporal)
Production planning and 
organisation, between and within 
day variation
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1.4 Aim and outline 
The overall aim of this thesis is to improve chemical exposure assessment for the 
workplace by quantification of sources of uncertainty and variability in various 
exposure settings. This aim is elaborated around two themes.
From measuring  to empirical modelling
 In Chapter 2 a field comparison of widely used inhalable aerosol samplers 
in the European rubber manufacturing industry was described. In this industry large 
amounts of measurement data are available. However different aerosol samplers 
are used to collect these measurements. Differences in performance ratios of these 
aerosol samplers introduce uncertainty in the aggregation of measurement data into 
large datasets to be used for retrospective exposure and time trend modelling. An 
empirical statistical model was developed to quantify the performance ratios of these 
samplers in order to decrease parameter uncertainty due to measurement errors.
 Chapter 3 described how a limited number of personal air measurements, 
collected among bricklaying students at vocational training centres for future 
construction workers, can be used to characterize determinants of exposure to 
respirable dust and crystalline silica from trial mortar. An empirical statistical model 
was developed to quantify the dominant sources of interindividual and intra-individual 
variability in the measured exposure concentration in the studied population. 
Dealing with uncertainty and variability
 In the application of models variation in outcomes due to sources of variability 
and uncertainty need to be taken into account. Chapter 4 described a method to 
separate parameter uncertainty and interindividual variability in the predictions of the 
generic human physiologically-based pharmacokinetic (PBPK) model BIONORMTOX 
by means of nested Monte Carlo simulations. In this chapter, the concentration of 
acetone in human blood was simulated during and after 4 hours of exposure to 
2-propanol via air and compared to measured exposure data. Sources of uncertainty 
and variability were identified and quantified separately. This study illustrates how 
separating information on uncertainty and variability can help decision makers to 
interpret modelled results.
 To support chemical risk assessment by means of human biomonitoring, 
reference values need to be derived that are coherent for both external and internal 
exposure levels.  Chapter 5  demonstrated how the BIONORMTOX model can be 
applied to evaluate coherence between occupational exposure limits (OELs) and their 
corresponding biological limit values (BLVs). Internal concentrations of 2-propanol 
and acetone were simulated after inhalation exposure at the level of their OELs. The 
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fraction of workers with predicted internal concentrations lower than the BLV, i.e. the 
´false negatives´, was taken as a measure for incoherence. The impact of variability 
and uncertainty in input parameters was separated by means of nested Monte Carlo 
simulation.
 In chapter 6 a case study was described on the application of PBPK modelling 
combined with measured biomonitoring data to backtrack the air concentration of 
acrylonitrile (ACN) during a chemical incident. Reversed dosimetry was applied in 
combination with nested Monte Carlo simulation to quantify the variation in the 
predicted air concentrations as a result of uncertainty in chemical-specific input data 
and variability in physiological parameters. Factors that had a significant influence on 
the variation were identified to support the application of the method as demonstrated. 
Finally, in chapter 7 additional model simulations were presented for a number of 
typical exposure scenarios in which internal chemical concentrations were assessed. In 
accordance with the practice of chemical exposure assessment, variation in workplace 
air concentrations was also taken into account in the quantification of sources of 
variability and uncertainty in the predicted internal concentrations in these scenarios. 
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Abstract 
Several studies have been done in Europe to evaluate exposure to dust and fumes 
in the rubber industry. However, different aerosol sampling devices have been used 
which perform differently depending on the environmental conditions and particle 
size distribution. To compare measurements of rubber dust and fumes among 
countries and surveys we initiated a field comparison of personal inhalable samplers 
using a novel reference inhalable aerosol sampler (CALTOOL). Measurements were 
done in four factories in the Netherlands, Sweden, Poland and Germany in the  mixing 
and milling and curing department. The Seven-hole sampler, PAS-6 sampler, Millipore 
(25 and 37 mm) cassette, IOM sampler and a Polish sampler were mounted on the 
reference CALTOOL device and used simultaneously. All samplers except the IOM 
sampler undersampled inhalable dust. To compare measurements from different 
studies and countries, correction factors should be applied to all but the IOM sampler, 
which was the only sampler that performed similar to the CALTOOL  sampler.
2.1 Introduction
Several studies, larger and smaller, have been done in European countries in the past 
decades evaluating exposure to rubber dust and fumes (Dost et al., 2000; Vermeulen 
et al., 2000a; Fracasso et al.,  1999; Meijer et al., 1998; Kromhout et al., 1994; 
Rogaczewska and Ligocka, 1994; Szadkowska-Stanczyk et al., 2001). A considerable 
number of different sampling devices were used to measure inhalable aerosols. It has 
been shown that different personal samplers for inhalable aerosols perform differently 
depending on environmental conditions and particle size distribution (Kenny et al., 
1997; Ter Kuile, 1984; Li et al., 2000; Witscher et al., 2004; Aizenberg et al., 2001).
We initiated a field comparison in four countries of several personal inhalable 
samplers applied in the European rubber manufacturing industry. A recently developed 
reference inhalable aerosol sampler, CALTOOL, was used as a reference (D. Mark et 
al., 2003). This was done to compare measured concentrations of inhalable aerosols 
in  a  European Union Concerted Action to retrospectively assess levels of exposure 
and trends in time for rubber dust and fumes as well as for other chemicals in the 
rubber manufacturing industry throughout Europe — the EXASRUB project (De Vocht 
et al., 2005).
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2.2 Materials and methods 
Measurement strategy
Total inhalable aerosol was measured in four rubber manufacturing factories in the 
Netherlands, Poland, Sweden and Germany producing tires, rubber boots or technical 
rubber goods (Table 1). Each factory was visited for five consecutive working days in 
one week, resulting in 20 sampling days in total. Measurements were done for 6–7 h 
within one work-shift to (1) provide an estimate of exposure to inhalable aerosols for 
an entire working day and (2) ensure that the quantity of collected inhalable dust was 
above the limit of detection (LOD) in all samplers tested.
Table 1 Characteristics of factories and time period when measurements were done
Measurements were done in the milling and mixing departments where predominantly 
larger particles (dae>10 μm) are generated in the handling and milling and mixing of 
chemicals, and in the curing departments where primarily smaller particulates (dae <10 
μm) (rubber fumes) are generated  as a result of the vulcanising of rubber products. 
Except in the Swedish factory, where fnal curing of products did not take place, 
measurements were done in the milling and mixing and in the curing departments 
simultaneously using two identical CALTOOL devices. The CALTOOL devices were 
placed close to the Banbury mixer within the mixing and milling departments and 
close to the curing presses in curing departments in the vicinity of the working area 
of an employee without impeding their work. In the Swedish factory, the second 
CALTOOL device was placed in another  mixing  and  milling department in the vicinity 
of the opening of a Banbury  mixer.
Country Date Production Departments
The Netherlands 23–27 June Tires for cars and agricultural 
machines
Milling and mixing/curing
Poland 7–11 July Rubber boots  Milling and mixing/curing
Sweden 18–22 August Technical rubber goods 
(building industry)
Milling and mixing
Germany 6–10 October Technical rubber goods 
(automotive industry) 
Milling and mixing/curing
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Samplers
As a reference sampler for measuring inhalable aerosols, the CALTOOL device was 
used (Mark, 2003). This is a life-size aluminium mannequin equipped with its own 
internal sampling device in the ‘‘head’’ of the CALTOOL. It was developed as a 
standard to ensure that inhalable aerosols are  measured  conform the internationally 
standardized ISO-ACGIH-CEN inhalability convention (CEN 1993; ISO 1995; ACGIH, 
1999).
Fig. 1 The CALTOOL device equipped with the different personal samplers (Note: the 
Millipore 25 mm cassette is shown closed-faced in figure, but was used open-faced in this 
study)
The CALTOOL cassette with a filter diameter of 47 mm is placed in a plastic cassette 
holder, which is connected to the inlet of the pump of the CALTOOL device. An airflow 
of 20 l/min is used to mimic the average human respiration rate (EPA, 1997; Mark, 
2003). It was developed as a standard for measuring inhalable aerosols and has 
been extensively tested in a wind tunnel and a calm air chamber with different wind 
speeds and aerosol particle sizes. In addition, it has also been tested in a variety of 
workplaces (Kromhout et al., 2005) using several types of personal samplers. The 
body of the CALTOOL can accomodate a number of personal samplers for comparing 
the performance of these samplers in situ under different conditions with the 
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standardized performance of the CALTOOL.
In this study, the CALTOOL was equipped with six personal samplers (Fig. 1), which 
have been used extensively in different countries in the European rubber manufacturing 
industry during the past three decades (Dost et al., 2000; Vermeulen et al., 2000a; 
Fracasso et al., 1999; Meijer et al., 1998; Kromhout et al., 1994; Roga- czewska and 
Ligocka, 1994; Szadkowska-Stanczyk et al., 2001): Seven-hole sampler (SKC Inc.) 
aspired at a flow rate of 2 l/min through seven equally spaced orifces of 4 mm. It was 
placed on the chest, pointing outwards (Kenny et al., 1997); PAS-6 sampler (ter Kuile, 
1984) is positioned at the clavicle with the orifice hanging downwards, ascribed at a 
flow of 2 l/min (Kenny et al., 1997). In our study two PAS-6 samplers were positioned 
on the CALTOOL, one on the left and one on the right clavicle, to analyse possible 
differences in measured concentrations caused by the position of the CALTOOL 
compared to the aerosol source. Millipore filter cassette (Millipore Inc, USA)  with a 
diameter of 25 mm. This sampler has been used open- faced with a flow rate of 2 l/
min, and was positioned on the clavicle, the opening  pointing  downwards (Li et al. 
2000).
Millipore filter cassette (Millipore Inc) with a diameter of 37 mm, but otherwise 
identical to the cassette with a diameter of 25 mm. It has been used open-faced with 
a flow rate of 2 l/min, and was also positioned on the clavicle, the opening pointing 
downwards (Witscher et al., 2004).
IOM personal inhalable sampler (Mark and Vincent, 1986) was positioned on the 
chest with the opening facing outwards (Kenny et al., 1997; Li et al. 2000) using a flow 
rate of 2 l/min.
The sixth sampler, henceforth indicated as ‘‘Polish Sampler’’, has been used in the 
Polish rubber manufacturing industry in the past. This sampler has an opening of 
42 mm. Inside, a 50 mm filter is placed on top of a supporting plastic grid covered 
by a plastic ring. It was used for stationary measurements in Poland with a flow rate 
between 20 and 50 l/min and with a flow rate of 2 l/min for personal measurements. 
The latter was used in this study. Although widely used in the Polish rubber industry, 
information about the use of this sampler was not available. Three samplers were 
connected to the outlets of the pump in the CALTOOL and the other three were 
connected to three additional Gilian GilAir 5 pumps suspended on a belt around the 
waist of the CALTOOL device.
In  addition,  (7)  the  CALTOOL  was  also  equipped with the Respicon sampler® 
(Koch et al., 2002) for confirming of the particle size distribution.  All samplers were 
placed on fixed positions on the CALTOOL  device as specified by the manufacturers/
developers of the sampling  heads (see above).
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Quality control
Whatmann GF/A glass fibre filters were used for all samplers, the diameter depending 
on the type of sampler (25, 37, 47 or 50 mm). Before use, the filters were conditioned 
in a temperature (20–23°C) and relative humidity (35 ± 5%) controlled environmental 
clean room for at least 12 h. After discharging the filters, they were pre-weighted twice 
on an analytical Mettler AX105 balance with a resolution of 10 μg. After sampling, this 
gravimetrical procedure was repeated and the difference between the pre- and post-
weighting weights was used to calculate the concentration of inhalable aerosols.
Per type of sampler one field blank per day was included. These blanks were handled 
similar to the exposed filters; they were also placed in the samplers and kept there 
during the whole day, but without connecting them to a pump. The differences 
between the pre- and post-weights were corrected for the average weightloss of the 
field blanks for the particular sampler type. Furthermore, to analyse possible influence 
of instabilities in climatic conditions in the room where all filters were weighed, control 
filters for each filter type used in the study were kept in this room and were weighed 
every weighing session. Differences in the filter weight of these control filters were 
found to be less than 1%.
Also, the flow rate of the different outlets of the CALTOOL device, as well as the flow 
of the Gillian GilAir pumps were checked before and after each measurement, using 
calibrated flow meters. An average of the start and the end flow rates was used in the 
calculations of the inhalable aerosol concentrations (difference smaller than 10% for 
93% of measurements).
Environmental conditions
Temperature and relative humidity were measured in the workplaces once during each 
sampling day with a SOLOMAT MPM2000 thermo- and hygrometer. Furthermore, 
wind speed was measured at both 5 and 50 cm away from the orifce of the CALTOOL 
device in three spatial directions.
Performance ratios
General linear mixed models (GLMM; McCulloch and Searle 2001) were used 
to calculate performance ratios, taking into account the repeated nature of the 
measurements in a factory. A ratio smaller than one indicates undersampling of the 
personal sampler and a ratio larger than one indicates over-sampling of the personal 
sampler relative to the CALTOOL sampler. Shapiro- Wilks tests (range WSW = 0.36 – 
0.98) and graphical analysis indicated that the ratios per sampler were in general not 
normally distributed and included a number of outliers for each of the samplers. Log-
transforming these ratios resulted in an approximately normal distribution (sampler 
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range WSW = 0.74 – 0.95). In addition, possible confounding factors that could influence 
the performance of the samplers (i.e.: distance to source, relative humidity, wind 
speed and direction, and temperature) were also analysed in multivariate GLMMs. 
Distance to the source was added to the GLMM as a dummy variable dividing the 
distance from the CALTOOL device to the source into a near field area (<1 m from the 
source) and a far field area (>1 m from the source) (Cherrie et al., 1996). This resulted 
in the following general model to estimate performance ratios:
with:
lnratio Log transformed performance ratio
β00 Intercept, or average performance ratio
β10 Deviance of ratio from overall ratio for each sampler
β20 Other factors that could influence performance (distance to source, wind  
 speed, etc.)
bfactory Between factory variance (random effect)
εij Residual, within factory variance component
Because of the differences in particle size distributions in mixing and milling 
departments and in curing departments, two separate statistical models were 
elaborated. All statistical analyses were  conducted using SAS statistical software. 
Furthermore, models were fitted using a compound symmetric within-factory 
covariance matrix and an unstructured between-factory covariance matrix. Akaike’s 
Criteria diagnostic values were used to compare the fit of different models.
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Table 2 Limit of detection (LOD) (three times the standard deviation above the average 
value of the blanks) per country and absolute average differences and standard deviations 
of filter weighing in mg/m3 per sampler
a Average of PAS-6 on the left and PAS-6 on the right shoulder
2.3 Results
The differences in concentrations measured with the PAS-6 samplers on the left and 
the right clavicle of the CALTOOL device were small, with a median relative difference 
of 30% (n=23) and a coefficient of variation of 26%. Nine percent of all measurements 
were below the LOD (three times the standard deviation of the average value of the 
blanks; range 0.03–0.30 mg/m3 (Table 2)); ranging from 5% in Sweden, 6% in Poland, 
7% in Germany and 15% in the Netherlands. These measurements were removed 
from the analyses because replacing them with LOD/√2 would bias estimates of 
performance ratios. Differences in filter weighing between the two pre- and post-
weighing determinations were minimal (Table 2), with a largest absolute difference 
of 0.09 mg/m3. Conditions during the measurement surveys are described in Table 3. 
Temperatures during the measurements in the Netherlands were approximately 10°C 
higher than in the other countries. Relative humidity ranged from 32 to 59% and was 
approximately 10% higher in Poland than in the other countries. Wind speed at 5 and 
50 cm was low, with 49% of observations below 0.10 m/s, 83% below 0.25 m/s, and 
one situation where the wind speed was higher than 0.50 m/s.
 The majority of samples where collected in the mixing and milling 
departments (n=216). Sixty five measurements were taken in the curing departments 
in the Netherlands, Germany and Poland. Summary statistics for all measurements are 
presented in Table 4 and are shown graphically per country in Fig. 2 as well (CALTOOL 
measurements only). Overall, measured concentrations were highest in Poland [0.25–
CALTOOL IOM
Mil 37 
mm
Mil 25 
mm
Seven 
Hole
Polish PAS6a
The Netherlands 0.23 0.30 0.06 0.10 0.04 0.09 0.04
Poland 0.19 0.05 0.10 0.04 0.05 0.11 0.15
Sweden 0.11 0.11 0.06 0.11 0.11 0.25 0.00
Germany 0.09 0.21 0.06 0.06 0.06 0.03 0.16
Weighing difference between first and second determination
Average 0.02 0.01 0.00 0.01 0.00 0.01 0.03
Standard 
deviation
0.06 0.02 0.04 0.02 0.02 0.03 0.03
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1.82 mg/m3 geometric mean (GM)], with measurements in the Netherlands [0.12–
0.80  mg/m3 (GM)], Sweden [0.16–0.52 mg/m3 (GM)] and Germany [0.29–0.83 mg/
m3 (GM)] comparable at approximately a factor 2 lower. In the curing departments, 
the highest concentrations of inhalable  aerosols  were  measured  in  Germany  [0.29–
0.64 mg/m3 (GM)].
Differences in average concentrations between personal samplers were up to 
twofold. The IOM sampler measured the highest concentrations (GM=0.72 mg/m3) 
of inhalable aerosols, followed by the CALTOOL (GM=0.57 mg/m3) measurements, 
PAS-6 (GM=0.55 mg/m3 (average of left and right clavicle)), Seven- hole sampler 
(GM=0.42 mg/m3), Millipore 37 mm cassette (GM=0.41 mg/m3), Millipore 25 mm 
cassette (GM=0.38 mg/m3), and the lowest concentrations were measured by the 
Polish sampler (GM=0.33 mg/m3).
Geometric means (GM) and geometric standard deviations (GSD) of the raw 
performance ratios are shown in Table 5. Results of these univariate analyses show 
that, except for performance of the IOM sampler, all samplers under-sample relative 
to the CALTOOL. Furthermore, the smallest GSD is also found for the seven-hole 
sampler and IOM sampler (1.41) and the largest GSD for the Polish sampler (1.69).
The results of the  statistical  models  are  presented in Table 6 and the estimated 
performance ratios in Table 7. The residuals of the statistical models were approximately 
normally distributed for both models. As shown in Table 6, differences in performance 
ratios are primarily caused by temporal differences within the factories  (r2  = 0.16  and 
0.09  for  mixing  and  milling)
Table 3  Range in  wind  speed, relative  humidity and  temperature during  measurements 
in each country
NO not observed 
Country Date
Wind speed at 5 
cm (min–max) 
(m/s)
Wind speed at 50 cm 
(min–max) (m/s)
Relative 
humidity 
(min–max) 
(%)
Temperature 
(min–max) 
(°C)
Netherlands 23–27 June 0.00–0.07 NO 32–34 34.0–40.0
Poland 7–11 July 0.15–0.35 0.11–0.25 47–59 22.7–25.0
Sweden 18–22 August 0.00–0.69 0.00–0.26 38–49 22.7–29.0
Germany 6–10 October 0.00–0.17 0.00–0.26 32–45 21.0–34.0
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Table 4 Number of measurements (n), geometric mean (GM) concentrations in mg/m3 
and geometric standard deviation (GSD) per country and sampler type for the mixing and 
milling and curing departments separately
Mixing and milling and curing, respectively), and only to a small extent to differences 
between factories (σ2BF = 0.04 and 0.00). Akaike’s diagnostic values showed that 
the different samplers explained 17% of the unexplained variance in the mixing  and 
milling  departments, while it only  explained 5% in the curing departments. The 
estimated performance ratios relative to the CALTOOL device ranged from 0.51 
(Polish sampler)  to  1.47  (Millipore 25 mm) (Table 7). Closeness to  the  source 
appeared to be of importance for the Millipore  cassettes  (25 and  37 mm)  in  mixing 
and  milling  departments  and performance ratios were approximately twice as high 
Sampler CALTOOL IOM
Mil 37 
mm
Mil 25 
mm
7 Hole Polish PAS6-left PAS6-right
Country Curing
NL
n 4 3 3 3 4 4 2 4
GM 0.28 0.32 0.17 0.18 0.12 0.18 0.29 0.20
GSD 1.41 1.24 1.15 1.37 2.20 1.76 2.11 1.77
POL
n 2 2 1 2 1 1 0 1
GM 0.42 0.31 0.55 0.25 0.56 0.55 – 0.60
GSD 2.01 2.84 - 2.33 – – –
GER
n 5 3 5 2 5 5 3 0
GM 0.47 0.64 0.37 0.29 0.33 0.32 0.32 –
GSD 1.32 1.08 1.14 1.41 1.25 1.34 1.39 –
All
GM 0.38 0.41 0.30 0.22 0.23 0.27 0.31 0.25
GSD 1.52 1.74 1.56 1.61 2.13 1.71 1.56 2.02
Mixing and milling
NL
n 5 3 5 5 5 5 5 5
GM 0.27 0.80 0.31 0.30 0.25 0.24 0.27 0.20
GSD 1.73 1.81 2.72 2.04 1.65 1.71 2.24 2.60
POL
n 8 8 8 8 8 8 8 7
GM 1.57 1.82 0.85 0.86 1.07 0.81 1.12 1.25
GSD 2.10 2.42 1.87 1.97 2.20 1.97 3.08 1.88
SWE
n 10 10 9 10 8 9 10 10
GM 0.52 0.45 0.30 0.29 0.34 0.16 0.38 0.45
GSD 1.62 1.78 1.70 1.82 1.51 2.03 1.69 1.71
GER
n 5 4 5 5 5 5 5 5
GM 0.70 0.83 0.53 0.50 0.67 0.57 0.64 0.74
GSD 1.45 1.12 1.17 1.46 1.66 1.74 1.42 1.49
All
GM 0.67 0.83 0.46 0.44 0.52 0.35 0.53 0.55
GSD 2.27 2.37 2.11 2.12 2.23 2.56 2.49 2.40
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Sampler GM R GSD R
7 Hole 0.68 1.41
IOM 1.04 1.41
Millipore 25 mm 0.65 1.66
Millipore 37 mm 0.67 1.50
PAS6-left 0.73 1.52
Polish sampler 0.54 1.69
in the far field as in the near field: 1.13 versus 0.61 and 1.47 versus 0.63 for the 37 mm 
cassettes and 25 mm cassettes, respectively. All samplers, except the IOM sampler 
with ratios of 1.12 and 1.00 in the mixing and milling and curing departments and 
the Millipore samplers in the far field, respectively, measure less inhalable aerosols 
than the CALTOOL. Small differences in performance ratios were found between both 
departments, but confidence limits of the ratios largely overlapped.
Performance ratios were on average within a factor of two between factories (R95=1.89). 
The performance ratios were more variable from day to day (R95=5.75). Between-factory 
and day-to-day variation in performance ratios was about twice as high in the mixing 
and milling departments (2.61 and 6.44, respectively) than in the curing departments 
(1.19 and 3.68, respectively).
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Fig. 2 Measured inhalable particulate matter (mg/m3) with the CALTOOL sampler in the 
mixing and milling and in the curing departments in a factory, in the Netherlands, Poland, 
Sweden and in Germany
Table 6 Results of statistical models for mixing and milling and for curing departments
2.4 Discussion
This study resulted in 40 runs with in total 281 stationary measurements. Environmental 
conditions in the workplaces that were measured in this study were considered not to 
be different from general conditions, with wind speeds being comparable to average 
wind speeds in a study in 55 work areas covering a wide range of workplaces (Baldwin 
Discussion
This study resulted in 40 runs with in total 281 station-
ary measurements. Environmental conditions in the
workplaces that were measured in this study were con-
sidered not to be diﬀerent from general conditions, with
wind speeds being comparable to average wind speeds in
a study in 55 work areas covering a wide range of
workplaces (Baldwin and Maynard 1998). The measured
inhalabl a rosol concentrations in Poland were two- to
threefold higher than in the Netherlands, Sweden and
Germany. Presumably, this is caused by less up-to-date
technology and exposure control measures. The actual
levels of exposure however, did not have a signiﬁcant
eﬀect on the performance of the samplers, indicating
that at least within the exposure range present in the
surveyed workplaces (<10 mg/m3) the performance ra-
tios for each personal sampler apply to all surveyed
departments and countries, Our study suggests that
performance ratios are, however, somewhat more vari-
able in departments where higher concentrations are
measured as was shown in the diﬀerence in R95 between
the mixing and milling, and the curing departments.
In addition, our data shows that the LOD for both
the IOM sampler and the CALTOOL device were
somewhat higher than for the other samplers (Table 2).
Presumably, the ﬁlters for the CALTOOL device are
larger than those for the other samplers making it more
diﬃcult to stabilize them. The ﬁlters for the IOM sam-
pler on the other hand were weighted in the sampler
cassette, which had been described earlier (Smith et al.
1998; Lide´n and Bergman 2001) to have variable weight
stability.
Univariate analyses of the raw performance ratios
(Table 5) showed that only the geometric standard
deviations of the seven-hole sampler and the IOM
sampler were below 1.50, and have an acceptable degree
of equivalence with the CALTOOL device for sub-
sequent measurements where the measured concentra-
tions are equal to, or lower than, 50% of the limit values
for total inhalable dust in each country (CEN 1998).
None of the d trib tions of the performanc rati s had
a GSD £ 1.30, which was suggested to represent an
acceptable degree of equivalence with the CALTOOL
device for measurements with measured concentration
higher than 50% of the country-speciﬁc occupational
exposure limits (CEN 1998).
Only the IOM had a performance ratio that did not
diﬀer signiﬁcantly from the CALTOOL device and
therefore has a performance in line with the conven-
tion for inhalable aerosol in calm air conditions. Pre-
viously, CALTOOL ﬁeld tests had shown that the
IOM sampler and the PAS-6 samplers performed best
(Kromhout et al. 2006), although the ratios observed
where somewhat higher and suggest slight over-
sampling [IOM: (GM) R=1.33 (n=66); PAS-6: (GM)
R=1.02 (n=28)], which was also noted for the IOM
sampler in the study by Witscher et al. (2004). Per-
formance ratios of the IOM and PAS6 samplers in our
study were somewhat lower; R(GM)=1.07 (n=32) for
the IOM sampler and R(GM)=0.75 (n=32) for the
PAS6 sampler (Table 7); but the relative diﬀerence
between both samplers was similar in to that found in
the study by Kromhout et al. (2006). In our study the
PAS-6 performed signiﬁcantly less than the CAL-
TOOL device, as did the Seven-Hole, the Polish sam-
pler and the Millipore cassettes in near ﬁeld situations.
ble 6 Results of statistical models for mixing and milling and for curi g departments
parameters Mixing and milling (n=145) Curing (n=59)
B SE B SE
Fixed eﬀects
Intercept 0.250 0.127 0.391 0.121
IOM 0.361 0.117 0.384 0.153
Mil 37 mm 0.244 0.121 0.002 0.162
Mil 25 mm 0.215 0.119 0.098 0.170
Seven-hole sampler 0.039 0.117 0.112 0.144
Polish sampler 0.432 0.116 0.045 0.144
Pas 6 (left)L 0.000 0.000
Correction factors
Nearﬁeld Mil 37 mm 0.613 0.248 0.165 0.211
Nearﬁeld Mil25 mm 0.852 0.273 0.023 0.218
Random eﬀects
r2BF 0.037 0.004
r2WF 0.164 0.092
AIC (full model) 172.4 43.2
AIC (intercept only) 210.2 45.4
b=Estimates (in log-space) of the ﬁxed eﬀects in the statistical models (i.e. estimate average performance ratio=e(bintercept+bsampler))
SE=Standard error of parameter estimate (in log-space)
r2BF=Between-factory variance estimate
r2WF=Within-factory variance estimate
AIC=Akaike’s information criterion
626
33
Field comparison of inhalable aerosol samplers applied in the european rubber manufacturing industry
2
and Maynard, 1998). The measured inhalable aerosol concentrations in Poland were 
two- to threefold higher than in the Netherlands, Sweden and Germany. Presumably, 
this is caused by less up-to-date technology and exposure control measures. The actual 
levels of exposure however, did not have a significant effect on the performance of the 
samplers, indicating that at least within the exposure range present in the surveyed 
workplaces (<10 mg/m3) the performance ratios for each personal sampler apply to 
all surveyed departments and countries, Our study suggests that performance ratios 
are, however, somewhat more variable in departments where higher concentrations 
are measured as was shown in the difference in R95 between the mixing and milling, 
and the curing departments.
 In addition, our data shows that the LOD for both the IOM sampler and 
the CALTOOL device were somewhat higher than for the other samplers (Table 2). 
Presumably, the filters for the CALTOOL device are larger than those for the other 
samplers making it more dificult to stabilize them. The filters for the IOM sampler 
on the other hand were weighted in the sampler cassette, which had been described 
earlier (Smith et al., 1998; Liden and Bergman, 2001) to have variable weight stability.
 Univariate analyses of the raw performance ratios (Table 5) showed that only 
the geometric standard deviations of the seven-hole sampler and the IOM sampler 
were below 1.50, and have an acceptable degree of equivalence with the CALTOOL 
device for sub- sequent measurements where the measured concentrations are equal 
to, or lower than, 50% of the limit values for total inhalable dust in each country (CEN 
1998). None of the distributions of the performance ratios had a GSD ≤ 1.30, which 
was suggested to represent an acceptable degree of equivalence with the CALTOOL 
device for measurements with measured concentration higher than 50% of the 
country-specific occupational exposure limits (CEN 1998).
 Only the IOM had a performance ratio that did not differ significantly from 
the CALTOOL device and therefore has a performance in line with the  conven- tion 
for inhalable aerosol in calm air conditions. Previously,  CALTOOL field tests had 
shown that the IOM sampler and the PAS-6 samplers performed best (Kromhout et 
al. 2006), although the ratios observed where somewhat higher and suggest slight 
over- sampling [IOM: (GM) R=1.33 (n=66); PAS-6: (GM) R=1.02 (n=28)], which was 
also noted for the IOM sampler in the study by Witscher et al. (2004). Performance 
ratios of the IOM and PAS6 samplers in our study were somewhat lower; R(GM)=1.07 
(n=32)  for the IOM sampler  and  R(GM)=0.75  (n=32)  for  the PAS6 sampler (Table 
7); but the relative difference between both samplers was similar in to that found in 
the study by Kromhout et al. (2006). In our study the PAS-6 performed significantly 
less than  the  CALTOOL device, as did the Seven-Hole, the Polish sampler and the 
Millipore cassettes in near field situations.
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Table 7 performance ratios and 95% confidence intervals per sampler type estimated with 
the generalized linear mixed model as well as R95s for the milling and mixing departments 
and the curing departments separately, as well as pooled results
Kenny et al. (1997) concluded that the Millipore cassettes under-sample larger 
particles and that their performance increases with decreasing particle size. This 
study supports this statement since distance to a source was a factor influencing 
the Millipore cassettes only. Performance ratios of 0.61 [0.47–0.80] and 0.63 [0.48–
0.82] for the 37 and 25 mm cassettes respectively, suggest under-sampling in near 
field conditions, while performance ratios of 1.13 [0.70–1.81] and 1.47 [0.87– 2.49] 
suggest over-sampling under far field conditions. These differences however were 
not statistically significant. Since most workers in the rubber manufacturing industry 
are usually working in the vicinity of the source, measured concentrations should be 
corrected using near field performance ratios.
 The ratios for the Millipore 37 mm cassettes [R=0.50 and R=0.77 for the 
open-faced and for the closed-faced cassettes, respectively (Kromhout et al., 2006)] 
were similar to somewhat higher than the ratio found in our study, R(GM)=0.5, but the 
ratios in Kromhout et al. were not corrected for closeness to the source. In contrast to 
the results of our study, where distance to the source only affected performance of the 
Millipore cas- settes, the study by Kromhout et al. (2006) surprisingly suggested that 
under field conditions the IOM sampler over-sampled compared to the CALTOOL, 
more under near field conditions [R(GM)=1.34–2.41] than under far field conditions 
[R(GM)=1.02–1.46]. Furthermore, their results also suggest that over-sampling of 
the IOM sampler increases with an increase of the respirable dust fraction, both in 
the near field [R(GM)=1.34 (<10% respirable dust) to R(GM)=2.41 (>40% respirable 
dust)] and in the far field [R(GM)=1.02 (<10% respirable dust) to R(GM)=1.46 (>40% 
respirable dust)]. In our study, however, (Table 7), performance ratios were somewhat 
higher in the mixing and milling departments where predominantly larger particulates 
are generated (R(GM)=1.12 [0.86–1.32]) than in the curing department where primarily 
Kenny et al. (1997) concluded that the Millipore cas-
settes under-sample larger particles and that their
performance increases with decreasing particle size.
This study supports this statement since distance to a
source was a factor inﬂuencing the Millipore cassettes
only. Performance ratios of 0.61 [0.47–0.80] and 0.63
[0.48–0.82] for the 37 and 25 mm cassettes respectively,
suggest under-sampling in near ﬁeld conditions, while
performance ratios of 1.13 [0.70–1.81] and 1.47 [0.87–
2.49] suggest over-sampling under far ﬁeld conditions.
These diﬀerences however were not statistically signif-
icant. Since most workers in the rubber manufacturing
industry are usually working in the vicinity of the
source, measured concentrations should be corrected
using near ﬁeld performance ratios.
The ratios for the Millipore 37 mm asse tes [R=0.50
and R=0.77 for the open-faced and for the closed-faced
cassettes, respectively (Kromhout et al. 2006)] were
similar to somewhat higher than the ratio found in our
study, R(GM)=0.5, but the ratios in Kromhout et al.
wer not orrected for closen ss t the sourc . In con-
trast to the results of our study, where distance to the
source only aﬀected performance of the Millipore cas-
settes, the study by Kromhout et al. (2006) surprisingly
suggested that under ﬁeld conditions the IOM sampler
ov r-sampled c mpared to the CALTOOL, more under
near ﬁeld conditions [R(GM)=1.34–2.41] than under far
ﬁeld conditions [R(GM)=1.02–1.46]. Furthermore, their
results also suggest that over-sampling of the IOM
sampler increases with an increase of the respirable dust
fraction, both in the near ﬁeld [R(GM)=1.34 (<10%
respirable dust) to R(GM)=2.41 (>40% respirable
dust)] and in the far ﬁeld [R(GM)=1.02 (<10% respi-
rable dust) to R(GM)=1.46 (>40% respirable dust)]. In
our study, however, (Table 7), performance ratios were
somewhat higher in the mixing and milling departments
where predominantly larger particulates are generated
(R(GM)=1.12 [0.86–1.32]) than in the curing depart-
ment where primarily smaller particles are formed
(R(GM)=1.00 [0.81–1.23]), although the conﬁdence
intervals largely overlap. As in our study, results from
wind tunnel tests by Mark et al. (submitted) also sug-
gested that performance ratios increased with larger
particulates. Previously it had been noted in calm air
chamber tests with six identical samplers placed ‘‘in the
breathing zone’’ of a CALTOOL measuring particulates
emitted from a source in front of the lower chest of the
CALTOOL and a momentum directed upward, that
concentrations measured at diﬀerent positions on the
CALTOOL could diﬀer by a factor of 3, but may extend
up to 10–100, depending on the particular circumstances
(Mark et al. 2003). In our study however, smaller dif-
ferences were found between inhalable aerosol concen-
trations measured by two PAS-6 samplers on the left
shoulder and right sh ulder, resulting in an average
diﬀerence of less than 30%. Presumably the variation in
our study was smaller than that found in the study by
Mark et al. (2003) since we did not measure near point
sources. Diﬀerent industries and working conditions
presumably generate exposure to diﬀerent particle size
distributions and consequently diﬀerent performance
ratios of the samplers (Kenny et al. 1997).
Similar to the results of this study, earlier wind tunnel
tests by Kenny et al. (1997) also showed under-sampling
of the inhalable fraction by the Seven-hole sampler. A
study in a calm air chamber by Witscher et al. (2004)
showed that the Millipore 25 mm cassette considerably
under-sampled larger particles (>10 lm) and had an
eﬃciency of only 7% for particles of 40–100 lm. How-
ever, both the Seven-hole sampler an the Millipore
25 mm cassette have not been compared previously
under ﬁeld conditions with the CALTOOL device. To
our knowledge, the performance of the Polish sampler
has also not been evaluated previously.
Applicati n of the CALTOOL correction factors in-
creases the diﬀerences between measured concentrations
of inhalable aerosols already present between the
Netherlands, Germany, Poland and Sweden (Fig. 3).
Table 7 performance ratios and 95% conﬁdence intervals per sampler type estimated with the generalized linear mixed model as well as
R95s for the milling and mixing departments and the curing departments separately, as well as pooled results
Performance ratiosa with 95% conﬁdence intervals
Personal sampler Milling and Mixing (n=145) Curing (n=59) Pooled (n=204)
IOM 1.12 (0.86–1.32) 1.00 (0.81–1.23)
Millipore 37 mm cassette - 0.71 (0.58–0.87) 0.67 (0.54–0.84)
Farﬁeld (n=9) 1.13 (0.70–1.81) –
Nearﬁeld (n=26) 0.61 (0.47–0.80) –
Millipore 25 mm – 0.61 (0.49–0.75) 0.66 (0.53–0.83)
Farﬁeld (n=9) 1.47 (0.87–2.49) –
Nearﬁeld (n=25) 0.63 (0.48–0.82) –
Seven-hole 0.75 (0.58–0.97) 0.61 (0.50–0.73) 0.68 (0.54–0.85)
Polish sampler 0.51 (0.39–0.65) 0.65 (0.54–0.78) 0.54 (0.43–0.67)
PAS 6 0.78 (0.61–1.00) 0.68 (0.53–0.86) 0.75 (0.59–0.94)
R95 between factoriesb 2.61 1.19 1.89
R95 between daysb 6.44 3.68 5.75
aEstimates from mixed-eﬀects models
bR95=exp((2·1.96)·�variancebetween-factory)
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smaller particles  are formed (R(GM)=1.00 [0.81–1.23]), although the confidence 
intervals largely overlap. As in our study, results from wind tunnel tests by Mark et 
al. (2003) also suggested that performance ratios increased with larger particulates. 
Previously it had been noted in calm air chamber tests with six identical samplers 
placed ‘‘in the breathing zone’’ of a CALTOOL measuring particulates emitted from a 
source in front of the lower chest of the CALTOOL and a momentum directed upward, 
that concentrations measured at different positions on  the CALTOOL could differ by 
a factor of 3, but may extend up to 10–100, depending on the particular circumstances 
(Mark et al., 2003). In our study however, smaller differences were found between 
inhalable aerosol concentrations measured by two PAS-6 samplers on the left shoulder 
and right shoulder, resulting in an average difference of less than 30%. Presumably 
the variation in our study was smaller than that found in the study by Mark et al. 
(2003) since we did not measure near point sources. Different industries and working 
conditions presumably generate exposure to different particle size distributions and 
consequently different performance ratios of the samplers (Kenny et al., 1997).
 Similar to the results of this study, earlier wind tunnel tests by Kenny et 
al. (1997) also showed under-sampling of the inhalable fraction by the Seven-hole 
sampler. A study in a calm air chamber by Witscher et al. (2004) showed that the 
Millipore 25 mm cassette considerably under-sampled larger particles (>10 μm) and 
had an eficiency of only 7% for particles of 40–100 μm. However, both the Seven-hole 
sampler and the Millipore 25 mm cassette have not been compared previously under 
field conditions with the CALTOOL device. To our knowledge, the performance of the 
Polish sampler has also not been evaluated previously.
Application of the CALTOOL correction factors increases the differences between 
measured concentrations of inhalable aerosols already present between the 
Netherlands, Germany, Poland  and Sweden (Fig. 3).
This suggests that differences in manufacturing technology and exposure control 
technology between the countries in the European Union might be larger than expected 
and they might have been partly hidden by differences in used personal samplers in 
the specific countries.
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Fig. 3 Measured inhalable particulate matter (mg/m3) with and without the CALTOOL 
correction factor. Measurements with the PAS-6 sampler (Netherlands), the Seven-hole 
sampler (Germany), the Polish sampler (Poland) and the Millipore 37 mm cassette 
(Sweden)
2.5 Conclusion
In conclusion, our results show that there are significant differences in the 
performance of several personal inhalable aerosol samplers under field conditions in 
different departments in the European rubber manufacturing industry. Consequently, 
studies on levels of exposure to rubber dust and fumes in different countries cannot 
be compared directly. However, performance ratios appeared to be stable and can be 
used to adjust measurements in the rubber manufacturing industry done with the 
IOM, the Seven-Hole, the PAS-6, the  Millipore  25 and 37 mm open-face or the Polish 
sampler to CALTOOL-concentrations, which can mutually be compared.
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Abstract 
Background Construction workers are educated at vocational training centers before 
they begin their working lives. Future bricklayers and their instructors are exposed to 
respirable dust and possibly to hazardous respirable crystalline silica from trial mortar.
 
Method Thirty-six personal air samples were collected at 6 training centers to estimate 
exposure to respirable dust for both students and teachers. A selection of 22 samples 
was analyzed for crystalline silica.
Results Average respirable dust exposures ranged from 0.59 mg/m3 for teachers to 1.45 
mg/m3 for students performing recycling and cleaning tasks. In 45% of the analyzed 
samples, respirable crystalline silica was detected. Exposure to silica remained below 
the Dutch OEL (75 μg/m3).  Exposure was significantly less for teachers than it was 
for students. This effect was found in both types of vocational training centers that 
are present in the Netherlands. Dry sweeping, as performed at all locations in this 
study, contributed considerably to the exposure to respirable dust. A first step in 
reducing exposure to dust and silica at training centers would therefore be to avoid dry 
sweeping. The presence of a dust extraction system, although not optimally designed, 
also significantly lowered exposure.
Conclusions To assess a construction worker’s lifetime exposure to respirable dust 
and crystalline silica, the vocational training period should also be taken into account. 
Several epidemiological studies have shown that time since first exposure can be an 
important risk factor for chronic health effects.
3.1 Introduction
Exposure to respirable crystalline silica in the construction industry has been widely 
recognized as a health hazard (Linch et al., 1998; Linch, 2002; Steenland, 2005). It 
is strongly associated with the incidence of silicosis, and because it has also been 
classified as a human carcinogen, exposure levels should be as low as possible (IARC 
Working Group on the Evaluation of Carcinogenic Risks to Humans, 1997).
 The awareness of the hazardous properties of respirable crystalline silica in 
the construction industry has increased globally over the past years (Lumens and 
Spee, 2001, Flanagan et al., 2006). Subsequently, occupational exposure limits (OELs) 
have been lowered in many countries. 
 As a result, control measures are now available for many tasks in the 
construction industry; however, control measures do not always guarantee that 
exposure levels will be safe (Linch, 2002; Rappaport et al,. 2003; Flanagan et al., 
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2006). Exposure levels in the construction industry still frequently exceed the limits 
(Flynn and Susi, 2003; Tjoe et al., 2003; Flanagan et al., 2006). Also, workers’ behavior 
has been shown to be a relevant determinant of exposure (Lumens and Spee, 2001). 
 From another perspective, it is not only the level of exposure that is relevant 
to avoiding adverse health effects, but also the accumulated exposure over someone’s 
working life in the case of health effects due to chronic exposure. As OELs are based 
on a working life of 40 years, special attention should be paid to exposure starting at 
an early age, which may extend the working life exposure period. Young people (ages 
13 to 16 years) have immature lungs that are especially vulnerable to damage from 
foreign particles, and many construction workers begin their trades in their mid-teens. 
The adverse health effects that occur in a later stage of the working life because of 
exposure at a young age show the relevance of studying a young population (Kreuzer 
et al., 1999). This applies to many sectors with exposure to agents with chronic health 
effects.
 Several authors have studied health effects from hazardous substances 
among apprentices in vocational training programs like car painting (Eifan et al., 
2005), the food industry (Gautrin et al., 2002; Walusiak et al., 2002; Walusiak et al., 
2004), and welding (El-Zein et al., 2003). 
 In this study, we focused on exposure to respirable dust and its crystalline 
silica content among students in vocational training centers in the Netherlands where 
future construction workers are educated and trained. Exposure to respirable dust and 
crystalline silica at training centers (mainly indoors) has, to our knowledge, not been 
studied, as most studies have focused on exposure at construction sites. 
 Concern about dust exposure in vocational schools prompted the 
establishment of a working group, which was initiated by stakeholders representing 
building materials production, education institutions, and Arbouw, the Dutch institute 
for working conditions in the construction industry. As a first step, a questionnaire was 
distributed among all known training centers (N = 340) to get an indication of health 
complaints related to dust exposure and to list the main characteristics of the schools. 
The response to the questionnaire was low (22%), which could be partly because it was 
unknown how many of these training centers actually offered bricklaying education. 
 In the Netherlands, two types of bricklaying training centers are present: 
governmental schools and apprentice workshops. Many young bricklayers take part 
in an apprentice system in which they work 3 or 4 days and go to school 1 or 2 days. 
The apprentice system lasts 2–4 years. During these years young bricklayers spend 
5–32 hr per week at school, depending on their school and the phase of education they 
are in. This system is maintained cooperatively by the construction companies. The 
main differences between governmental schools and apprentice workshops are the 
characteristics of the school buildings. Apprentice workshops tend to be much more 
spacious than the “classical” school buildings of governmental schools. Volumes of 
Chapter 3
44
classrooms therefore differ considerably.
 Although it became clear from the questionnaire that there was concern 
about exposure to dust, it also showed limited use of exposure control measures 
such as vacuum cleaning, wetting of the floor, and controlling of the humidity of the 
classrooms. Furthermore, limited use of personal protective equipment (about 20% 
of the respondents) was reported. 
 Based on the outcomes of the questionnaires, we decided to perform an 
exposure survey to assess exposure to respirable dust and respirable crystalline silica 
at 6 different bricklaying training centers, 4 from governmental schools and 2 from 
apprentice workshops. We focused on exposure of both students and teachers during 
bricklaying and related activities. Possible control measures that had already been 
taken to reduce exposure were also considered.
3.2 Methods
Description of Workplaces and Processes
As part of the education program for future bricklayers, students follow extensive 
practical lessons. During these lessons, students build a variety of pieces to learn 
the various bricklaying techniques and patterns. Work pieces are taken apart after 
completion by the students. 
 Usually 5 to 25 students work in the training rooms during practical lessons. 
Students spend about 5 to 32 hours per week on practical lessons for 2 to 4 years, 
depending on their school year and school type. Teachers usually assist students in 
building work and regularly demonstrate techniques. They also take part in cleaning, 
which is done either after the practical lessons or at the end of the day. In some cases, 
extra cleaning is carried out at the end of the work week. Usually teachers spend about 
20 to 30 hours per week in the training room. Some also teach theory to the students. 
Some teachers have their own office next to and separated from the training room.
 Others do their paperwork at a desk in the training room. 
The following tasks could be distinguished during practical lessons: bricklaying, 
taking apart work pieces, cleaning the building materials (bricks), and cleaning the 
classroom. Most tasks are performed regularly.  Usually a combination of all these 
tasks is carried out during the day. The potential exposure duration to (respirable 
silica) dust for students therefore varies from 5 to 32 hours per week over 2 - 4 years.
Mortar
Student bricklayers use a special trial mortar that does not contain cement and 
therefore does not harden irreversibly. The trial mortar consists of sand with less than 
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10% lime instead of the traditional sand and cement. Pieces of work can easily be 
taken apart after building; therefore, both the trial mortar and bricks can be used many 
times.
Measurement Strategy
Sampling and analysis were carried out in accordance with the code of conduct “Use of 
data in health research” from the Dutch Federation of Biomedical Scientific Societies 
[http://www.federa.org/, accessed 23 September, 2009], which is in accordance with 
EU regulations. Exposure to dust and silica was assessed for both students and 
teachers at 6 training centers for 2 days during an 8-week period. During sampling, 
all relevant tasks were considered, including (1) constructing activities (actual 
bricklaying), (2) recycling activities (including taking apart and cleaning), and (3) a 
combination of these two.
 Other determinants of exposure that were studied included (1) type of training 
center (governmental school or apprentice workshop), (2) type of cleaning (with a 
broom or with a vacuum cleaner), (3) type of materials used, (4) wetting the floor 
before sweeping, (5) presence and use of a dust-extraction (forced-ventilation) system, 
(6) number of students present per classroom during sampling, (7) dimensions of the 
classrooms, and (8) type of floor (wood or cement).
 A dust-extraction system (forced-ventilation) was present at one of the visited 
locations. This is a general ventilation system in which the air is filtered and partly 
recycled. It is also equipped with a flexible hose that can extract dust locally during 
dusty activities. 
 At all locations, personal 6- to 8-hour time-weighted average exposure 
measurements were performed with personal air sampling equipment. For each day, 1 
teacher and 2 students were sampled. Sampling equipment was transferred from one 
student to another student to achieve a 6- to 8-hour measurement, since students did 
not spend the whole working day in the practice classrooms. This was done only for 
similar tasks performed by both students. Teachers were all sampled strictly individual 
for 6 to 8 hours. In this case, the sampling period also included additional tasks such 
as theory lessons for some hours (< 2).  In total, 36 personal measurements were 
collected from teachers (n = 12) and students (n = 24). 
Sampling and Analysis
Respirable dust samples were collected on PVC filters (25 mm, 0.8-μm pores) using 
Dewell Higgins cyclones (Casella) in combination with Gillian Gilair 5 pumps at a flow 
rate of 2.0 L/min. Filters were pre- and post-weighed under conditioned circumstances 
using a Mettler AT261 Delta Range analytical balance (limit of detection: 10 μg). On 
every sampling day, a field blank was taken.
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Initially, 19 of the 36 collected samples were selected to be analyzed for respirable 
crystalline silica. This selection included samples from all different locations and 
all sampled days in this study. In each location, at least 1 sample was analyzed 
representing the personal exposure of the teacher and 2 samples representing the 
students’ exposure. A representation of all performed tasks was selected from the 
student samples. 3 to 4 (out of 6) personal samples per location were analyzed for 
crystalline silica. 
 A selection of 19 filters was sent to an external laboratory for respirable 
crystalline silica analysis by the Fourier transform infrared spectroscopy (FT-IR) 
method [National Institute for Occupational Safety and Health (NIOSH) 2003]. In 
addition, 3 filters were sent to another laboratory for quality control and also analyzed 
by FT-IR. Altogether, 22 of the 36 personal samples were analyzed for respirable 
crystalline silica. 
Data Analysis
All statistical analyses were performed using SAS Version 8.2 software (SAS Institute 
Inc., Cary, NC). Linear mixed models were built using the log-transformed respirable 
dust concentration as the dependent variable and potential exposure affecting factors 
as explanatory variables.
3.3 Results
Respirable Dust
Table 1 presents the main characteristics of all visited locations including measured 
exposure levels to respirable dust.
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Table 1. Overview of Measurement Results and Relevant Characteristics per Training Center
GM = geometric mean; GSD = geometric standard deviation; max = maximum; min = 
minimum; OEL = occupational exposure limits.
a Estimate based on working visit.
Although basically similar activities were studied at 6 comparable locations, a large 
diversity of actual activities and dimensions of classrooms existed (Table 1). Classroom 
area and volume appeared to be larger at apprentice workshops. At these schools, the 
number of students present during the measurements was also lower (maximum 8).
Table 2 shows the descriptive statistics for the exposure to respirable dust distribution 
for both students and teachers. The measurements appeared to be lognormally 
distributed. Duration of the measurements varied from 3 to 8 hours (180 to 480 
minutes).
Table 2. Task-Based Exposure to Respirable Dust in mg/m3 for Both Teachers and Students
AM =  arithmetic mean; GM = geometric mean; GSD = geometric standard deviation; 
max = maximum; min = minimum
School
Type
of school
Classroom
Area (m2) 
/ volume 
(m3)
Cleaning
method
Wet/
dry
Classroom
ventilation
Control measure
Students 
present / 
tested (n)
Dust
Available Used
GM
(min–
max)
GSD
Exceedence 
OEL for 
silica (%)
1
Apprentice 
workshop
400/2,400 Sweeping
Mostly 
dry
Mechanical None — 5-Aug 6
0.78
(0.61–1.30)
1.32 < 0.1
2
Apprentice 
workshop 300/1,800
a
Sweeping, 
vacuum 
cleaning
Dry Natural
Vacuum 
cleaner
On and 
off
4-Aug 6
0.72
(0.37–1.40)
1.64 < 0.1
3 Governmental 256/1,152
Sweeping, 
sweeping 
machine
Mostly 
dry
Mechanical
Dust-
extraction 
system
Full time 5-Dec 6
0.65
(0.24–1.56)
2.11 11.0
4 Governmental 240/1,000 Sweeping
Mostly 
dry
Natural
Electrostatic 
filter
On and 
off
Jun-20 6
1.15
(0.57–1.73)
1.49 < 0.1
5 Governmental 288/1,500 Sweeping Dry Mechanical
Electrostatic 
filter
On and 
off
Mar-25 6
1.43
(0.78–2.17)
1.42 < 0.1
6 Governmental 160/600 Sweeping Dry None
Electrostatic 
filter
During 
breaks
Apr-16 6
0.91
(0.53–1.25)
1.48 < 0.1
Person Task n AM GM GSD Min Max
Teacher Teaching 12 0.65 0.58 1.67 0.24 1.4
Student
Bricklaying only 12 1.12 1.06 1.42 0.56 1.84
Bricklaying and taking apart 6 1.04 0.99 1.37 0.73 1.56
Taking apart only 6 1.50 1.45 1.33 0.99 2.17
All 24 1.20 1.13 1.42 0.56 2.17
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Compared with teachers (GM = 0.58 mg/m3), students are on average exposed to 
nearly a twofold higher level of respirable dust (GM = 1.13 mg/m3). Bricklaying only (GM 
= 1.06 mg/m3) and bricklaying combined with taking apart and recycling tasks (GM 
= 0.99 mg/m3) yielded similar results. Recycling tasks tend to cause higher exposure 
levels (GM = 1.45 mg/m3).  It appears that the variability of exposure concentrations 
within a specific task was relatively low (range of GSDs 1.33–1.67), although data were 
collected from six different locations.
On average, exposure to dust at apprentice workshops was slightly lower, compared 
with governmental schools (Table 3).
Table 3. Exposure to Respirable Dust (mg/m3) per School Type
GM = geometric mean; GSD = geometric standard deviation; max = maximum; min = 
minimum
Brooms were used for cleaning at all locations. Sometimes the classroom floor was 
wet before sweeping to reduce exposure, but this occurred rarely. At some locations, 
a vacuum cleaner or sweeping machine with dust extraction was available (schools 2 
and 3); however, it did not replace all sweeping activities.
Respirable Crystalline Silica
In 10 of 22 analyzed samples, respirable crystalline silica was detected. At every 
location except one, silica was found in at least one sample.
The percentage of respirable crystalline silica in the analyzed respirable dust appeared 
to be relatively low (0.2%–4.0%), although quartz concentrations up to 46 μg/m3 
were measured. The probability of exceeding the OEL for respirable silica (75 μg/m3) 
on a given day varied from 0% (Locations 1, 2, 4, 5, and 6) to 11% (Location 3) (see 
Table 1).
Statistical Analysis 
Linear mixed models were applied to the exposure data to characterize relevant 
determinants of exposure to respirable dust. As teachers were sampled on both 
 School n GM GSD Min Max
Governmental 24 0.99 1.47 0.24 2.17
Apprentice
workshops
12 0.75 1.47 0.37 1.4
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sampling days, per school repeated measurements were available for this group. As 
the sampled students varied from day to day, no repeats were available. Mixed models 
were applied using log-transformed dust concentration as the dependent variable. 
Random factors school and worker (teachers only) were corrected for in the model. 
Table 4 shows all significant determinants (p < 0.05). 
Table 4. Results of Multivariate Regression Analysis for Significant Determinants of Exposure 
to Respirable Dust (p < 0.05)
Se: standard error; * p < 0.05, ** p < 0.01
The model as shown in Table 4 explained 54% of the total variance. Furthermore, 
it explained 79% and 81% of the variability in exposure among schools and among 
individuals within the schools, respectively.
Type of school had a significant effect on average exposure to respirable dust, as was 
also expected on the basis of the data in Table 3. Governmental schools had 55% 
significantly higher respirable dust exposure compared with the apprentice workshops. 
Taking teaching as a reference, all bricklaying and related tasks raised exposure to dust 
significantly with a factor between 1.8 and 2.3. 
 The presence of a dust-extraction system (School 3) resulted in 40% lower 
exposure to respirable dust, although the design of this system could have been more 
effective by focusing on local dust extraction rather than forced ventilation.
 The effects of type of cleaning, type of materials used, wetting the floor and 
type of floor, and the number of students present could not be proven in the collected 
data.
 The small number of positive silica samples excludes a proper analysis of the 
respirable silica results. The correlation between respirable dust concentrations  and 
crystalline silica concentration was not high (r = 0.53). 
Determinant of exposure Effect β (se) Background /  Multiplier
Intercept (background) -0.75 (0.15)* 0.47
Type of school (governmental) 0.44 (0.15)* 1.55
Dust-extraction system present -0.52 (0.20)* 0.60
Bricklaying only 0.58 (0.14)** 1.78
Demolition tasks (taking apart, recycling) 0.82 (0.17)** 2.27
Bricklaying and demolition tasks 0.70 (0.18)** 2.02
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3.4 Discussion 
Measured exposures to respirable dust in this study are moderate (GM = 0.90 mg/
m3, range = 0.24–2.17 mg/m3) compared with exposures in the construction industry 
(Linch et al. 1998; Lumens and Spee 2001; Rappaport 2003; Tjoe et al. 2003; Flanagan 
et al. 2006).
 A twofold difference in exposure concentrations was observed between 
teachers (GM = 0.58 mg/m3) and students (GM = 1.13 mg/m3). This can be explained 
by the fact that teachers were less involved in bricklaying activities than students. 
In addition, some teachers also taught theory lessons, which took place outside the 
bricklaying classrooms.  
 Although various bricklaying and related activities showed some variability in 
respirable dust concentration, their effect seemed to be rather low (GM bricklaying = 
1.06 mg/m3; GM taking apart = 1.45 mg/m3).
 The assessed silica levels in this study do not exceed the Dutch OEL. At five 
of the six locations the probability was below 0.1%, but at one location the probability 
of exceedance of the OEL was estimated to be 11%.
Given that no exposure surveys in similar settings have been performed to our 
knowledge, relating our findings to published data is complicated. Rappaport et 
al. (2003) analyzed exposure data from 36 construction sites in the United States 
and found an average respirable dust exposure for bricklaying activities of 2.13 
mg/m3 (n = 11). These samples also included the use of hand drills, saws, and 
jackhammers. The average exposure level of all bricklaying and related tasks in this 
study (excluding teaching) is lower (1.13 mg/m3), although in the same range. Typical 
for the measurements in our survey, however, is that all activities were performed 
indoors and that no other construction activities were performed in the classrooms. 
Furthermore, no electrical tools such as in Rappaport et al.’s study were being used 
during the measurements.
 Riala (1988) performed a study among construction site cleaners. Exposure 
to respirable dust varied from 2.5 to 4.5 mg/m3 for vacuum cleaning and from 11 to 
21 mg/m3 for dry sweeping. These measurements were task-based with an average 
sampling time of about 90 minutes (Flanagan et al. 2006). Riala’s study demonstrated 
the influence of dry sweeping on exposure to dust and possibly silica. Although at 
one location in this study a vacuum cleaner was sometimes used, dry sweeping was 
carried out at all locations. Dry sweeping probably contributes to a large extent to 
the respirable dust exposure at training centers. Also, wetting the classroom floor 
before sweeping could reduce exposure to dust considerably; this, however, could 
not be demonstrated in the present study because wetting the floor was rarely carried 
out. Spee et al. (1998) showed a 5- to 20-fold reduction of respirable dust exposure 
as a result of watering the floor by spraying before sweeping as compared with dry 
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sweeping. 
 At one location in this study there was a central dust-extraction system. 
Although it was improperly designed, this system resulted in significantly lower (40% 
reduction) exposure levels compared with other locations. Dry sweeping was still 
performed, however, although less frequently compared with other locations.  The 
effect of this extraction system could have been more impressive if no dry sweeping 
would have been performed. Local extraction of dust or vacuum cleaning could  also 
have improved the situation.
 In our survey, respirable silica was detected in 45% of the analyzed filters. As 
mentioned, the fraction of respirable silica in the total respirable dust was relatively 
low (0.2%–4.0%) compared with other studies performed by our research group 
and others in the construction industry and related sectors (Lumens and Spee 2001; 
Rappaport et al. 2003; Tjoe et al. 2003; Flanagan et al. 2006). However, it is in line 
with previous results for construction site cleaners where respirable silica represents 
2% to 6% of the respirable dust (Riala 1988). Although trial mortar is used at training 
centers instead of regular cement-based mortar, both trial mortar and regular mortar 
contain sand, and thus crystalline silica. 
3.5 Conclusions
Students at bricklaying training centers are exposed to moderate levels of respirable 
dust during practice lessons. Exposure does not exceed the current OEL (5 mg/m3 in 
the Netherlands). Teachers are exposed to lower levels of respirable dust but generally 
spend more time in practice classrooms compared with students.
 Silica exposure is likely, although exposure levels have not exceeded the OEL 
(75 μg/m3 in the Netherlands) in this study. 
 Because many dusty activities are performed indoors, a significant decrease 
of exposure would be easily achieved by cleaner techniques. Elimination of dry 
sweeping and a faster cycle of bricklaying and taking down of work pieces to avoid 
drying (and thus an increase of dustiness) of the mortar would reduce exposure to 
dust and silica. Presence of a dust-extraction system would be more beneficial if 
this system is correctly installed and consequently used. Controlling of the humidity 
in the classrooms and wetting the floor before sweeping could also result in lower 
exposure to respirable dust. However,  respirable dust containing crystalline silica 
concentrations in classrooms should be reduced to a minimum therefore cleaning of 
classrooms should  be carried out preferably by use of vacuum cleaners  instead of 
brushes and brooms.
 Although this study does not show alarming results, it is nevertheless 
relevant to aim for reduction of exposure levels in practice classrooms because young 
individuals are involved, who appear to be substantially exposed before the actual 
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start of their careers. In addition, education will form the basis of their working skills, 
behavior, and hygiene for the rest of their working lives.
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Abstract 
Parameter uncertainty and interindividual variability in the predictions of a generic 
human physiologically-based pharmacokinetic (PBPK) model were separated by 
means of nested Monte Carlo simulations. Separate information on uncertainty 
and variability can help decision makers to identify whether they should focus on 
identification of sensitive individuals rather than on additional research to obtain 
more accurate estimates for particular parameters. In this study, the concentration 
of acetone in human blood was simulated during and after 4 hours of exposure to 
2-propanol via air. It was shown that the influence of interindividual variability and 
uncertainty  varies over time, from the uptake phase, via a steady-state phase, into 
the elimination phase. During the uptake phase, interindividual variability played a 
significant role in the predicted variation of acetone concentrations in blood, with 
variability up to a factor of 2 to 3 (90th/10th percentile ratio). After exposure ceased, the 
parameter uncertainty increased up to a factor of 100 after 16 hours, whereas variability 
remained unchanged. Parameter importance analysis indicated that variability in 
human physiology had the largest influence on predicted acetone concentrations 
in blood during exposure. Uncertainty in the metabolic rate of acetone was most 
important after the exposure had ceased and overruled variability. 
4.1 Introduction 
In the past few decades, physiologically based pharmacokinetic (PBPK) modelling 
mainly focused on specific chemicals of high concern (Andersen, 1991; Chiu et al., 
2007; Clewell et al., 2000; Clewell et al., 2001; Ramsey and Andersen, 1984). More 
recently, PBPK models have been developed that can be applied to a wider range 
of chemicals (Barton et al., 2000; Beliveau and Krishnan, 2005; Cahill et al., 2003). 
For instance, Quantitative Structure-Activity Relationships (QSARs) are used to derive 
substance-specific tissue-water partitioning coefficients. Particularly, the first-tier 
exploration of the toxicokinetics of relatively data-poor substances is supported by 
the PBPK models with a wider applicability domain. However, a drawback of generic 
models can be a higher uncertainty in the model outcomes. In order to use PBPK 
models for risk assessment, the most important sources of uncertainty and variability 
need to be characterized (Barton et al., 2007). One type of uncertainty relates to the 
input parameters of a model. Several researchers have identified model parameters 
that significantly influence the outcomes of PBPK models. Brochot et al. (2007) showed 
the blood:air partition coefficient, tissue volumes of well-perfused tissues and the 
metabolic rate to be the main sources of variation in their PBPK model for butadiene. 
Sweeney et al. (2003) found that the metabolic rate was the main source of variation in 
model predictions after oral administration of acrylonitrile, whereas the physiological 
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parameters alveolar ventilation and blood flow to the liver were most important after 
inhalation. Liao et al. (2007) indicated that exposure and physiological parameters 
played a major role in the overall variation of predicted internal concentrations of 
trichloroethylene, whereas substance-specific parameters derived from QSARs played 
a minor role.
Despite several initiatives to point out sources of variation in model predictions, only 
occasionally an explicit distinction has been made between (i) variation caused by 
physiological differences between individuals and (ii) variation caused by uncertainty 
in parameter values (Chiu et al., 2009; Mork et al. 2009). Interindividual variability 
has a physiological foundation and is found in any population. It can be described, 
but not reduced (Nestorov, 2001). Parameter uncertainty reflects a lack of knowledge 
about the true value of a parameter which can be caused by factors such as random 
error, systematic error and a lack of empirical basis (Cullen and Frey, 1998; Morgan 
and Henrion 1990). In principle, uncertainty can be reduced, such as by more precise 
measurements (Ragas et al., 2009a, b; Nestorov, 2001). In this paper we assume that 
variation in model predictions can be caused by interindividual variability, uncertainty 
or a combination of both phenomena.  
Uncertainty analysis is increasingly recognized in the development of PBPK models 
(Barton 2007). One option is to define parameter distributions, for example through 
Bayesian techniques, usually followed by (nested) Monte Carlo simulation. In 
nested Monte Carlo simulation it is possible to quantify the impact of variability and 
uncertainty in parameter distributions separately (US EPA, 2001; Ragas et al. 2009a). 
The aim of the present paper is to separate and quantify the influence of interindividual 
variability and parameter uncertainty on internal body concentrations predicted by an 
existing generic human PBPK model. Nested Monte Carlo simulation was applied 
to separate variability and uncertainty in the model predictions. For the parameter 
estimation we derived distributions based on scientific literature. As a case study, we 
applied the generic PBPK model (IndusChemFate) to simulate occupational exposure 
to the solvent 2-propanol (isopropanol or IPA) and its primary metabolite acetone. 
A comparison between the experimental results of a human exposure study and our 
model results is also provided.
4.2 Materials and methods 
Model structure
The generic Microsoft Excel-based PBPK model IndusChemFate predicts tissue, blood 
and urine concentrations for user-defined exposure settings based on physicochemical 
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and toxicokinetic data (Jongeneelen and Ten Berge, 2011). The structure of the model 
is illustrated in Figure 1. Uptake via inhalation, skin and ingestion can be simulated. 
Physiological parameters, such as blood flow and tissue dimensions, are pre-defined 
in the model and scaled to cardiac output and body weight respectively.
Figure 1. Structure of the generic PBPK model. The continuous lines represent blood flows 
between tissues, whereas the dashed lines represent the exchange of the parent compound 
or metabolites between the respiratory tract and the arterial blood. 
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Michaelis-Menten saturable metabolism is optional in any of the tissues and is 
dependent on the availability of data for the metabolic parameters Vmax (maximum 
velocity of metabolism) and Km (Michaelis-Menten constant) per substance and 
per tissue type. Tubular reabsorption in the kidneys (based on lipophilicity) and 
enterohepatic circulation (based on molecular weight) can be assessed optionally 
in submodels. Dermal absorption of a substance via the skin is incorporated in the 
model based on Ten Berge (2009).
As recommended by Jongeneelen and Ten Berge (2011), the IndusChemFate 
algorithms were updated by implementing a new QSAR for tissue:water partitioning. 
In the present study we included the following QSAR for polar chemicals, as developed 
by Hendriks et al. (2005) (Equation 1). 
Equation 1 – QSAR by Hendriks et al. (2009) :
Ktw = tissue-water partition coefficient
Kow = octanol-water partition coefficient 
pnl,t = percentage of neutral lipid in tissue
ppl,t = percentage of polar lipid in tissue
pp,t = percentage of protein in tissue
pH2O,t = percentage of water in tissue
bnl,t = intercept for neutral lipids
bpl,t = intercept for polar lipids
bp,t = intercept for proteins
anl = affinity exponent for neutral lipid
apl = affinity exponent for polar lipid
ap = affinity exponent for protein
This QSAR calculates the affinity of chemicals for all tissues based on the octanol:water 
partition coefficient and tissue composition by considering the tissue constituents’ 
lipids (both neutral and polar), proteins and water. 
Finally, the representation of the lungs was updated in the IndusChemFate model to 
account for the so-called washin–washout principle for (polar) chemicals, i.e. reduced 
inhalation uptake and higher exhalation in comparison to what is expected based on 
blood:air partition coefficients due to high solubility in water and therefore in mucus 
membranes in the respiratory tract (Johanson, 1991). Bronchioles, alveolae and 
mucosa were included as separate compartments, following Mork et al. (2009) and 
Mork and Johanson (2006) (Figure 1). The washin–washout effect is simulated for 
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the parent compound and possible metabolites separately with the chemical-specific 
blood:air partitioning coefficient and blood:water partitioning coefficient. Details can 
be found  in the supplementary information.
Model parameterisation
Interindividual variability 
Interindividual variability under resting conditions was quantified by assigning 
distributions to physiological parameters based on an extensive literature search 
(Table 1). Physiological parameters were considered to be variable only, as the 
distributions were based on information for a large number of individuals. For all 
physiological parameters except fractions, a lognormal distribution was chosen. 
Lognormally distributed variables have been reported in many scientific fields, 
including measurements of human parameters, such as body weight and blood 
pressure (Gaddum, 1945;  Slob, 1994;  Wayne, 1990). The cardiac output and alveolar 
ventilation parameters were correlated with a correlation coefficient of 0.8 (Levitzky, 
2003). 
Fractions, such as for organ volumes, were described by betaPERT distributions 
because detailed data on the amount of variation were lacking. BetaPERT distributions 
are based on a most likely, a maximum and a minimum value, similar to triangular 
distributions. Unlike a triangular distribution, the betaPERT distribution is smoothed 
around the most likely value. Thus, more emphasis is placed on the most likely value 
to match the normal distribution-shaped curve (Van Hauwermeiren and Vose, 2009). 
The most likely values for the fractional parameters were derived from literature (Table 
1). Minimum and maximum values were estimated based on Price et al. (2003), 
who used the data of the NHANES III survey to estimate interindividual variability 
in physiological parameters. The relationship between most-likely values and their 
extremes was approximately a factor of 1.5 for all tissues, except for adipose tissue, 
for which it was a factor of 3. This information was used to derive the minimum and 
maximum values from the most-likely values reported in literature for all fractional 
parameters. The fractional transfer parameters that describe the blood flow between 
the different lung compartments and the arterial blood in the parameterization of the 
washin-washout principle in the respiratory tract, were based on the data provided by 
Mork et al. (2009). Beta distributions were selected since both mean and standard 
deviation of these data were available. 
Because point values from the original model were replaced by parameter distributions, 
selection of independent values for fractions could lead to a sum of fractions above 
or below 1. To avoid this, the individual fractions were normalised relative to their 
sum (Kooistra et al., 2005). Tissue composition parameters (expressed as fractions of 
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neutral and polar lipids, proteins and water in Equation 1) were determined separately 
for each of the tissues considered and were assumed variable (Schmitt, 2008; see 
Table A-2). 
The metabolic parameters, i.e. the affinity constant (Km) and maximum metabolic rate 
(Vmax) for 2-propanol and acetone, were considered as both variable and uncertain. 
Variation in these parameter values may originate from both interindividual variability, 
such as differences in enzymatic activity between individuals, and uncertainty due 
to differences in experimental design, a limited number of measurements and 
measurement uncertainty. The variability component of Vmax and Km is described by 
lognormal distributions, based on reported interindividual variation in the activity of 
the metabolic enzymes involved, i.e. ADH and Cyp2E1 for 2-propanol and acetone 
respectively (Dorne et al., 2004; Martinez et al., 2010) (Table 1).
Table 1 – Variability distributions of the human physiological parameters and metabolic 
parameters as used in the simulations. Further specification is presented in the supplementary 
information (Table A1).
Description 
of variable
Units
Distribution 
type Specification 
a Population References
Alveolar 
ventilationb 
l/h Lognormal 511 (1.27) adolescent, 
young to middle 
aged, and older 
adult male and 
female subjects 
(n=116)
(Adams, 1993;  
US-EPA, 1997)
Cardiac 
output
l/h Lognormal 390 (1.24) male and female 
subjects (16-56 
years, n=93)
(Milnor, 1990)
Body weight kg Lognormal 71.4 (1.24) (US) male and 
female subjects 
18-75 years, all 
races (n=12504)
(NCHS, 1987;  US-
EPA, 1997)
Thickness of 
epidermis
cm Lognormal 0.0084 (1.22) male and female 
subjects 20-68 
years (median 
47 years, n=71)
(Sandby-Moller 
and Wulf, 2003)
Thickness 
of stratum 
corneum
cm Lognormal 0.0015 (1.37) male and female 
subjects 20-68 
years (median 
47 years, n=71)
(Sandby-Moller 
and Wulf, 2003)
Volume of 
produced 
urine
l/h Lognormal 0.091 (1.51) (US) male and 
female subjects 
(40-79 years, 
n=313)
(Raman et al., 
2004)
Chapter 4
62
Arterial 
fraction
unitless betaPERT 0.251 (0.167, 
0.376)
adult men (40 
years, 75 kg)
(Milnor, 
1968;  Schmid-
Schoenbein and 
Ross, 1990)
Cardiac output fractions to tissues
Adipose 
tissue
unitless betaPERT 0.061 (0.020, 
0.184)
male and female 
subjects with 
apparently 
normal 
circulation (16-
76 years, n=104)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Brain unitless betaPERT 0.117 (0.078, 
0.176)
male and female 
subjects with 
apparently 
normal cerebral 
circulation and 
cardiac function 
(16-79 years, 
n=630)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Heart unitless betaPERT 0.056 (0.037, 
0.083)
male and female 
subjects with 
apparently 
normal 
myocardial 
circulation (20-
69 years, n=274)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Kidneys unitless betaPERT 0.177 (0.118, 
0.265)
normotensive, 
resting male and 
female subjects 
with apparently 
normal renal 
and cardiac 
functions (17-69 
years, n=979)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Liver arterial unitless betaPERT 0.068 (0.046, 
0.103)
young and 
middle aged 
male and female 
subjects with 
normal portal 
pressure (n=35)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Liver venous unitless betaPERT 0.189 (0.126, 
0.283)
healthy male 
and female 
subjects (n=237)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Description 
of variable
Units
Distribution 
type Specification 
a Population References
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Lung unitless betaPERT 0.034 (0.023, 
0.051)
males and 
females, some 
patients under 
examination of 
potential heart 
disease (n=75)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Muscle unitless betaPERT 0.142 (0.095, 
0.214)
healthy male 
and female 
subjects (15-75 
years, n= 713)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Skeleton unitless betaPERT 0.115 (0.077, 
0.173)
healthy male 
and female 
subjects (n=85)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Skin unitless betaPERT 0.059 (0.039, 
0.089)
healthy male 
subjects (15-60 
years, n=146)
(Leggett et al., 
1996;  Williams 
and Leggett, 1989)
Tissue volume fractions of total volumes
Adipose 
tissue
unitless betaPERT 0.187 (0.062, 
0.561)
males (n=64) 
and females 
(n=76), aged 
23.44 ± 1.26 
years
(Stokic et al., 
2002)
Blood unitless betaPERT 0.071 (0.047, 
0.106)
adult male and 
female subjects 
(n=16)
(Wadsworth, 
1954;  Yiengst and 
Shock, 1962)
Bone unitless betaPERT 0.075 (0.050, 
0.113)
male and female 
subjects (16 - 86 
years; females: 
43.5-55.2 kg, 
males: 59.6-65 
kg) (n=13)
(Woodard and 
Holodny, 1960)
Brain unitless betaPERT 0.021 (0.014, 
0.032)
Male and female 
subjects (21-39 
years, n=552)
(Dekaban, 1978)
Heart unitless betaPERT 0.005 (0.003, 
0.008)
male and female 
subjects (16-65 
years, n=60)
(Olivetti et al., 
1995;  Snyder et 
al., 1975)
Intestines unitless betaPERT 0.016 (0.011, 
0.024)
male and female 
adult subjects 
(Snyder et al., 
1975)
Kidney unitless betaPERT 0.004 (0.003, 
0.006)
male and female 
subjects (20-40 
years, (n=3428)
(Snyder et al., 
1975)
Liver unitless betaPERT 0.023 (0.015, 
0.034)
male and female 
subjects (18-59 
years, n=367)
(Snyder et al., 
1975)
Description 
of variable
Units
Distribution 
type Specification 
a Population References
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Lung unitless betaPERT 0.014 (0.009, 
0.021)
male and female 
subjects (18-40 
years, n=516)
(Snyder et al., 
1975)
Marrow unitless betaPERT 0.047 (0.031, 
0.071)
male and female 
subjects (16 - 86 
years; females: 
43.5-55.2 kg, 
males: 59.6-65 
kg; n=13)
(Woodard and 
Holodny, 1960)
Muscle unitless betaPERT 0.400 (0.267, 
0.600)
male and female 
adult subjects 
(n=6)
(Snyder et al., 
1975)
Skin unitless betaPERT 0.058 (0.039, 
0.087)
male and female 
adult subjects
(Snyder et al., 
1975)
Metabolic parameters for 2-propanol
Maximum 
velocity of 
metabolism 
(Vmax)
mg*hr-
1*kgbw-0.75
lognormal 300 (1.34) - (Clewell et al., 
2001; Dorne et al. 
2004)
Michaelis-
Menten 
constant (Km)
mg*l-1 lognormal 10 (1.34) - (Clewell et al., 
2001; Dorne et al. 
2004)
Metabolic parameters for acetone
Maximum 
velocity of 
metabolism 
(Vmax)
mg*hr-
1*kgbw-0.75
lognormal 3.5 (1.34) - (Clewell et al., 
2001;Martinez et 
al.2010)
Michaelis-
Menten 
constant (Km)
mg*l-1 lognormal 10 (1.34) - (Clewell et al., 
2001;Martinez et 
al.2010)
Fractional transfer coefficients for washin-washout module
Mucosa to 
arterial blood
Unitless Beta 25.26, 8.88 (0,1) - (Mork et al.,2009)
Bronchioles 
to mucosa
Unitless Beta 29.67, 3.67 (0,1) - (Mork et al.,2009)
Description 
of variable
Units
Distribution 
type Specification 
a Population References
a Lognormal distributions are presented as geometric mean (geometric standard deviation), 
betaPERT distributions as most likely value (minimum, maximum), beta distributions as 
alpha, beta (minimum, maximum);
b Alveolar ventilation and cardiac output were assumed to be correlated with a correlation 
coefficient of 0.8 (Levitzky, 2003).
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Parameter uncertainty
A literature search was performed to quantify the uncertainty in the physico-chemical 
and metabolic parameters for 2-propanol and acetone and the chemical affinity 
intercepts and exponents of Equation 1 (Table 2). Physico-chemical properties, such 
as vapor pressure and the octanol-water partition coefficient, only depend on the 
chemical of concern and were therefore treated as uncertain only. For all parameters, 
except the affinity exponents and intercepts, a lognormal distribution was chosen 
because it avoids negative values, it captures a large value range, and the uncertainty in 
many processes and parameters follows a skewed distribution (Kooistra et al., 2005). 
Temperature-dependent parameters, such as vapor pressure and water solubility, 
were recalculated to body temperature (37 ̊C) following MacLeod et al. (2007) and 
Beyer et al. (2002). The values for the metabolic parameters of acetone, i.e., Km 
and Vmax, were based on Clewell et al. (2001) and Kumagai and Matsunaga (1995). 
Differences between these two studies were interpreted as uncertainty, among others 
due to differences in experimental design (in vivo or in vitro). The values reported by 
Clewell et al. (2001) were selected as the mean values for the uncertainty distribution 
for Km and Vmax. The coefficient of variation was based on both studies. Due to data 
limitations, the coefficients of variation in Km and Vmax for 2-propanol were assumed 
to equal those of acetone.  
The chemical affinity intercepts and exponents were described by betaPERT 
distributions. The minimum, maximum and most likely values of these distributions 
were based on measured data published by Hendriks et al. (2005). 
Model simulation
Comparison with human exposure study 
Exposure to 2-propanol (isopropanol or IPA) was simulated for a reference population 
of adult males and females (18-65 years old). The setup of the simulation study followed 
the  exposure scenario by Rose et al. (1999), representing occupational exposure to 
a solvent by inhalation. The study by Rose et al. (1999) was used to compare our 
simulation results with, as it provides human-experimental data over time, including 
the measured variation for all subjects. In this experiment, 18 healthy male individuals 
were exposed to 360 ppm 2-propanol (885 mg/m3) in air for 4 h. The experiment 
was conducted at rest in an exposure room under controlled conditions. The level 
of acetone in blood was measured at hourly intervals during the experiment and at 
30 minutes after the experiment. Additionally, the same exposure scenario has been 
simulated at 1% of the original air concentration (88.5 mg/m3) to represent more 
realistic exposure levels for an occupational exposure setting. 
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The literature-based variability distributions for human physiology (Table 1) and 
uncertainty distributions for substance-specific parameters for 2-propanol and 
acetone (Table 2) were used in this simulation.
Table 2 – Uncertainty distributions of chemical-specific parameters used in the simulations.
Description of Variable Units
Distribution 
type Specification 
a N b References
2-propanol (IPA)
Octanol-water 
partitioning coefficient 
(Kow)
unitless lognormal 1.24 (1.12) 6 (Abernethy et al., 1988;  
Dillingham et al.1973;  
Funasaki et al., 1986;  
Hansch, 1985;  Leo et 
al., 1969)
Vapor pressure at 25°C Pa lognormal 5.88E+03 (1.03) 5 (Butler and 
Ramchandani, 
1935;  Daubert and 
Danner, 1989;  Dean, 
1985;  Riddick et al., 
1986;  Stull, 1947;  
Verschueren, 1983)
Water solubility at 25°C mg*l-1 lognormal 4.16E+05 (1.10) 2 (Kamlet et al., 1987;  
Taft et al., 1985)
Density at 25°C g*l-1 lognormal 7.84E+02 (1.00) 3 (Butler and 
Ramchandani, 
1935;  Dean, 1985;  
Verschueren, 1983)
Maximum velocity of 
metabolism (Vmax)
mg*hr-
1*kgbw-0.75
lognormal 300 (2.30) 1 (Clewell et al., 2001)c
Michaelis-Menten 
constant (Km)
mg*l-1 lognormal 10 (2.30) 1 (Clewell et al., 2001) c
Acetone
Octanol-water 
partitioning coefficient 
(Kow)
unitless lognormal 0.53 (1.21) 6 (Hansch and Leo, 1985; 
Hansch and Hoekman, 
1995; Leo et al., 1969) 
Vapor pressure at 25°C Pa lognormal 3.05E+04 (1.02) 5 (Daubert and Danner, 
1989;  Riddick et al., 
1986;  Stull, 1947) 
Water solubility at 25°C mg*l-1 lognormal 6.04E+05 (1.25) 4 (Kamlet et al., 1987;  
Taft et al., 1985)
Density at 25°C mg*m-3 or 
g*l-1
lognormal 790 (1.00) 4 (Dean, 1985;  Riddick et 
al., 1986;  Stull, 1947;  
Verschueren, 1983)
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a Lognormal distributions are presented as geometric mean (geometric standard deviation), 
betaPERT distributions as most likely value (minimum, maximum), beta distributions as 
alpha, beta (minimum, maximum);
b Number of observations used from literature
c Reference only used for mean value. CV analogue with metabolic parameters for acetone 
d Quantitative Structure Activity Relationship
The model performance was quantitatively evaluated by calculating the root mean 
square error (RMSE) based on the difference between the measured and predicted 
median concentration of acetone in blood (Equation 2). The RMSE summarizes both 
the random error and the systemic bias.
Maximum velocity of 
metabolism (Vmax)
mg*hr-
1*kgbw-0.75
lognormal 3.5 (2.30) 2 (Clewell et al., 
2001;  Kumagai and 
Matsunaga, 1995)
Michaelis-Menten 
constant (Km)
mg*l-1 lognormal 10 (2.30) 2 (Clewell et al., 
2001;  Kumagai and 
Matsunaga, 1995)
QSARd for the blood-water partition coefficient
Affinity exponent for 
neutral lipids 
unitless betaPERT 1 (0.8, 1.25) (Hendriks et al., 2005)
Affinity exponent for 
polar lipids 
unitless betaPERT 0.94 (0.75, 1.18) (Hendriks et al., 2005)
Affinity exponent for 
proteins 
unitless betaPERT 0.63 (0.50, 0.79) (Hendriks et al., 2005)
Intercept for neutral 
lipids 
unitless betaPERT 0.04 (0.01, 0.12) (Hendriks et al., 2005)
Intercept for polar 
lipids 
unitless betaPERT 2.0 (0.67, 6.0) (Hendriks et al., 2005)
Intercept for proteins unitless betaPERT 2.9 (0.97, 8.7) (Hendriks et al., 2005)
Description of Variable Units
Distribution 
type Specification 
a N b References
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Equation 2 – Calculation of the RMSE:
RMSElog  = root mean square error in the log domain
n = number of observations (measured data)
Ct msd = measured value (median blood concentration acetone) reported by Rose 
 et al. (1999)
Ct est = estimated value (median blood concentration acetone) by the model
Nested Monte Carlo simulation
To separate interindividual variability in physiological parameters from true uncertainty 
in physico-chemical parameters, a nested Monte Carlo simulation was performed (Frey, 
1992). First, a set of 100 values for each of the variability parameters was randomly 
generated from the variability distributions using Crystal Ball (Oracle, version 11). This 
was repeated for the uncertainty parameters. Next, a nested Monte Carlo simulation 
was performed in which one single value for each uncertain parameter was fixed and 
100 variability values were iterated by running the IndusChemFate model 100 times. 
This results in a distribution that reflects interindividual variability in a hypothetical 
population that represents one potential realization of an uncertainty reality. This 
process was repeated 100 times, for all values in the uncertainty set, resulting in 100 
population variability distributions. Thus a total of 10,000 iterations was performed 
in which each set of uncertain parameters was combined with each set of variable 
parameters (i.e. 100 x 100 combinations).
Next, the 100 simulations for every uncertainty set (reflecting population variability 
within a population) were ranked and the mean value was calculated. Subsequently 
the uncertainty sets (or population distributions) were ranked, based on these means. 
The variance between these population distributions reflects uncertainty. Since 100 
sets for both variability and uncertainty were used, each of the 10,000 ranked model 
estimations represents both a variability and an uncertainty percentile that was used 
for presentation of the results.
Importance analysis 
Spearman rank correlation coefficients were calculated to quantify the relative 
influence of the input parameters on the output parameters. There were, however, 
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two modifications required in the calculations of the Spearman rank correlation 
coefficients. First, the correlation between the cardiac output and alveolar ventilation 
was corrected for by using partial Spearman rank correlation coefficients to avoid 
counting the impact of these parameters twice in the importance analysis (Hamby, 
1994). Second, for parameters that are both variable and uncertain, i.e. the metabolic 
parameters Vmax and Km, the values sampled from the variability distribution depend on 
the values sampled from the (nested) uncertainty distribution of the same parameter 
(Busschaert et al., 2011). This makes it difficult to quantify the exclusive importance of 
variability for those parameters that are both variable and uncertain. The problem was 
circumvented by transforming the values sampled from the variability distribution into 
percentile scores, using the sampled value of the (nested) uncertainty distribution as 
the mean. These percentile scores were subsequently used to determine the Spearman 
rank correlation coefficient that was exclusively related to variability. Finally, the 
calculated (squared) rank correlation coefficient per input parameter (R2) was divided 
by the sum of all squared rank correlation coefficients of the input parameters to 
calculate the relative contribution to the total variance per parameter. The importance 
analysis was performed 4h and 16h after the onset of the exposure.
4.3 Results
Uncertainty and variability 
Figure 2 shows the concentration of acetone in venous blood as predicted by the 
model over time from the onset of exposure, as well as the measured values of the 
experiment by Rose et al. (1999) including the 10th and 90th percentiles. The simulated 
median concentrations are close to the measured median concentrations (RMSE = 
1.18; implying an average deviation of 18%). After the exposure has ceased (t=4h), the 
measured concentration reaches its peak and then decreases. The model simulation 
does not exactly reproduce the experimental data here, as the decrease in concentration 
is delayed in the model simulation.
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Figure 2. Simulated (dashed line) and measured (continuous line) median acetone 
concentration in blood during and after inhalation of 360 ppm (885 mg/m3) 2-propanol in 
air for 4h under resting conditions. The 10th and 90th percentiles of the 18 male individuals 
from the experimental by Rose et al. (1999) are indicated as error bars. The dotted lines 
represent the 10th and 90th percentiles for variability at median uncertainty. RMSE = 1.18, 
RMSElog = 0.07, n=5.  
The cumulative probability plots (Figure 3) display uncertainty and variability in the 
predicted acetone concentration during and after exposure. Each of these plots shows 
three lines; each line representing one potential population: the 10th, 50th and 90th 
percentiles of the 100 populations from the nested Monte Carlo simulation. Variance 
within one cumulative distribution, reflected by the slope, represents interindividual 
variability within the population. Variance between the cumulative distributions, or 
between possible populations, represents uncertainty (see Figure 3d). 
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Figure 3. Cumulative probability plots for acetone in blood at t = 1, 4, 4.5, 8 and 16h after 
inhalation of 360 ppm (885 mg/m3) 2-propanol in air for 4 h under resting conditions. 
The 10th, 50th, and 90th percentiles of the simulated population distributions are displayed 
(dashed lines) as well as the measured concentrations by Rose et al. (1999) at t=1, 4 and 
4.5h (continuous lines in Figures 2a,b,c). Variation within one single cumulative distribution 
represents interindividual variability whereas variation between different distributions (or 
populations) represents uncertainty (2d). Measured data are corrected for endogenous 
acetone levels.
This is also shown in Figure 4 as 90th/10th percentile ratios for several moments 
during and after exposure. Figure 4a shows that the predicted blood concentration 
of acetone varies within a factor of 2 to 3 due to interindividual variability (90th/10th 
percentile ratio) during the exposure phase (1 to 4h) and also after the exposure has 
ceased (4 to 16h). The uncertainty ratio in the predicted blood concentration is up to a 
factor of 2 during  the exposure phase (90th/10th percentile ratio). After exposure, the 
uncertainty ratio increases over time up to a factor of 100 at the end of the simulated 
period (t=16h). The same trend is visible at 1% of the original exposure concentration 
(88.5 mg/m3; Figure 4b), although the overall uncertainty increases more rapidly and 
up to a higher level (at t=16h) compared to the original scenario.
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Figure 4 Calculated variability (grey) and uncertainty (black) ratios for the simulated 
acetone in blood concentration at t = 1, 4, 4.5, 8 and 16h after inhalation of 360 ppm 
(885 mg/m3) 2-propanol in air (A) and 3.6 ppm (88.5 mg/m3) 2-propanol in air (B) for 4 
h under resting conditions (Rose et al. (1999)). Variability ratio = (p90-variability at p50-
uncertainty) / (p10-variability at p50-uncertainty). Uncertainty ratio = (p90-uncertainty at 
p50-variability) / (p10-uncertainty at p50-variability).
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Importance analysis 
Figure 5a shows the results of the parameter importance analysis for the blood 
concentration of acetone at t = 4h and t = 16h considering both the uncertain and 
the variable parameters. During the exposure phase (t = 4h) variability plays a major 
role in the total variation in blood concentration of acetone (about 60% of the total 
variation), predominantly caused by the physiological parameters body weight and 
alveolar ventilation. Uncertainty results from the metabolic parameters for 2-propanol 
(around 15%) and acetone (around 25%). After 16h, the relative importance of the 
human physiological parameters decreases to around 10% of the total model variation. 
The variation in the blood concentration of acetone is then largely determined by 
uncertainty (about 80%), which is predominantly caused by the uncertainty in the Vmax 
for acetone (around 50% of the total variation).
Figure 5b shows the results of the importance analysis based on a model simulation 
with 1% of the original concentration (88.5 mg/m3). The results show a similar course 
with increasing uncertainty over time (t= 4h to 16h). However, the uncertainty in the 
metabolic parameters for acetone dominates the total model variation at both points 
in time while human physiology (body weight and alveolar ventilation) plays only a 
minor role.
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Figure 5. Parameter importance analysis for acetone in blood directly after exposure to 
2-propanol (4h) and at the end of the simulation (16h) after inhalation of 360 ppm (885 
mg/m3) 2-propanol in air (A) and 3.6 ppm (88.5 mg/m3) 2-propanol in air (B) for 4h 
under resting conditions (Rose et al. (1999)). For every time step (4h and 16h) the relative 
contribution of variability and uncertainty to the total variation in the model simulation is 
presented. Each bar in the figure represents the influence of the parameter as a percentage 
of the total variation in the model simulation. Within each bar a distinction is made 
between the contribution of variability and uncertainty.
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4.4 Discussion 
In this section, we discuss the validity and implications of the results. First, the validity 
of the predicted acetone concentration in blood is discussed based on a comparison 
with experimental data published by Rose et al. (1999) and an analysis of relevant 
model assumptions. Next, the relative importance of interindividual variability versus 
uncertainty is discussed as well as the assumptions that may have influenced this 
importance. Finally, possible implications for human risk assessment of chemicals 
that result from this approach are indicated.
Model predictions versus measurements 
During the exposure phase, the simulated concentration of acetone in blood is in 
close agreement with the experimental data from Rose et al. (1999). However, the 
decline in the measured concentration directly after the experiment (t=4.5h) is 
faster than simulated by the model, although still within the predicted range (10th to 
90th percentiles). One possible explanation for this difference is the relatively large 
geometric standard deviation (GSD) that was used for the Km and Vmax values for 
2-propanol and acetone metabolism as only a limited number of values were reported 
in literature, i.e., a set of values for acetone determined by Kumagai and Matsunaga 
(1995) and for 2-propanol and acetone by Clewell et al. (2001). We used the values by 
Clewell et al. (2001) as most likely estimates because this study consistently derived 
human metabolic data for both substances. However, additional simulations (Figure 
A-1) indicate that the Vmax and Km values reported by Kumagai and Matsunaga (1995) 
result in predicted concentrations that better match the experimental concentrations 
as measured by Rose et al. (1999), in particular after the exposure phase of the 
experiment. This illustrates that the selection of the metabolic parameters and thus 
the clearance (Vmax / Km) may have a large effect on the results as predicted by the 
model.
 Second, a potential source of systematic uncertainty is the QSAR by Hendriks 
et al. (2005) that was used to predict blood:air partitioning coefficients (Kba). For 
2-propanol and acetone, the estimated Kba was up to a factor of 8 higher compared 
to measured data (Fiserova-Bergerova and Diaz 1986;  Sato and Nakajima, 1979; 
Paterson and Mackay, 1989). However, additional model simulations showed that 
the estimated and the experimental blood:air partition coefficients result in similar 
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acetone concentrations in blood (within a factor of 1.1) during exposure (see Figure 
A-2).
 A third possible explanation for the discrepancy between experimental and 
predicted acetone concentrations in blood after exposure has ended (t = 4.5 h) is the 
temperature correction for the Kba from 25˚C to body temperature (37˚C). However, 
additional model simulations at both temperatures (Figure A-3) did not show an effect 
on the acetone concentrations in blood, suggesting that in this exposure scenario, 
temperature correction was not influential. 
Finally, the representativeness of the experimental study by Rose et al. (1999) is 
not optimal, since the studied population is relatively small (n=18) and only male 
volunteers were included. 
Variability versus Uncertainty 
After 4 hrs of exposure, we found that the variation in the predicted blood concentration 
of acetone is dominated by interindividual variability in physiological parameters such 
as body weight and alveolar ventilation (Figure 5). Uncertainty and variability in the 
metabolic parameters of acetone and 2-propanol (Vmax and Km) play a minor role. For 
the metabolic parameters of acetone, this can be explained by the fact that acetone 
formation is much faster than acetone metabolism at 4 hrs of exposure, as can be 
deduced from the increasing acetone levels in blood. This result is specific for the 
high exposure concentration of 360 ppm 2-propanol as applied by Rose et al. (1999). 
This is illustrated in the additional model simulation at 3.6 ppm 2-propanol (Figure 
5b). The metabolic parameters of acetone become more influential at lower exposure 
concentrations because the acetone metabolism does not get saturated and a steady 
state concentration for acetone in blood is more quickly reached. In this steady-state 
situation, the metabolic parameters of acetone become more important than the 
physiological parameters body weight and alveolar ventilation. It can be concluded 
that uncertainty and variability in the metabolic parameters Vmax and Km of acetone 
become relevant when a steady state situation is reached or when metabolism is 
faster than formation, e.g. after exposure has ceased (Figure 5).
Since the acetone concentration in blood after 4 hrs of exposure is mainly determined 
by its formation rate (i.e., the metabolism of 2-propanol), one would initially expect the 
metabolic parameters of 2-propanol to play an important role in the variation of the 
predicted acetone concentration. However, Figure 5 shows that these parameters only 
play a minor role. This can be explained by the fact that the concentration of 2-propanol 
in blood quickly reaches a steady-state. The steady-state concentration is mainly 
determined by (1) the exposure concentration, (2) the intake rate (i.e., inhalation), 
and (3) the rate of metabolism of 2-propanol. The excretion and exhalation rates of 
2-propanol play a minor role because these are relatively small compared to the rate 
of metabolism. A twofold higher rate of metabolism will result in an approximately 
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twofold lower steady-state concentration of 2-propanol. The formation rate of acetone 
depends on (1) the concentration of 2-propanol, and (2) the rate of metabolism of 
2-propanol. Thus, if the rate of metabolism increases by a factor of 2, the steady-state 
concentration will decrease by a factor of 2 and the net result is that the formation rate 
of acetone remains the same. It can be concluded that uncertainty and variability in the 
metabolic parameters Vmax and Km of 2-propanol become irrelevant when 2-propanol 
reaches a steady-state and therefore interindividual variability in the physiological 
parameters body weight and cardiac output is the major source of variation in the 
model prediction at 4 hrs of exposure.
 The influence of correlation between physiological parameters was taken into 
account by scaling tissue volumes and blood flows to body weight and cardiac output, 
respectively. Furthermore, alveolar ventilation and cardiac output were correlated 
in our study. To further explore the potential impact of other correlations between 
physiological parameters, we ran the model with a correlation coefficient of 0.8 
between body weight on the one hand and adipose tissue volume, alveolar ventilation 
and cardiac output as reasoned important parameters on the other hand. The results 
show a decrease in variability up to 25%, compared with the default scenario (Figure 
A-4). These results indicate that the neglect of correlations may have resulted in an 
overestimation of the impact of interindividual variability. Further research is needed to 
explore the influence of more realistic correlations of human physiological parameters 
in the current model.
Implications
Information on the impact of interindividual variability and uncertainty on model 
predictions can help to set management priorities: should priority be given to the 
identification and protection of sensitive individuals (i.e., when interindividual 
variability plays an important role) or to additional research in order to obtain more 
accurate predictions (i.e., when uncertainty plays an important role)? Our example 
of 2-propanol and acetone shows that the answer to this question depends on the 
exposure phase:
1. The uptake phase during which variation in model predictions is dominated by 
interindividual variability in physiological parameters. During this phase, data 
on interindividual variability will be useful to identify individuals with relatively 
high acetone concentrations in blood. Accurate determination of the metabolic 
parameters is less important in this phase because these parameters hardly 
influence the blood concentration of acetone. In this example, individuals with 
a relatively low body weight and high cardiac output have the highest blood 
concentrations. In a workplace setting, such information could be used to reduce 
risks, e.g. by the development of a person-oriented communication strategy. 
2. The steady-state phase during which variation in model prediction is determined 
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by interindividual variability as well as uncertainty. The balance between 
interindividual variability and uncertainty depends on: (1) the sensitivity of the 
model outcome for the individual parameters, (2) the amount of variation in the 
model parameters, and (3) the dominant elimination route.
3. The elimination phase during which variation in model predictions depends on 
the relative importance of the elimination routes.
In our example, metabolism was the dominant elimination route during the steady-
state and elimination phases and consequently uncertainty in Km and Vmax was the 
most important source of variation. Under these conditions, it is worthwhile to put 
extra effort in an accurate determination of the metabolic parameters since this can 
significantly improve the model predictions. 
Our example shows that the influence of interindividual variability and uncertainty 
on predicted acetone concentrations in blood is not fixed but varies over time. The 
influence of interindividual variability decreases and the influence of uncertainty 
increases as the system moves from an uptake phase, via a steady-state phase, into 
an elimination phase. However, it should be stressed that these results are specific for 
exposure settings (substance, concentration and duration) for which metabolism is 
the most dominant elimination route.
Important factors that determine the relative importance of interindividual variability 
and uncertainty include: (1) the exposure phase of interest (i.e., uptake, steady-state or 
elimination), (2) the exposure level (e.g., whether saturation occurs), (3) the metabolic 
processes and rates involved (e.g., whether the parent compound drives the risk or its 
metabolite), (4) the sensitivity of the model parameters, (5) the range of variation of 
the model parameters, and (6) the elimination routes involved.  Additional research is 
needed to better understand how, when and to what extent these factors influence the 
relative importance of interindividual variability and uncertainty.
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Abstract
The coherence between occupational exposure limits (OELs) and their corresponding 
biological limit values (BLVs) was evaluated for 2-propanol and acetone. A generic 
human PBPK model was used to predict internal concentrations after inhalation 
exposure at the level of the OEL. The fraction of workers with predicted internal 
concentrations lower than the BLV, i.e. the ´false negatives´, was taken as a measure 
for incoherence. The impact of variability and uncertainty in input parameters was 
separated by means of nested Monte Carlo simulation. Depending on the exposure 
scenario considered, the median fraction of the population for which the limit values 
were incoherent ranged from 2% to 45%. Parameter importance analysis showed that 
body weight was the main factor contributing to interindividual variability in blood and 
urine concentrations and that the metabolic parameters Vmax and Km were the most 
important sources of uncertainty. This study demonstrates that the OELs and BLVs 
for 2-propanol and acetone are not fully coherent, i.e. enforcement of BLVs may result 
in OELs being violated. In order to assess the acceptability of this “incoherence”, a 
maximum population fraction at risk of exceeding the OEL should be specified as well 
as a minimum level of certainty in predicting this fraction.
5.1 Introduction
Monitoring of workplace exposure to chemicals has become common practice in many 
countries (Angerer et al., 2011). In this context, occupational exposure limits (OELs) 
for air, such as Threshold Limit Values (TLVs), Maximale Arbeitzplatz-Konzentration 
werten (MAK-werten) and Derived No Effect Limits for workers (DNEL Worker), 
have been derived to control the health risk of chemical exposure in occupational 
settings. Additionally, biological limit values (BLVs) such as Biological Exposure 
Indices (BEI) and Biologische Arbeitsstoff-Toleranzwerten (BAT) have been derived 
as reference values for biological media, such as blood and urine. Another approach 
in which external dose-based guidance values, such as the tolerable daily intake 
(TDI) or reference dose (RfD), are translated into so-called biomonitoring equivalent 
(BE) values is increasingly being used in the public health context, but so far not in 
occupational settings (Hays, 2007; Hays et al., 2008). 
 Although BLVs are currently still limited in number (derived for roughly 50 
industrial chemicals), they strongly support and legitimize the application of biological 
monitoring as a method to measure and control human exposure to chemical 
substances (Angerer et al., 2007; Boogaard et al., 2011). Biological monitoring is 
embedded in EU regulations DIR 80/1107/EEC, DIR 89/391/EEC and DIR 98/24/EC. 
 BLVs are typically derived from OELs, based on an empirical relationship 
between external exposure levels and corresponding internal concentrations (ACGIH, 
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2001; Angerer et al., 2011). In these cases, enforcement of BLVs should guarantee 
that OELs are not being exceeded since these OELs were originally derived from 
experimental toxicological data (Thomas et al., 1996). A violation of an OEL may 
remain unnoticed when the BLV is not being exceeded at an exposure level that 
corresponds to the OEL. In the present study, an OEL and its corresponding BLV are 
therefore called coherent if the predicted internal concentration after exposure to the 
OEL equals or exceeds the BLV. False negatives, i.e. internal concentrations below the 
BLV after exposure at the level of the OEL, should be avoided.
 In recent years, several physiologically based pharmacokinetic (PBPK) models 
have been developed to support the derivation of BLVs (Adams et al., 2005; Bartels et 
al., 2012; Leung, 1992; Tardif et al., 2002; Truchon et al., 2012). However, coherence 
testing between BLVs and OELs with PBPK models has only been performed to a 
limited extent. Thomas et al. (1996) predicted the interindividual variability in the 
concentrations of chemicals in worker’s exhaled breath and urine after exposure to 
OELs of 6 industrial chemicals. They compared the results with the corresponding 
BLVs. For the urinary metabolites of benzene, methyl chloroform and trichloroethylene, 
they found that 54% to 97% of the worker population is protected at the level of 
the BLV. However, Thomas et al. (1996) only considered interindividual variability 
in input parameters, and not uncertainty. It is important to distinguish these two 
sources of variation since they have different implications for policy makers. Whereas 
interindividual variability indicates the population fraction at risk and provides insight 
into the characteristics of susceptible individuals (Nestorov, 2001), uncertainty 
determines the reliability of model predictions (Cullen, 1998; Morgan, 1990) and 
provides insight into the most efficient ways to improve model predictions, e.g. by 
more precise measurements (Nestorov, 2001; Ragas, 2009).
 The aim of the present study was to test the coherence between the OELs 
and BLVs of two commonly used solvents, i.e. 2-propanol and acetone. The BLVs 
of these substances were originally derived from the OELs using linear regression 
between external and internal exposure levels. The PBPK model BioNormtox (Huizer 
et al., 2012) was used here to predict blood and urine concentrations after exposure 
to air concentrations at the level of the OEL. These predicted internal concentrations 
were then compared to the corresponding BLVs, resulting in a measure of coherence. 
The impact of uncertainty and interindividual variability was quantified separately by 
means of nested Monte Carlo simulation.
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5.2 Material and Methods
BioNormtox model
Outline
We used the PBPK model BioNormtox, an extended version of the IndusChemFate 
model as previously described by Huizer et al. (2012), to assess the coherence 
between OELs and BLVs for 2-propanol and acetone. In the same publication, it was 
shown that simulations for these substances were in line with experimental human 
data. The model is briefly described here; a more detailed model description can be 
found in Huizer et al. (2012). The human body is represented in BioNormtox by 10 
main compartments: (1) lung, (2) heart, (3) brain, (4) skin, (5) fat, (6) muscles, (7) 
bone, (8) stomach and intestines, (9) liver and (10) kidney (Figure 1). The lungs are 
subdivided into bronchioles, mucosa, and alveolae to model the washin–washout 
effect of solvent vapors in the respiratory tract, following Mork (2009) and Mork 
and Johanson (2006).  Partitioning between different compartments is based on a 
QSAR for tissue:water partitioning, originally developed by Hendriks et al. (2005). 
Metabolism (Michaelis-Menten kinetics) is based on the metabolic parameters Vmax 
(maximum velocity of metabolism) and Km (Michaelis-Menten constant).
Parameter uncertainty and variability
Variation in the model output was quantified as interindividual variability and 
uncertainty separately, based on assigned parameter distributions by Huizer et al. 
(2012). Interindividual variability for resting conditions was described using literature-
based distributions for all physiological parameters (Table 1). Lognormal distributions 
were used for continuous physiological parameters, whereas fractional parameters 
were assigned betaPERT distributions.
 Uncertainty distributions were derived for physico-chemical parameters of 
2-propanol and acetone (lognormal) and chemical affinity intercepts and exponents 
(betaPERT). The metabolic parameters Km and Vmax were considered as variable 
and uncertain, since variation in these parameter values may originate from both 
interindividual variability (i.e., differences in enzymatic activity between individuals) 
and uncertainty (i.e., differences in experimental design and measurement 
uncertainty). For the present study, all parameter distributions related to physico-
chemical properties and biotransformation of 2-propanol and acetone were taken 
from Huizer et al. (2012) (Table B-1, B-2).
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Figure 1.  Structure of the BioNormtox model. The continuous lines represent blood flows 
between tissues, whereas the dashed lines represent the exchange of the parent compound 
or metabolites between the respiratory tract and the arterial blood.
Excreted compound / metabolites in urine 
Inhalation 
Exhalation 
 
 
V 
E 
N 
O 
U 
S 
 
 
 
 
 
 
 
 
 
 
 
B 
L 
O 
O 
D 
 
A 
R 
T 
E 
R 
I 
A 
L 
 
 
 
 
 
 
 
 
 
B 
L 
O 
O 
D 
 
Heart 
 
 
Brain 
 
 
Dermis 
 
 
Adipose 
 
 
Muscle 
 
 
Bone + Marrow 
 
 
Stomach + 
Intestine 
 
 
Liver 
 
 
Kidney 
 
 
Bronchioles 
 
 
Alveolae 
 
 
Mucosa 
 
Lungs 
Dermal 
uptake 
 
 
Ingestion 
 
Chapter 5
92
Table 1 – Variability distributions for physiological parameters in rest and during light work 
as used in the model simulations (see also Huizer et al. 2012 for further details).
Description of variable Units
Distribution 
type At rest 
a At light work a
Multiplier 
(rest to 
exercise)
Alveolar ventilation b l/h Lognormal 511 (1.27) 1334 (1.14) not 
applicable
Cardiac output b l/h Lognormal 390 (1.24) 591 (1.11) not 
applicable
Body weight kg Lognormal 71.4 (1.24) 71.4 (1.24) d not 
applicable
Thickness of epidermis cm Lognormal 0.0084 (1.22) 0.0084 (1.22) d not 
applicable
Thickness of stratum 
corneum
cm Lognormal 0.0015 (1.37) 0.0015 (1.37) d not 
applicable
Volume of produced 
urine
l/h Lognormal 0.091 (1.51) c 0.091 (1.51) d not 
applicable
Arterial fraction unitless betaPERT 0.251 (0.167, 
0.376)
0.251 (0.167, 
0.376) d
not 
applicable
Cardiac output fractions to tissues
Adipose tissue unitless betaPERT 0.061 (0.020, 
0.184)
0.104 (0.035, 
0.313)
1.7
Brain unitless betaPERT 0.117 (0.078, 
0.176)
0.07 (0.047, 
0.105)
0.6
Heart unitless betaPERT 0.056 (0.037, 
0.083)
0.056 (0.037, 
0.083)
1
Kidneys unitless betaPERT 0.177 (0.118, 
0.265)
0.088 (0.059, 
0.133)
0.5
Liver arterial unitless betaPERT 0.068 (0.046, 
0.103)
0.034 (0.023, 
0.051)
0.5
Liver venous unitless betaPERT 0.189 (0.126, 
0.283)
0.094 (0.063, 
0.141)
0.5
Lung unitless betaPERT 0.034 (0.023, 
0.051)
0.034 (0.023, 
0.051)
1
Muscle unitless betaPERT 0.142 (0.095, 
0.214)
0.313 (0.209, 
0.470)
2.2
Skeleton (bone) unitless betaPERT 0.115 (0.077, 
0.173)
0.115 (0.077, 
0.173)
1
Skin unitless betaPERT 0.059 (0.039, 
0.089)
0.107 (0.071, 
0.160)
1.8
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a Lognormal distributions are presented as geometric mean (geometric standard deviation), 
betaPERT distributions as most likely value (minimum, maximum), beta distributions as 
alpha, beta (minimum, maximum);
b Alveolar ventilation and cardiac output were assumed to be correlated with a correlation 
coefficient of 0.8 (Levitzky, 2003). 
c Includes individuals from general population in all states of exercise, based on Raman et 
al. 2004.
d unchanged at light work compared to situation in rest
Model adjustments
In comparison to the original model, two major adjustments were made: (1) renal 
excretion was now modeled as a process that is described by the water soluble fraction 
of the substance in renal blood and the production rate of urine, i.e. replacing the 
original arbitrary cut-off value for glomerular filtration (Eq. B-1), and (2) the parameter 
distributions for human physiology were changed to conditions that correspond to 
light work in order to simulate more realistic workplace scenarios. A summary of the 
parameter distributions for human physiology in rest and at light work is presented in 
Table 1. The derivation of parameter distributions for light work is described in more 
detail below.
Human physiology
Increased exercise may lead to changes in tissue perfusion and ventilation 
characteristics. These changes originate from three main physiological principles: 
(1) increase of cardiac output, (2) increase of alveolar ventilation, and (3) change 
of distribution of the cardiac output over tissues (Fiserova-Bergerova, 1983). 
Corresponding parameter distributions for human physiology in the BioNormtox 
model were adjusted to represent light work. In line with Astrand et al. (1983), we 
defined light work as a workload of 35-50W. This corresponds to daily scenarios for 
most occupational settings, including work related to cleaning, construction, farming, 
industrial processing, machine operating and painting (Ainsworth et al., 2011).
Fractional transfer coefficients for washin-washout module of model
Mucosa to arterial 
blood
unitless Beta 25.26, 8.88 (0,1) 25.26, 8.88 
(0,1),d
not 
applicable
Bronchioles to mucosa unitless Beta 29.67, 3.67 (0,1) 29.67, 3.67 
(0,1), d
not 
applicable
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Cardiac output and alveolar ventilation
Data from Astrand (1983) were used to derive a lognormal distribution that describes 
human variability of cardiac output during light work. Similarly, a distribution for the 
description of variability in alveolar ventilation was derived based on data by Astrand 
(1983).
Fractional blood flows 
For the perfusion of tissues during light work, the parameter distributions for fractional 
blood flows (as fraction of the total cardiac output) in rest were used as a starting 
point, since these distributions were well established based on a large number of 
empirical data by Huizer et al. (2012). Deterministic multipliers were used to convert 
these distributions from rest to light work (Eq. 1).
Eq. (1) – Principle of scaling of fractional blood flows to tissues in rest to light work. 
QC tissue light work = QC tissue rest * R tissue      (1)
Where QC tissue light work is the fractional blood flow to a tissue at light exercise (% of 
cardiac output), QC tissue rest  the fractional blood at rest (% of cardiac output) and R 
tissue the multiplier per tissue type (dimensionless). The multipliers were calculated 
as the ratio between typical values for fractional blood flows to tissues at rest and 
during light work. The mean values reported in Huizer et al. (2012) were used as 
typical values at rest. Typical values during light work were derived from multiple data 
sources and then aggregated per tissue type (Table B-3).
Other physiological parameters
The original distribution representing the volume of produced urine was left unchanged 
as it includes data from individuals both in rest and during light work (Raman et 
al., 2004). The fractional transfer coefficients for the washin-washout module in the 
model were also left unchanged, since these are related to the alveolar ventilation and 
are therefore scaled via this parameter (Mork, 2009).
Coherence testing 
The coherence between OELs and BLVs was determined by comparing the simulated 
blood or urine concentrations after inhalation exposure at the level of the OEL for 
the defined exposure duration to the corresponding BLV of the parent chemical or its 
metabolite. We calculated the fraction of ‘false negatives’ in the worker population, 
i.e. the fraction of workers with predicted internal concentrations below the BLV after 
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exposure to the OEL. These false negatives indicate cases where a violation of the OEL 
does not necessarily result in a violation of the BLV. The larger the fraction of ‘false 
negatives’, the less coherence is demonstrated.
 Exposure to acetone and 2-propanol via inhalation was simulated with the 
BioNormtox model for the following scenarios (Table 2): 
(1) A scenario of 8 hours constant exposure to acetone at the OEL (500 ppm in air) 
during light exercise, to test the coherence with the BLV of acetone in urine; 
(2) A scenario of 8 hours constant exposure to 2-propanol at the OEL (200 ppm in air) 
during light exercise, to test the coherence with the BLVs of acetone in blood; 
(3) A scenario of 8 hours constant exposure to 2-propanol at the OEL (200 ppm in air) 
during light exercise, to test the coherence with the BLVs of acetone in urine; 
(4) A scenario of 5 times 8 hours exposure to 2-propanol at the OEL (200 ppm in air) 
during light exercise, to test the coherence with the BLV of 2-propanol in urine at the 
end of the workweek (t=104 hours).
To account for the endogenous urinary level of acetone in the general population, 
which is implicitly accounted for in the BLV, the endogenous urinary concentration 
was added to the predicted urinary concentration of acetone. This endogenous urinary 
concentration was sampled from a lognormal distribution, based on literature data 
(Table B-5) (Ghittori et al., 1996; Kawai et al., 1992; Pezzagno et al., 1986; Satoh et al., 
1995; Wang et al., 1994; Wigaeus et al., 1981).
Table 2 – Occupational Exposure Limits (OELs) and Biological Limit Values (BLVs) for 
acetone and 2-propanol.
* from onset of exposure (t = 0h), ** 1188 mg/m3 acetone, *** 490 mg/m3 2-propanol.
Occupational Exposure Limit Biological Limit Value
Parent compound in working atmosphere Acetone in blood Acetone in urine
(ppm) Time (h) * Reference (mg/l) Time (h) Reference (mg/l) Time (h) Reference
Acetone
 
500 ** 8 MAK,1993 - - - 80 8 BAT,1995
TLV, 1996 - - - 50 8 BEI, 1999
2-propanol 200 *** 8 MAK, 1996 25 8 BAT, 2009 25 8 BAT, 2009
TLV, 2003 - - - 40 5 x 8 BEI, 2006
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Nested Monte Carlo simulation
Interindividual variability in physiological parameters and true uncertainty in physico-
chemical parameters were separated by means of nested Monte Carlo simulation using 
Crystal Ball software (Oracle, version 11). For each scenario in Table 2, a nested Monte 
Carlo simulation was performed based on a randomly selected set of 100 values from 
each of the variable parameters and a randomly selected set of 100 values from each 
of the uncertain parameters. In the analysis, the uncertain parameter sets were fixed 
one by one and the 100 variability values were iterated, running the BioNormtox model 
after each iteration. This process was repeated for each uncertainty set, resulting in 100 
population distributions where each distribution reflects the interindividual variability 
within a population. The results of the simulations were then ranked, based on the 
median values of the population distributions to reveal the variance between these 
populations as a measure of uncertainty. Finally, the 10th, 50th and 90th population 
distributions were plotted as cumulative probability plots in which variability and 
uncertainty are both represented.
Importance analysis
The relative contribution of the input parameters to the variability and uncertainty 
of the output parameters was calculated by means of a modified Spearman rank 
correlation method as described by Huizer et al. (2012). First, the correlation 
coefficients were recalculated to correct for correlation between the cardiac output 
and alveolar ventilation by using partial Spearman rank correlation coefficients 
(Hamby, 1994). Second, the overall importance of parameters that were defined as 
both variable and uncertain, i.e. the metabolic parameters Vmax and Km, was separated 
into an uncertainty and a variability component (Huizer et al., 2012). The importance 
analysis was performed for each of the scenarios in Table 2.
5.3 Results
Coherence between OELs and BLVs for acetone and 
2-propanol
The cumulative probability plots in Figure 2 display uncertainty and variability in 
predicted concentrations of acetone in blood and urine after inhalation exposure to 
acetone and 2-propanol in accordance with the scenarios in Table 2. In each of these 
plots, three curves are displayed, representing three of the 100 simulated potential 
populations. They correspond with the 10th, 50th and 90th uncertainty percentiles of 
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the simulation results for each exposure scenario. Variance within one cumulative 
distribution, reflected by the slope, represents interindividual variability within the 
population. The variation between the cumulative distributions, reflecting different 
populations, represents uncertainty (illustrated with the arrows in Figure 2c). In the 
same figures, the applicable BLV is depicted. 
 Coherence between the OEL and the corresponding BLV is demonstrated 
when inhalation exposure at the level of the OEL does not result in concentrations in 
blood or urine below the BLV. The level of coherence was specified by quantification 
of the predicted fraction of ‘false negatives’, i.e. individuals with predicted internal 
concentrations below the BLV after exposure to the OEL, in the worker population 
(variability) and the corresponding probability level of this prediction (uncertainty). 
Figure 2 shows that there is a 50% chance that the fraction of false negatives is 2% 
of the population in comparison with the American BLV (BEI) for acetone in urine, 
whereas there is 10% chance that this fraction is 10% . In case the German BLV (BAT) 
for the same scenario is considered, there is a 50% chance that population fraction of 
false negatives is 45%, whereas there is 10% chance that this is as much as 75%.
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Figure 2. Cumulative probability plots of the simulated median (continuous line), 10th 
and 90th (dotted lines) concentration percentiles in blood and urine after inhalation of 
acetone (2a) and 2-propanol (2b, c, d) at the level of the OEL for 8h during light exercise. 
Corresponding BLVs for each scenario are also displayed.
 In Table 3 the coherence between the OELs and the BLVs for acetone and 
2-propanol is presented for each simulated scenario. This coherence is expressed as 
the predicted fraction of false negatives in the worker population for three different 
probability levels (i.e., the 10th, 50th and 90th percentile). Table 3 shows that the median 
fraction of false negatives in the worker population ranges from 2% to 45% over 
the four different scenarios. The 10th percentile of the false negatives in the worker 
population ranges from 10% to 93%, while the 90th percentile ranges from 0% to 
20%.  The largest uncertainty in the calculated fraction is found for 2-propanol in the 
end of workweek scenario.  
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Table 3 – Predicted fraction of false negatives in the working population, i.e. workers with 
predicted internal concentrations lower than the biological limit value after inhalation 
exposure at the level of the OEL, as a measure of incoherence between limit values for 
acetone and 2-propanol as simulated with the BioNormtox model in four exposure scenarios.
Parameter importance
Figure 3 shows the results of the parameter importance analysis. For all scenarios, 
variability plays a major role in the variation in blood and urine concentrations (60% to 
80% of the total variation), mainly as a result of the human physiological parameters 
body weight and alveolar ventilation. Uncertainty and variability in the metabolic 
parameters Vmax and Km are also an important source of variation (10% to 30% of 
the total variation), in particular for the 2-propanol scenarios. Other parameters that 
have a relatively large influence on the simulated blood and urine concentrations are 
parameters that are related to the QSAR for tissue partitioning, expressed as Ktw (lipid, 
protein and water fractions of tissues and their corresponding affinity exponents and 
intercepts) and Kow.
Exposure scenario Biological Limit 
Value
Predicted population 
fraction of false 
negatives (incoherence) 
in % (median value with 
p10 – p90 uncertainty 
range)
No. External Internal 
1. Acetone
(500 ppm - 8 h)
Acetone in urine
(end-of -workday)
BAT (D): 80 mg/l 45% (20 – 75)
BEI (US): 50 mg/l 2% (0 – 10)
2. 2-Propanol
(200 ppm - 8 h)
Acetone in blood
(end-of-workday)
BAT (D):  25 mg/l 5%  (2 – 32)
3. 2-Propanol
(200 ppm - 8 h)
Acetone in urine
(end-of workday)
BAT (D): 25 mg/l 28% (8 – 67)
4. 2-Propanol
(200 ppm - 5 x 8 h)
Acetone in urine
(end-of-workweek) 
BEI (US): 40 mg/l  17% (0 – 93)
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Figure 3. Parameter importance analysis of the simulated scenarios for acetone (2a) and 
2-propanol (2b, c, d). For every scenario the contribution of variability and uncertainty to 
the total variation is presented per parameter. 
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5.4 Discussion 
First, model parameterizations and assumptions that may have influenced the results 
are discussed. Next, the coherence between the OELs and BLVs for 2-propanol and 
acetone is discussed. Finally, possible implications for policy makers are outlined.
Influence of parameterization and assumptions
To support the comparison between OELs and BLVs, the majority of the model 
parameters related to human physiology was scaled from rest to light work. As 
the availability of empirical human physiological data on fractional blood flows to 
tissues during light work was limited, the parameters distributions established for 
rest conditions were extrapolated to light work, using so called multipliers. This way, 
the robustness of the parameterization in rest as derived by Huizer et al. (2012) was 
maintained. However, the absence of detailed information about tissue lumping (i.e., 
the aggregation of similar tissues into groups) in multiple literature sources (Table 
B-3), as well as the lack of a specific definition of ‘light work’ may have influenced the 
final parameterization of the model. However, a comparison with data from Fiserova-
Bergerova (1983) (Table B-4) indicates that the reported blood flows to relevant 
organs, such as the muscles, kidneys and liver, during light work are in line with the 
parameterization of the BioNormtox model. 
 Additional model simulations (Figure 4 and Figure B-1) show that the scaling 
of physiological parameters from rest to light work has a significant influence on 
the predicted blood and urine concentration of acetone; the internal concentrations 
decrease with decreasing exercise levels. Mork and Johanson (2006) reported similar 
results for acetone based on experimental human data and model simulations. 
Schaller and Triebig (2002) also report an increase of the acetone concentration in 
urine with increasing activity. These results illustrate that the level of physical exercise 
significantly influences the relationship between external and internal exposure 
concentrations. For our exposure scenarios, we would have found lower coherence 
levels at lower exercise levels. To put it in another way: at lower exercise levels there is 
a higher risk of the OEL being exceeded while the BLV is not being exceeded.
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Figure 4. Cumulative probability plots of the simulated median (continuous line), 10th and 
90th (dotted lines) concentration percentiles in urine after inhalation of acetone at the level 
of the OEL for 8h in rest and during light exercise. Corresponding BLVs for this scenario are 
also displayed.
 
Another factor that may have influenced the model predictions is the parameterization 
of renal excretion. Urinary excretion in PBPK models for 2-propanol and acetone has 
generally been parameterized as a first-order process (Clewell et al., 2001) or based on 
partitioning (Kumagai and Matsunaga, 1995). Mork and Johanson (2006) neglected 
this route entirely in their acetone model, stating that urinary excretion is not a 
significant elimination route for this substance. In our model renal excretion depends 
on the water soluble fraction of the substance in renal blood and the production rate 
of urine, replacing the  arbitrary cut-off value for glomerular filtration in the Huizer 
et al. (2012) model. This modification also allowed a probabilistic approach of the 
urinary excretion through the derived parameter distributions involved.  This results in 
urinary excretion levels around 1% of the total dose for both 2-propanol and acetone, 
which is in line with the published models and the background documentation of the 
BLVs (ACGIH, 2001; DFG, 2012). 
 Finally, possible covariation between metabolic parameters Vmax and Km was 
not considered in our analyses, due to a lack of quantitative information on the exact 
correlation between these two parameters. However, as covariation is expected to be 
relevant mainly for the variability components of Vmax and Km, based on interindividual 
variation in the activity of metabolic enzymes (Dorne  et  al.,  2004;  Martinez  et 
al.,  2010), and the importance of uncertainty was considerably higher in comparison 
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with interindividual variability for these parameters in our analyses, it is expected that 
ignoring the possible covariation has influenced the results only to a limited extend.
Coherence between exposure limits for 2-propanol 
and acetone 
In this study, four different exposure scenarios were assessed. These scenarios include 
variation in exposure concentration, exposure duration, type of biological medium 
(blood and urine) and metabolic phase (parent and first metabolite). 
 Based on our coherence test, we found that the BLVs for 2-propanol and 
acetone are likely (i.e., with 50% certainty) to be coherent with their OEL for the 
majority of the working population (55% to 98%). Our results are comparable to those 
of Thomas et al. (1996), who predicted ´ protected population´ fractions ranging from 
54% to 97% after exposure to benzene, methyl chloroform and trichloroethylene. 
However, Thomas et al. (1996) only included interindividual variability in input 
parameters, and not uncertainty. Our approach has the advantage that the probability 
of the predictions can also be specified.
 For a further interpretation of our results, it is important to understand 
the scientific basis underlying the BLVs, i.e. the BAT and BEI values for acetone and 
2-propanol. German BAT values are limit values which should not be exceeded, 
whilst the BEI values are advisory levels that may be exceeded by a fraction of the 
population. However, this is in most cases not explicitly defined (Morgan and Schaller, 
1999). In the case of acetone and 2-propanol, both the BEI and BAT values have been 
established based on a relationship between external (inhalation) and internal (urine) 
exposure. Nevertheless, the BLVs differ substantially, i.e. 50 for the BEI vs. 80 mg/l 
urine for the BAT. This is most likely a result of differences in the interpretation of the 
assessed (exposure) data, as is illustrated in the background documentation of the 
BAT for acetone in which a range of potential limit values from 50 to 80 mg/l urine 
is suggested. As a consequence of the arbitrary choice for 80 mg/l as a suitable BAT 
value, our results show a lower coherence level for this BAT value than for the BEI 
value. 
 The results of the parameter importance analyses provide insight into the 
main factors contributing to the variability and uncertainty in the model predictions. 
The physiological parameters body weight and alveolar ventilation and the metabolic 
parameters Vmax and Km turn out to be the most important sources of variation. 
Body weight is by far the most dominant parameter, as the volume of all model 
compartments is related to body weight. Internal concentrations tend to decrease 
with increasing body weight, implying that for individuals with a large body weight 
there is a higher chance of incoherence between the OEL and the BLV. The Vmax for 
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acetone is an important source of uncertainty, pointing towards acetone metabolism 
as an important elimination route. 
 Partitioning parameters become more important in scenarios in which 
urinary concentrations are predicted, which can be explained by the fact that only the 
dissolved fraction of acetone in blood is being excreted into urine.
Practical implications 
The present study shows that OELs and BLVs of 2-propanol and acetone are not fully 
coherent, i.e. enforcement of BLVs does not always guarantee that OELs are being met. 
These OELs were originally derived from toxicity data and are therefore more directly 
linked to possible adverse health effects than BLVs. However, it should be stressed 
that incoherence does not necessarily imply adverse health effects. It is generally 
acknowledged that internal exposure is a better dose metric for toxicity than external 
exposure because the dose at the receptor site is an important driver of toxicity. 
Assuming equal receptor sensitivity, the value of the NOEL will mainly be determined 
by those individuals that reach relatively high internal concentrations under similar 
external exposure conditions. In our case, this would typically be the lightweight 
people with a high exercise level. Our study showed that heavy people with a low 
level of exercise have the highest risk of incoherence. This indicates that sensitivity is 
inversely related to incoherence, i.e. individuals with a high risk of incoherence (i.e., 
heavy persons with a low exercise level) will be sufficiently protected at the level of the 
OEL. Reasoning along these lines, a coherence level of 50% would provide sufficient 
protection for the entire population.
 The definition of coherence that we used in our case study is applicable only 
to cases where the OEL is derived from toxicity data and the BLV is subsequently 
derived from the OEL, e.g., based on an empirical relationship between external and 
internal concentrations. This definition of coherence changes if the BLV would be 
established directly based on toxicity data and the OEL would subsequently be derived 
from the BLV. In that case, the OEL and BLV are coherent only if the BLV is not being 
exceeded at the exposure level that corresponds to the OEL. In the context of risk 
assessment, coherence testing based on experimentally derived BLVs is preferred over 
BLVs that are derived from OELs based on the empirical relationship between external 
and internal concentrations. However, in practice data limitations may constrain this 
approach. 
 The large impact of exercise levels on the coherence of OELs and BLVs 
shows that OELs should not only consist of a concentration limit, but also include 
a specification of the exercise level for which it applies. Although it is generally 
recognized that the exercise levels influence internal concentrations, e.g. Astrand 
(1983) and Safe Work Australia (2012), specifications of exercise levels are typically 
limited to broad classifications such as “light work”, “moderate work” and “heavy 
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work”! A more detailed specification of these reference exercise levels for occupational 
exposure standards will support the safe application of OELs and BLVs under varying 
working conditions. 
 Our results show that uncertainty in the predicted concentrations is mainly 
caused by uncertainty in metabolic parameters (i.e. Vmax and Km of 2-propanol and 
acetone) and partitioning parameters (i.e. Ktw). If uncertainty is to be reduced, 
research should focus on a more accurate determination of these metabolic and 
partitioning parameters. However, the first step is to determine whether reduction of 
uncertainty – and thus additional research – is desirable or necessary. This requires 
the specification of a minimum level of certainty for the predicted coherence level of 
the worker population, e.g. a 90% probability level that the limit values are coherent 
for 50% of the worker population. In the present situation in which BLVs are based on 
experimentally derived OELs, regulatory authorities have two options if a coherence 
test shows that the combined levels of certainty and coherence level cannot be 
realized, i.e. either lower the BLV until sufficient coherence is realized or initiate new 
research to reduce uncertainty. 
A major step forward in the reduction of incoherence would be the derivation of BLVs 
with PBPK modeling, analogous to the BE approach of Hays et al (2008), in which 
the maximum allowed population fraction at risk and the level of certainty is defined 
upfront.
Conflict of interest statement 
The authors declare that there are no conflicts of interest
Supplementary information
Supplementary information is available in Appendix B. 
5.5 References 
 • ACGIH, Documentation of the threshold limit values for biological exposure 
indices. In: ACGIH, (Ed.), Documentation of the Threshold Limit Values and 
Biological Exposure Indices, 7th Ed., Cincinnati, 2001.
 • Adams, J. C., et al., 2005. A physiologically based toxicokinetic model of inhalation 
exposure to xylenes in Caucasian men. Regul Toxicol Pharmacol. 43, 203-14.
 • Ainsworth, B. E., et al., 2011. 2011 Compendium of Physical Activities: a second 
update of codes and MET values. Med Sci Sports Exerc. 43, 1575-81.
 • Angerer, J., et al., 2011. Human biomonitoring assessment values: approaches 
and data requirements. Int J Hyg Environ Health. 214, 348-60.
 • Angerer, J., et al., 2007. Human biomonitoring: state of the art. Int J Hyg Environ 
Chapter 5
108
Health. 210, 201-28.
 • Astrand, I., 1983. Effect of physical exercise on uptake, distribution and elimination 
of vapours in man. in: Fiserova-Bergerova, V., (Ed.), Modelling of Inhalation 
Exposure to Vapours: Uptake, Distribution and Elimination. vol. 2. CRC Boca 
Raton, Florida.
 • Bartels, M., et al., 2012. Development of PK- and PBPK-based modeling tools for 
derivation of biomonitoring guidance values. Computer Methods and Programs 
in Biomedicine. 108, 773-788.
 • Boogaard, P. J., et al., 2011. Human biomonitoring as a pragmatic tool to 
support health risk management of chemicals--examples under the EU REACH 
programme. Regul Toxicol Pharmacol. 59, 125-32.
 • Clewell, H. J., 3rd, et al., 2001. Development of a physiologically based 
pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol Sci. 
63, 160-72.
 • Cullen, A. C. F., H.C. , 1998. Probabilistic techniques in exposure assessment. A 
handbook for dealing with variability in uncertainty in models and inputs. Plenum 
Press, New York, USA.
 • DFG, D. F., 2012. MAK Values 2012. List of MAK and BAT Values 2012. Wiley-VCH 
Verlag GmbH & Co. KGaA, pp. 1-298.
 • Dorne, J. L., Walton, K.,Renwick, A. G., 2004. Human variability for metabolic 
pathways with limited data (CYP2A6, CYP2C9, CYP2E1, ADH, esterases, glycine 
and sulphate conjugation). Food Chem Toxicol. 42, 397-421.
 • Fiserova-Bergerova, V., 1983. Modeling of inhalation exposure to vapors; uptake, 
distribution, and elimination. . CRC Press, Boca Raton, Florida. .
 • Ghittori, S., et al., 1996. Acetone in urine as biological index of occupational 
exposure to isopropyl alcohol. Ind Health. 34, 409-14.
 • Hamby, D. M., 1994. A review of techniques for parameter sensitivity analysis of 
environmental models. Environmental Monitoring and Assessment. 32, 135-154.
 • Hays, S. M., et al., 2007. Biomonitoring equivalents: a screening approach for 
interpreting biomonitoring results from a public health risk perspective. Regul 
Toxicol Pharmacol. 47, 96-109.
 • Hays, S. M., et al., 2008. Guidelines for the derivation of Biomonitoring 
Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul 
Toxicol Pharmacol. 51, S4-15.
 • Hendriks, A. J., et al., 2005. Critical body residues linked to octanol-water 
partitioning, organism composition, and LC50 QSARs: meta-analysis and model. 
Environ Sci Technol. 39, 3226-36.
 • Huizer, D., et al., 2012. Separating uncertainty and physiological variability in 
human PBPK modelling: The example of 2-propanol and its metabolite acetone. 
Toxicology Letters. 214, 154-165.
 • Kawai, T., et al., 1992. Curvi-linear relation between acetone in breathing zone air 
and acetone in urine among workers exposed to acetone vapor. Toxicol Lett. 62, 
85-91.
 • Kumagai, S., Matsunaga, I., 1995. Physiologically based pharmacokinetic model 
109
Testing the coherence between occupational exposure limits for inhalation and their 
biological limit values with a generalized PBPK-model: the case of 2-propanol and acetone
5
for acetone. Occup Environ Med. 52, 344-52.
 • Levitzky, M. G., 2003. Ventilation-Perfusion relationships. Pulmonary physiology. 
McGraw-Hill, New York, pp. 113-124.
 • Leung, H. W., 1992. Use of physiologically based pharmacokinetic models to 
establish biological exposure indexes. Am Ind Hyg Assoc J. 53, 369-74.
 • Martinez, C., Galvan, S.,Garcia-Martin, E.,Ramos, M. I.,Gutierrez-Martin, 
Y.,Agundez, J. A., 2010. Variability in ethanol biodisposition in whites is modulated 
by polymorphisms in the ADH1B and ADH1C genes. Hepatology. 51, 491-500.
 • Morgan, M. G., Henrion, M., 1990. Uncertainty: A guide to Dealing with 
Uncertainty in Quantitative Risk and Policy Analysis. Cambridge University Press, 
New York.
 • Morgan, M. S., Schaller, K. H., 1999. An analysis of criteria for biological limit 
values developed in Germany and in the United States. Int Arch Occup Environ 
Health. 72, 195-204.
 • Mork, A. K., Johanson, G., 2006. A human physiological model describing acetone 
kinetics in blood and breath during various levels of physical exercise. Toxicol Lett. 
164, 6-15.
 • Mork, A. K., Jonsson, F., Johanson, G., 2009. Bayesian population analysis of 
a washin-washout physiologically based pharmacokinetic model for acetone. 
Toxicol Appl Pharmacol. 240, 423-32.
 • Nestorov, I., 2001. Modelling and simulation of variability and uncertainty in 
toxicokinetics and pharmacokinetics. Toxicol Lett. 120, 411-20.
 • Pezzagno, G., et al., 1986. Urinary elimination of acetone in experimental and 
occupational exposure. Scand J Work Environ Health. 12, 603-8.
 • Ragas, A. M., Brouwer, F. P., Buchner, F. L., Hendriks, H. W., Huijbregts, M. A., 
2009. Separation of uncertainty and interindividual variability in human exposure 
modeling. J Expo Sci Environ Epidemiol. 19, 201-12.
 • Raman, A., et al., 2004. Water turnover in 458 American adults 40-79 yr of age. 
Am J Physiol Renal Physiol. 286, F394-401.
 • Safe Work Australia, Guidance on the interpretation of workplace exposure 
standards for airborne contaminants. Safe work Australia, 2012.
 • Satoh, T., et al., 1995. Acetone excretion into urine of workers exposed to acetone 
in acetate fiber plants. Int Arch Occup Environ Health. 67, 131-4.
 • Schaller, K. H., Triebig, G., 2002. Acetone [BAT Value Documentation, 1998]. The 
MAK-Collection for Occupational Health and Safety. Wiley-VCH Verlag GmbH & 
Co. KGaA.
 • Tardif, R., et al., 2002. Impact of human variability on the biological monitoring 
of exposure to toluene: I. Physiologically based toxicokinetic modelling. Toxicol 
Lett. 134, 155-63.
 • Thomas, R. S., et al., 1996. Variability in biological exposure indices using 
physiologically based pharmacokinetic modeling and Monte Carlo simulation. 
Am Ind Hyg Assoc J. 57, 23-32.
 • Truchon, G., et al., 2013. Evaluation of occupational exposure: comparison of 
biological and environmental variabilities using physiologically based toxicokinetic 
Chapter 5
110
modeling. Int Arch Occup Environ Health. 86, 157-65.
 • Wang, G., et al., 1994. Blood acetone concentration in “normal people” and in 
exposed workers 16 h after the end of the workshift. Int Arch Occup Environ 
Health. 65, 285-9.
 • Wigaeus, E., et al., 1981. Exposure to acetone. Uptake and elimination in man. 
Scand J Work Environ Health. 7, 84-94.
Uncertainty and 
variability in the exposure 
reconstruction of chemical 
incidents - the case of 
acrylonitrile
Daan Huizer, Ad M.J. Ragas, Rik Oldenkamp, Joost G.M. van Rooij, Mark A.J. Huijbregts
Published in: Toxicology Letters,. 2014 Dec 15;231(3):337-43
Chapter 6
Chapter 6
112
Abstract 
The application of human physiologically based pharmacokinetic (PBPK) modelling 
combined with measured biomonitoring data, has a great potential to backtrack 
external exposure to chemicals during chemical incidents. So far, an important 
shortcoming of ‘reversed dosimetry’ is that uncertainty and variability in the model 
predictions are often neglected. The aim of this paper is to characterize the variation 
in predicted environmental air concentrations by means of reversed dosimetry as a 
result of uncertainty in chemical-specific input data and variability in physiological 
parameters. Human biomonitoring data (N-2-cyanoethylvaline in blood) from a 
chemical incident with acrylonitrile (ACN) combined with the BioNormtox PBPK 
model are used as a case to reconstruct the air concentration and uncertainty thereof 
at the time of the incident. The influence of uncertainty in chemical-specific properties 
and exposure duration, and interindividual variability in physiological parameters 
on the reconstructed air exposure concentrations were quantified via nested Monte 
Carlo simulation. The range in the reconstructed air concentrations of ACN during the 
incident was within a factor of 3. Uncertainty in the exact exposure duration directly 
after the chemical accident was found to have a dominant influence on the model 
outcomes. It was also shown that uncertainty can be further reduced by collecting 
human biomonitoring data as soon as possible after the incident. Finally, the 
collection of specific information about individual physiological parameters from the 
victims, such as body weight, may further reduce the variation by 5 to 20% in our case 
study. Future research should include the comparison of reversed dosimetry model 
outcomes with measured air and biological concentrations to further increase the 
confidence in the model approach and its implementation in practice.
6.1 Introduction 
Assessing human exposure to uncontrolled emissions of hazardous substances after 
incidents is an increasingly important subject of research (Bongers et al., 2008; Hunault 
et al., 2014; Scheepers et al., 2011). During or in the aftermath of such incidents large 
amounts of information are collected within a short timeframe, primarily aimed at the 
identification of the population at risk, the quantification of these (acute) risks and 
decisions to be made regarding direct measures, such as evacuation (Bongers et al., 
2008). As time is usually a limiting factor, measured (air) exposure levels during and 
directly after incidents are scarce.
 In this context, human biomonitoring data may help to backtrack external 
exposure at the time of the incident, since this technique allows the collection of 
biological samples afterwards. Depending on the lifespan of biomarkers in the human 
body, the moment of data collection may vary from days to weeks, and sometimes 
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even months after the incident (Scheepers et al., 2011). Several methods for external 
exposure reconstruction have been described, some of which have been readily 
applied in the context of chemical incidents (Bader and Wrbitzky, 2006; Liao et al., 
2007; Lyons et al., 2008). As these methods generally make use of exposure prediction 
models that are applied backwards (or: in the reverse direction) in comparison with 
their original use, this application is also referred to as ‘reversed dosimetry’ (Clewell 
et al., 2008).
 For a successful reconstruction of external exposure to chemicals during 
incidents based on biological samples from exposed individuals, the following 
issues should be considered. First, large variation in measured concentrations in 
biological media under relatively similar exposure conditions can be expected. This is 
illustrated by Spaan et al. (2010) who found that differences in biomarker half-life and 
concentrations within and between people are substantial in homogeneous exposure 
groups, based on the analysis of about 7000 observations from more than 40 
biological monitoring studies with over 200 volunteers and various types of chemicals. 
Furthermore, the dynamics of exposure are likely to be different in incident exposure 
settings compared to exposure settings in occupational and public health studies: 
incidents usually result in a relatively short period (minutes to hours) of relatively 
high exposure levels, whereas occupational and public health scenarios generally 
deal with chronic exposure (starting from a single working day) to relatively low or 
moderate concentrations. Depending on the availability of contextual information of 
the incident, it may also be more difficult to define the exact moment and duration of 
the exposure. 
 Uncertainty about the relevant exposure scenario of the incident and variation 
in the collected biomonitoring data, may hinder the reconstruction of reliable estimates 
of the external exposure of individuals at the time of the incident. Therefore, it is 
important that the applied reconstruction method for the calculation of the (external) 
exposure at the time of the incident based on measured internal biomonitoring data, 
is able to take into account uncertainty and variability of the relevant parameters. So 
far, most of these methods neglect variation in the model predictions due to inter-
individual differences (variability) and uncertainty (in measured parameter values). 
However, insight in the influence of interindividual variability and uncertainty is 
essential to assess the reliability and usefulness of reconstructed exposure estimates 
after incidents. 
 The aim of this paper was to quantify the variation in predicted environmental 
air concentrations by means of reversed dosimetry modeling after a chemical incident 
as a result of uncertainty in chemical-specific input data and variability in physiological 
parameters. As an example, human biomonitoring data from a chemical incident with 
acrylonitrile were used to identify the main sources of variability and uncertainty on 
the reconstructed air concentration at the time of the incident.
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6.2 Material and Methods 
BioNormtox model
The human PBPK model BioNormtox was used to simulate concentrations of 
acrylonitrile (ACN) and its metabolites after a chemical incident. The model is briefly 
described here (see also Figure 1), while a more detailed model description can be 
found in Huizer et al. (2012) and Huizer et al. (2014). BioNormtox model contains 10 
biological compartments. Tissue:water partitioning is predicted with a Quantitative 
Structure-Activity Relationship (QSAR) as derived by Hendriks et al. (2005). The 
prediction of chemical absorption in the respiratory tract follows Mork and Johanson 
(2006) and Mork (2009) to account for the so-called washin–washout effect of polar 
chemicals. Biotransformation follows Michaelis-Menten kinetics with the parameters 
Vmax (maximum velocity of metabolism) and Km (Michaelis-Menten constant).
Figure 1. Structure of the BioNormtox model. The continuous lines (red) represent blood 
flows between tissues, whereas the dashed lines (blue) represent the exchange of the parent 
compound or metabolites between the respiratory tract and the arterial blood. 
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Variation in the model output can be quantified as interindividual variability and 
uncertainty separately, based on the assigned parameter distributions. Interindividual 
variability for both resting conditions and light work was defined by literature-
based distributions for human physiological parameters (Table C-1). Continuous 
physiological parameters, such as body weight and cardiac output, were considered 
to follow a lognormal distribution (Gaddum,1945; Slob,1994; Wayne,1990). Fractions, 
such as tissue composition (water, proteins and fat fractions), were described by Beta 
distributions or in case limited data were available by betaPERT disctributions (Van 
Hauwermeiren and  Vose,  2009). 
Uncertainty in physico-chemical and metabolic parameters was quantified with a 
lognormal distribution, except for the affinity exponents  and intercepts of the QSAR 
that were described by betaPERT distributions (Table C-2). The rationale behind the 
selection of the type of distribution for each group of parameters is described in detail 
by Huizer et al. (2012). 
Reversed dosimetry 
Similar to most other PBPK models, BioNormtox model simulates in ‘forward 
direction’, i.e. from external concentration in air to internal dose in blood and excreted 
urine. For the aim of the present study, the model application was reversed as described 
by Liao et al. (2007). To this end, so called Exposure Conversion Factors (ECFs) were 
calculated based on (forward) model simulations. An ECF is defined as the ratio of the 
external concentration (e.g. in air) to the internal concentration (e.g. in blood): 
(Eq. 1)
First, the model was used to generate a distribution of the predicted internal 
concentration at a fixed external exposure concentration, by means of a large number 
of model iterations. Both uncertainty and variability distributions for parameters in 
the BioNormtox model were accounted for in these iterations. Next, the distribution 
of the ECFs was obtained by dividing the fixed external exposure concentration to 
each predicted internal concentration from the distribution. The ECF distribution 
can subsequently be multiplied by a measured internal concentration to predict the 
distribution of the external concentration at the time of the chemical incident:
(Eq. 2)
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Parameter importance analysis
Spearman rank correlation coefficients were calculated to quantify the relative 
influence of the variability in physiological parameters and uncertainty in substance-
specific data to the variation in the ECF. Since cardiac output and alveolar ventilation 
between individuals are correlated, partial Spearman rank correlation coefficients were 
calculated for these two parameters (Hamby, 1994). This avoids that the influence of 
these parameters is counted twice in the parameter importance analysis. 
Case study: chemical incident with acrylonitrile
Setting of the case study
A study by Bader and Wrbitzky (2006), which described a chemical incident with 
inhalation exposure to acrylonitrile and subsequent collection of human blood samples, 
was found to be a suitable case study to test our modeling approach. The incident 
concerned the decontamination of a tank wagon containing acrylonitrile, whereby a 
cleaning worker was found unconscious in the wagon by his colleagues. One cleaning 
worker climbed into the wagon with a self-contained breathing apparatus whilst three 
other cleaning workers remained in the vicinity of the open wagon. 
Levels of N-2-cyanoethylvaline (CEV) were measured in the 4 (male) cleaning workers 
that rescued their colleague in the aftermath of the chemical incident (Bader and 
Wrbitzky, 2006; Tavares et al., 1996). In contrast to many biomarkers of exposure, 
the formation process of CEV in hemoglobin is irreversible and has a relatively long 
lifespan of 100 to 130 days, corresponding with the life span of erythrocytes in blood 
(Beutler, 1995; Bishop, 1964; Ostermangolkar et al., 1976). Blood samples were 
collected to measure the CEV concentrations after 25, 85, 115 and 174 days after the 
incident. Additionally, a cotinine analysis of the collected blood was performed to 
determine the smoking status of each worker. Further information about the incident 
(i.e. duration of the exposure) and human physiological data of the cleaning workers 
(i.e. height and body weight) were not reported.
Modeling acrylonitrile 
Biotransformation of acrylonitrile (ACN) follows both enzymatic and non-enzymatic 
pathways (ATSDR, 1990). For this study, the disappearance of ACN and the formation 
of the haemoglobin adduct CEV were of interest. The following pathways were 
considered in the backward exposure modeling: (1) oxidation of ACN to cyanoethylene 
oxide (CEO), (2) conjugation of ACN with glutathione (GSH), both enzymatic and 
non-enzymatic, (3) binding of ACN to blood sulfhydryls and (4) binding of ACN to 
117
Uncertainty and variability in the exposure reconstruction of chemical incidents – the case of acrylonitrile
6
haemoglobin (Figure C-1). The GSH conjugation and protein binding pathways were 
added to the BioNormtox model, based on the algorithms as provided by Sweeney et 
al. (2003). 
 Parameter distributions related to physico-chemical properties of ACN were 
derived from multiple literature sources. Data on the biotransformation parameters 
for ACN, including coefficients of variation (CV = standard deviation/mean), were 
obtained from the ACN PBPK model as published by Sweeney et al. (2003). All 
distributions for chemical-specific input parameters, i.e. physico-chemical and 
biotransformation parameters, were considered uncertain in the model simulations 
(Table 1).
 In addition to the default variability distributions for human physiological 
parameters, distributions were derived to represent the variability in GSH tissue 
concentrations, based on data by Sweeney et al. (2003), and haemoglobin content in 
humans (Beutler and Waalen, 2006) (C-3). Similarly, a distribution for the life span of 
human erythrocytes was derived to model the elimination pathway of CEV (Beutler, 
1995; Bishop, 1964; Ostermangolkar et al., 1976). Table 2 shows the variability 
distributions that were specifically gathered for the modeling of ACN exposure.
Table 1 – Uncertainty distributions of chemical-specific parameters for acrylonitrile used in 
the simulations.
Description of Variable Units Distribution type Specification 
a
N b
References
Acrylonitrile
Octanol-water partitioning 
coefficient (Kow)
unitless lognormal 0.89 (6.32) Collander, 1951; Pratesi 
et al, 1979; Fujiwasa 
and Masuhara, 1980; 
Veith et al, 1980; Valvani 
et al 1981; Tanii and 
Hashimoto, 1984; 
Hansch and Leo, 1985; Lu 
et al, 1986; USEPA 1979
Vapor pressure at 25°C Pa lognormal 1.43E+04 (1.02) Stull, 1947; Hoy, 1970; 
Daubert and Danner, 
1985; Howard et al 1986
Water solubility at 25°C mg*l-1 lognormal 7.55E+04 (1.06) Klein et al, 1957; Veith et 
al, 1980; Yalkowsky and 
Dannenfelser, 1992 
Density at 25°C g*l-1 lognormal 803 (1.01) Riddick et al, 1986; 
O’Neil, M.J., 2006
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a Lognormal distributions are presented as geometric mean (geometric standard deviation)
b Number of observations used from literature
Table 2 – Variability distributions of human physiological parameters that were added to 
BioNormtox model for the present study. 
Maximum velocity of 
metabolism (Vmax) 
oxidation ACN to CEO
mg*hr-
1*kgbw-0.75
lognormal 13.86 (1.63) Kedderis et al 1993, 
Lipscomb et al , Allen et 
al 1996 via Sweeney et 
al. 2003
Michaelis-Menten 
constant (Km) oxidation 
ACN to CEO
mg*l-1 lognormal 0.79 (1.20) Kedderis et al 1993 via 
Sweeney et al. 2003
Enzymatic GSH 
conjugation ACN
l*hr-
1*kgbw-0.7
lognormal 103.3 (1.53) Kedderis et al 1993, 
Lipscomb et al , Allen et 
al 1996 via Sweeney et 
al. 2003
Spontaneous GSH 
conjugation ACN
l*mmol-
1*h-1
lognormal 0.23 (1.53) Lipscomb et al
Binding to haemoglobin h-1 lognormal 1.19 (1.34) Allen et al 1996
Binding to sulfhydryls h-1 lognormal 0.0008 (1.34) Allen et al 1996
Description of 
variable
Units Distribution type Specification a References (N b)
Life span of human 
erythrocytes 
day Lognormal 110 (1.10) Beutler, 1995; Bishop, 
1964; Ostermangolkar et 
al., 1976 
Concentration of 
haemoglobin in 
blood (working 
population)
g/dl Lognormal 14.30 (1.06) Beutler and Waalen 2006 
(25648)
GSH tissue concentrations
GSH concentration 
in brain
umol/l lognormal 2.74 (1.52) Kudo et al.,1990; 
Trabesingeret al.,1999via 
Sweeney et al. 2003
GSH concentration 
in intestinal tissue
umol/l lognormal 3.55 (1.20) Engin and Ferahkose, 
1990; Santraet al.,2000; 
Wernermanet al.,1999 via 
Sweeney et al. 2003
GSH concentration 
in slowly perfused 
tissue (adipose, 
bone, muscles, 
skin, marrow)
umol/l lognormal 1.11 (1.22) Engelenet al.,2000; Luoet 
al.,1998; Pansarasaet 
al.,2000 via Sweeney et 
al. 2003
Description of Variable Units Distribution type Specification 
a
N b
References
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a Lognormal distributions are presented as geometric mean (geometric standard deviation)
b Number of observations used from literature
Back calculation of the ACN external exposure level
First, the BioNormtox model was applied to calculate the increase in the CEV 
concentration in haemoglobin as a result of inhalation exposure to ACN at the air 
concentration of 3 ppm (6.5 mg/m3). This value is within the range of air concentrations 
of ACN for which a German internal exposure equivalent for carcinogenic substances 
(EKA value) has been established (Bader and Wrbitzky, 2006; Bolt and Lewalter, 
2002; Deutsche, 2013; Lewalter and Bolt, 2002). As the exposure duration during the 
incident was not described, we considered two scenarios: (1) exposure to ACN in air at 
3 ppm for 5 minutes, and (2) exposure to ACN in air at 3 ppm for 60 minutes. For both 
scenarios a light exercise level, as defined by Huizer et al. (2014), was considered. 
Inhalation exposure was simulated without the use of respiratory protection equipment 
only. For each scenario, a nested Monte Carlo simulation with 10.000 iterations was 
performed.
 Next, for each of the two scenarios an ECF distribution was derived, based 
on the 10.000 iterations per scenario. The ECF was calculated as a ratio of the (fixed) 
ACN concentration in air to the predicted CEV concentration range, according to the 
method as described by Liao et al. (2007):
 
 (Eq. 3) 
where ACNair  is the air concentration of ACN (ppm) and CEVhb the concentration 
range of CEV in haemoglobin (pmol/g Hb).    
 The air concentration of ACN at the time of the chemical incident as described 
by Bader and Wrbitzky (2006) was then calculated by multiplying the ECF distribution 
by the measured CEV concentrations for each worker. Since smoking has a significant 
influence on the plasma levels of CEV, measured concentrations for smokers were 
corrected by subtracting the CEV level in the sample that was collected 175 days after 
the incident as individual background levels following Bader and Wrbitzky (2006).
GSH concentration 
in rapidly perfused 
tissue (heart, 
kidney, lung)
umol/l lognormal 2.54 (1.22) Gajewskaet al.,1995; 
Rowellet al.,1989; 
Wernermanet al.,1999 via 
Sweeney et al. 2003
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6.3 Results
Figure 2 shows the cumulative probability plots for the ECFs for both scenarios 
(exposure to 3 ppm ACN in air for 5 minutes and 60 minutes, respectively) after 25 and 
85 days since the chemical incident. In each of these plots, three curves are displayed 
representing the 10th, 50th and 90th uncertainty percentiles of the simulation results 
per scenario. Variance within one cumulative distribution represents (interindividual) 
variability in the ECF. The distance between the cumulative distributions represents 
uncertainty (illustrated with the arrows in Figure 2a).
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Figure 2. Cumulated probability plot of ECFs for the calculation of the CEV in haemoglobin 
concentration after exposure to 3 ppm acrylonitrile in air for 5 mins and 60 mins, based on 
the measured data after 25 (A, B) and 85 (C,D) days since the chemical incident. The 10th, 
and 90th percentiles are also displayed (dotted lines).
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In Table 3 the reconstructed air concentrations of ACN at the time of the incident are 
presented as mean value with corresponding 10th to 90th percentiles of the total 
model variation (10th to 90th uncertainty and variability range), for each of the four 
workers in both scenarios. Based on the measured data after 25 days the median 
reconstructed air concentration ranges from 5.6 to 18 ppm for the four workers in the 
5-minutes exposure scenario, whereas in the 60-minutes scenario the reconstructed 
air concentration is a factor of 12 lower (0.5 to 1.5 ppm). When the measured data 
after 85 days are considered, the range in reconstructed air concentrations is larger 
compared to the predicted air concentrations after 25 days. The recalculated air 
concentrations after 85 days range from 3.3 to 38 ppm for the 5-minutes scenario to 
0.2 to 2.7 ppm for the 60-minutes scenario.
Table 3 – Recalculated air concentrations ACN at the time of the incident. 
* individually corrected for smoking by subtracting the background concentration (measured 
concentration after 175 days)
** median value with (p10 uncertainty, p10 variability – p90 uncertainty, p90 variability) 
range
Figure 3 shows the influence of uncertainty and variability on the predicted 
concentration of CEV in haemoglobin as 90th/10th percentile ratios for both exposure 
durations (5 mins and 60 mins) after 25 and 85 days. The predicted concentration 
CEV varies within a factor of 1.5 to 2 due to uncertainty in all four situations, whereas 
the influence of variability is higher for the 85 days scenarios (factor of 2 to 3.5) in 
comparison with the 25 days scenarios (factor of 1.5 to 2).
Exposure scenario 25 days after the incident 85 days after the incident
No.
Exposure 
duration 
Worker
Measured 
concentration 
CEV (pmol/ g 
Hb) *
Reconstructed air 
concentration ACN 
at the time of the 
incident (ppm) **
Measured 
concentration 
CEV (pmol/ g 
Hb)
Reconstructed air 
concentration ACN 
at the time of the 
incident (ppm)
1. 5 mins 1 1800 17.9 (11.6 – 29.0) 995 37.9 (18.2 – 112.9)
2 670 6.7 (4.3 – 10.8) 88 3.3 (1.6 – 10.0)
3 559 5.6 (3.6 – 9.0) 406 15.5 (7.4 – 46.1)
4 564 5.6 (3.6 – 9.1) 283 10.8 (5.2 – 32.1)
2. 60 mins 1 1800 1.5 (1.0 – 2.5) 995 2.7 (1.5 – 5.6)
2 670 0.6 (0.4 – 0.9) 88 0.2 (0.1 – 0.5)
3 559 0.5 (0.3 – 0.8) 406 1.1 (0.6 – 2.3)
4 564 0.5 (0.3 – 0.8) 283 0.8 (0.4 – 1.6)
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Figure 3. Calculated variability (grey) and uncertainty (black) ratios for the simulated 
CEV in haemoglobin concentration after exposure to 3 ppm acrylonitrile in air for 5 
mins and 60 mins, based on the measured data after 25 and 85 days since the chemical 
incident. Variability ratio = (p90-variability at p50-uncertainty) / (p10-variability at p50-
uncertainty). Uncertainty ratio = (p90-uncertainty at p50-variability) / (p10-uncertainty at 
p50-variability).
 The results of the parameter importance analyses (Figure 4) indicate that 
uncertainty in the binding of ACN to haemoglobin (resulting in formation of the protein 
adduct CEV) causes roughly 50% of the predicted variation after 25 days (Figures 4a 
and 4b). Human physiological parameters body weight, alveolar ventilation and the 
haemoglobin (Hb) content of the blood are most important sources of variation in the 
ECF after 25 days. Analysis of the parameter importance data after 85 days (Figures 
4c and 4d) shows that the variability in life span of erythrocytes, the main elimination 
pathway for CEV, becomes an important factor in the variation of the ECF.
0
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6
5 mins exposure
(after 25 days)
60 mins exposure
(after 25 days)
5 mins exposure
(after 85 days)
60 mins exposure
(after 85 days)
variability ratio
uncertainty ratio
Uncertainty Variability 
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Hb concentration 
Arterial Fraction 
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Cardiac Output  
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100% 0% 42% 
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Uncertainty Variability 
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ACN Binding to hemoglobin  
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Hb concentration 
Blood fraction of total volume 
Fraction of cardiac output to Liver  
ACN-GSH conjug spontaneous 
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Cardiac Output  
Variability 
Uncertainty 
60 mins exposure, after 25 days 
b 
100% 0% 47% 
Uncertainty Variability 100% 0% 74% 
0% 10% 20% 30% 40% 50% 60% 
Life span of erythrocytes 
ACN Binding to hemoglobin  
Body Weight  
ACN-GSH conjug enzymatic 
Alveolar Ventilation 
Fraction of cardiac output to Liver  
ACN-GSH conjug spontaneous 
Hb concentration 
Variability 
Uncertainty 
5 mins exposure, after 85 days 
c 
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Figure 4.  Parameter importance analysis for the concentration of CEV in haemoglobin as 
a result of exposure to 3 ppm acrylonitrile in air for 5 mins (a, c) and 60 mins (b, d) after 
25 and 85 days since the chemical incident. For every scenario the relative contribution of 
variability and uncertainty to the total variation in the model simulation is also presented.
6.4 Discussion
The present study demonstrates that uncertainty in the exposure reconstruction 
after incidental exposure to chemicals can be assessed by the use of biological 
measurements in combination with nested Monte Carlo simulations within a PBPK 
model. The recalculated median air concentrations of ACN to which the four workers 
were exposed during the incident, ranged from 0.5 ppm to 38 ppm, depending on 
the simulated exposure durations and the two moments of data collection. With the 
exception of the predicted air concentration for 1 worker in the 5-minutes scenario 
based on a blood sample after 85 days, these values are below the Dutch limit value for 
acute health effects of 25 ppm and the American Acute Exposure Guideline Level of 57 
ppm (time weighted average of 1 hour exposure) (EPA, 2009; RIVM, 2007). This is in 
line with the observations that no acute health effects were reported after the incident 
(Bader and Wrbitzky 2006). In the following sections, the results of this case study are 
discussed and generalized for wider application where possible.
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Sources of variability and uncertainty in the model 
predictions 
Exposure Conversion Factors (ECFs) were calculated based on exposure to 3 ppm 
ACN in air for 5 and for 60 minutes. Note that our reported ECFs apply only for linear 
relationships, when there are no saturation effects in the biotransformation or when 
the saturated biotransformation pathway does not have a significant influence on the 
ACN concentration in blood. 
 In our model simulations we considered that Km and Vmax were uncertain only, 
as the data by Sweeney et al. (2003) did not provide sufficient insight to distinguish 
between variability and uncertainty in these metabolic parameters. However, 
interindividual variability in biotransformation may also be relevant. Consequently, the 
variation as a result of uncertainty may be overestimated while the variation originating 
from variability may be underestimated in our case study. Though, in practice this will 
have little effect since Km and Vmax values cannot be determined easily on an individual 
basis, meaning that this source of interindividual variability will always cause variation 
in the reconstructed external exposure concentration. 
 Based on the reconstructed data it is shown that additional information 
about individual physiological parameters from the workers, such as body weight 
and alveolar ventilation, can reduce the variation by 20% in the reconstructed air 
concentrations for the measurements that were collected after 25 days and 5 to 8% 
in the reconstructed air concentrations for the measurements after 85 days. Usually, 
these physiological parameter values can be easily retrieved. The magnitude of the 
reduction in the range of reconstructed air concentrations depends on the modeled 
chemical and the moment of data collection. In previous studies, the importance of 
human physiological data has also been demonstrated, especially during and shortly 
after exposure (Huizer et al. 2012; 2014). The shorter after the incident measurements 
are performed, the more relevant it is to collect individual physiological data.
 Similarly, exposure duration appears to have a relatively large influence on 
the reconstructed air concentration of ACN in this case study. As a consequence, it is 
considered very important to determine the exposure duration accurately, preferably 
by asking the individuals involved shortly after the incident. 
 The decrease of CEV in the measured data varies over time (from day 25 to 
day 85 after the incident) from 28% in ‘Worker 3’ to 87% in ‘Worker 2’. This finding 
clarifies the increase of the overall predicted relative variation in the air exposure 
concentration that were recalculated based on the data from 85 days after the incident, 
as variability in the life span of erythrocytes (the elimination route of CEV) is found to 
be the most important factor of variation in this scenario.
 Note that in our simulations no inhalation protection was considered, 
although it was described by Bader and Wrbitzky (2006) that one worker used this 
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type of protection. It is, however, unknown which of the workers used inhalation 
protection. A second aspect not included in the simulations, is the dermal exposure 
route. Since ACN is known to penetrate easily through the skin, the absence of the 
dermal route in our simulations may have overestimated the ECF-values and thereby 
the reconstructed air concentrations. In particular because the workers reported 
skin contact with soaked working clothes of their unconscious colleague (Bader and 
Wrbitzky, 2006)
Recommendations
Based on the results of the model simulations for acrylonitrile, it is recommended to 
document the exact exposure duration of all the individual exposed after the accident. 
Furthermore, collecting human biomonitoring data as soon as reasonably possible 
after the incident will minimize uncertainty. In addition, collecting (biological) 
measurements at different points in time can support modeling results. Unfortunately, 
the reconstructed results from our study could not be validated with measured air 
concentrations and known exposure duration. To get a better understanding and 
more confidence in the modeled results, it is meaningful to perform a similar study 
for a situation in which both external and internal concentrations, as well as exposure 
duration are known. 
 Further applicability of reversed dosimetry in combination with human 
biomonitoring may include the comparison of reconstructed concentrations with limit 
values, risk communication, interventions and decision making for follow-up health 
investigation among highly exposed individuals. When biomonitoring data become 
available quickly after a chemical incident, techniques that support a fast and reliable 
exposure reconstruction are desirable. This may include mobile measuring and 
analysis devices and pre-parameterized PBPK models for typical industrial chemicals. 
Supplementary information
Supplementary information is available in Appendix C. 
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7.1 Introduction
This thesis aimed to improve chemical exposure assessment for the workplace by 
quantification of sources of uncertainty and variability in various exposure settings. 
Both measuring and modelling approaches for chemical exposure assessment were 
considered. 
 One widely used approach is a combination of measuring actual chemical 
concentrations at the workplace, followed by statistical regression modelling 
to identify and quantify the main  exposure determinants that can be applied in 
exposure predictions models (Chapters 2 and 3). Although a similar approach for the 
assessment of internal exposure levels in workers can be followed, often physiologically 
based toxicokinetic (PBTK) models are used to estimate internal concentrations of 
chemicals. PBTK models tend to follow a mechanistic approach with an emphasis on 
the parameterization of physiological and chemical properties. 
 Depending on the method applied and the exposure setting of interest, 
variation in the estimated (internal) concentrations can be caused by sources of 
variability and/or uncertainty. Separate quantification of parameter uncertainty and 
inter- and intra-individual variability can provide insight in the underlying causes 
of the variation in exposure predictions, as elaborated in Chapter 4.  The added 
value of this method was demonstrated in an evaluation of the coherence between 
occupational exposure limits (OELs) and their corresponding biological limit values 
(BLVs) (Chapter 5), and in an reversed dosimetry approach in which air concentrations 
during a chemical incident were traced back from biological exposure measurements 
(Chapter 6).   
As this thesis aimed to improve chemical exposure assessment for the workplace, 
only scenarios in the so-called ‘post-registration’ domain were considered, i.e. 
concerning the quantification of actual exposure levels during the application and use 
of chemicals. Within this domain, both workplace air concentrations and subsequent 
internal concentrations of chemicals and/or their metabolites in workers were 
estimated based on measurements and by means of exposure prediction models. In 
this context, relevant sources of variation that influence the estimated air concentration 
of chemicals at the workplace include sampling technique, workplace and production 
characteristics and individual behaviour of workers. Additionally, human physiology 
and biotransformation were demonstrated to be sources of variation in exposure 
scenarios in which the internal concentration of chemicals in workers was assessed. 
Table 1 summarizes the sources of variation that were addressed in this thesis.
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Table 1 –Type and origin of variation components in the chemical exposure assessment at 
the workplace as described in the various chapters of this thesis.
To put the findings from the individual chapters into context, the different sources of 
variability and uncertainty in workplace air concentrations and internal concentrations 
are compared and discussed in sections 7.2 and 7.3, respectively. Finally, overall 
implications and recommendations for risk assessment at the workplace are described 
in section 7.4.
7.2 Assessment of workplace air 
concentrations
Typically, air concentrations of chemicals are measured among workers at their 
workplace by means of personal air sampling to quantify exposure. Different types 
of personal inhalable aerosol samplers that are used for exposure assessment under 
various working conditions and in different industries may introduce measurement 
errors and subsequently uncertainty in the measured air concentrations. For this 
reason, several authors have studied the performance of commonly used samplers 
(Kauffer et al., 2010; Kenny et al., 1997; Kenny et al., 1999; Li et al., 2000). Uncertainty 
in measured air concentrations due to personal inhalable aerosol samplers was 
quantified in Chapter 2 for a number of frequently applied aerosol samplers in the 
rubber manufacturing industry. Likewise, this is a potential source of uncertainty in 
statistical regression models that are derived from these measurements to predict 
exposure. Our study revealed that although the use of (certified) personal inhalable 
aerosol samplers may lead to a significant under-  or overestimation of the exposure, 
the corresponding influence of this measurement error on the total variation in the 
measured air concentration was limited as the different samplers explained only 5% to 
Class Type Origin Example
Relevant parameters 
(chapter in this thesis)
Uncertainty Parameter 
uncertainty
Measurement error, 
Analytical error,
estimation error
Sampling equipment
Analytical methods
Type of air sampler (2)
Physico-chemical 
properties (4,5,6)
Variability Interindividual 
variability
Human physiological 
variation
Physiology
Biotransformation 
Human physiological 
parameters (4,5,6)
Michaelis-Menten 
parameters (4,5,6)
Worker exposure 
factors (spatial)
Work organisation,
workplace design, 
workstyle
Exposure dynamics (2,3)
Intraindividual
variability
Production exposure 
factors (temporal)
Production planning 
and organisation
Exposure dynamics (2,3)
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17% of the total variance in the air measurements. This is in line with the findings of 
(Kromhout, 2002; Nicas et al., 1991), who report that measurement errors due to air 
sampling of chemicals or errors in analytical methods have only a minor contribution 
to the total variation in occupational exposure via air. As stated by (Kromhout, 2002; 
Kromhout et al., 1993) environmental and production factors, such as workplace 
characteristics, individual behaviour of workers and temporal variability have a much 
higher impact on the total variation as measured in personal air measurements 
among workers. This was confirmed in Chapter 3 in which a simple statistical 
regression model was described that explained more than 50% of the total variance 
in the measured respirable dust concentration in air among bricklaying students 
at vocational training centers, based on only a handful of workplace and individual 
behaviour characteristics.
7.3 Assessment of internal concentrations
Exposure scenarios
When assessing internal concentrations of chemicals or their metabolites in workers, 
human physiology and biotransformation will introduce additional variation in the 
results.  A limitation of the exposure scenarios that were decribed in the various 
chapters of this thesis is that a constant workplace air concentrations was assumed in 
the assessment of the internal concentrations of chemicals or metabolites in workers. 
In order to link the findings of the individual chapters of this thesis to the practice of 
chemical exposure assessment for the workplace, a number of exposure scenarios 
were defined (Table 2). These scenarios were intended to represent inhalation exposure 
to a chemical in various exposure settings. Variation in the external (workplace) 
concentration was included in these simulations, as well as differences in exposure 
duration. In correspondence with Chapters 4, 5 and 6 of this thesis, the scenarios were 
applied for the chemicals acetone, 2-propanol and acrylonitrile. 
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Table 2 –Exposure scenarios for the assessment of internal concentrations
1 95th-percentile (GSD), 2 MAK – Maximale Arbeitsplatzkonzentrationen (Ger), TLV 
– Threshold Limit Value (US), STEL – Short term Exposure Limit (US), 3 CEV - N-2-
cyanoethylvaline
For each exposure scenario in Table 2, additional simulations were performed with 
the BioNormtox model. To simulate the variation in the air concentration at the 
workplace, for each scenario  a lognormal exposure distribution was derived. The 
substance specific occupational exposure limit (OEL) was set as the 95th percentile of 
the distribution, which is in accordance with the European guidance for compliance 
testing that allows a maximum of 5% exceedence of the OEL (CEN, 1995). Variation in 
the workplace air concentration was represented by the geometric standard deviation 
(GSD) of the distribution. The scenarios in Table 2 cover both short term (15-minutes) 
and long term (8-hour or work week) exposure, i.e. when acute and chronic health 
effects are both considered relevant, based on the availability of occupational exposure 
levels (OEL) for the chemicals of interest.
 In order to simulate representative variation in workplace air concentrations, 
it should be acknowledged first that the overall variation originates from multiple 
variance components that can be generalized to some extent only. Often a distinction 
is made between interindividual (or between worker) variability and intra-individual 
(or within-worker) variability. Interindividual variability reflects predominantly 
(physiological) differences between, whereas intra-individual variability reflects 
Exposure scenario 
No. External Internal 
substance
air 
concentration1 
(mg/m3)
limit value2
exposure 
duration 
parameter
endpoint 
simulation 
1a. Acetone 2400 (2.48) STEL 15 min Acetone in urine 15 min
1b. 1200 (2.41) MAK / TLV 8 h Acetone in urine end of workday 
(8h)
2a. 2-propanol 980 (2.48) MAK 15 min Acetone in blood 15 min
2b. 490 (2.41) MAK / TLV 8 h Acetone in blood end of workday 
(8h)
2c. 490 (2.41) MAK / TLV 8 h Acetone in urine end of workday 
(8h)
2d. 490 (1.61) MAK / TLV 5 x 8 h Acetone in urine end of work 
week (104h)
3a. Acrylonitril 4.4 (2.41) TLV 8 h CEV3 in blood 5 days 
3b. 4.4 (2.41) TLV 8 h CEV in blood 25 days
3c. 4.4 (2.41) TLV 8 h CEV in blood 85 days
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variation within an individual. However, spatial or temporal factors, such as behaviour 
and workplace or production characteristics may affect both variance components. 
 Interindividual and intra-individual variability components for variation 
in the workplace air concentration in the different scenarios in Table 2 were taken 
from (Kromhout et al., 1993), who calculated within- and between-worker variance 
components from 20,000 personal workday air samples, and from (Kumagai and 
Matsunaga, 1999) who performed similar analyses for within-worker variability of 
short-term exposures. For the 8-h scenarios in Table 2, the median values of the 
geometric standard deviation (GSD) for the within- and between-worker variance 
components (2.0 and 1.43 respectively) as reported by (Kromhout et al., 1993) were 
considered representative. For the 15-min scenarios, (Kumagai and Matsunaga, 1999) 
only provided a GSD for the within worker variance of short term air measurements 
(GSD = 2.3). As no other representative data were found for the short term between-
worker variance, the between-worker GSD for the workday as provided by (Kromhout 
et al., 1993) was used. The overall GSD as used for the 8h and 15min simulations was 
calculated from the within- and between worker variability components following:
 For the end-of-workweek scenario (2d in Table 2), it was reasoned that the 
within-worker variance component as reported by (Kromhout et al., 1993) would 
overestimate the variation in the air concentration for a single individual on five 
consecutive workdays, since the variance between 5 x 8h average exposure values 
for an individual can be expected to be smaller than the variance between 8h average 
exposure values. The longer the averaging period; the smaller the variance. Therefore 
the within-worker variance component was corrected by dividing the reported value by 
a factor of five, following:
 The influence of the simulated variation in air concentrations on the overall 
variation of the internal concentration was consequently assessed for each scenario, 
using the distributions for quantifying the variability in physiological parameters and 
uncertainty in physico-chemical properties, as characterized for the BioNormtox 
model in correspondence with the various chapters of this thesis.
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Monte Carlo simulation and importance analysis
For each scenario in Table 2, a nested Monte Carlo simulation was performed using 
Crystal Ball software (Oracle, version 11). In correspondence with Chapter 4, 5 and 6, 
the simulations were based on a randomly selected set of 100 values from each of the 
variable parameter distributions and a randomly selected set of 100 values from each 
of the uncertain parameter distributions. Thus, a total of 10,000 iterations were run 
for each scenario. This method allowed a separate quantification of uncertainty and 
variability in the overall predicted variation in the internal concentration. 
 The relative contribution of each input parameter to the predicted variability 
and uncertainty was calculated by means of a modified Spearman rank correlation 
method as described in Chapter 4. This so-called importance analysis was performed 
for each of the scenarios in Table 2.  Next, for each scenario the individual input 
parameters were grouped by origin, whereby variation originating from the simulated 
workplace air concentration was identified, as well as variation due to human 
physiology and variation due to uncertainty in model parameters. Consequently, 
the relative contribution of variation in workplace air concentration and variation in 
human physiology to the predicted variability could be specified.
Simulation results
Figure 1 shows the 90th/10th percentile ratios in the estimated internal conentrations 
due to variation in the workplace air concentration, in human physiology and 
in uncertain parameters for all scenarios. Variation in the predicted internal 
concentrations varies from a factor of 7 to 15 (90th/10th percentile ratio) across the 
different scenarios. The simulated variation in workplace air concentration has a 
significant influence on the overall variation in the predicted internal concentration 
for all exposure scenarios, explaining 40% to more than 70% of the total predicted 
variation. Its relative importance is in all scenarios larger than the influence of human 
physiological parameters (9% up to 32%) and in all but one scenario larger than the 
impact of the summarized uncertainty in other model parameters (12% to 41%). The 
total predicted variation increases with an increase in exposure duration for the same 
internal parameter (scenario 1a versus 1b and scenario 2a versus 2b).
These results are in line with the findings of Liao et al. who showed that variation in air 
concentrations and physiological parameters play a large role in the overall variation of 
predicted internal concentrations based on assessments with a generic PBPK model 
that was coupled with exposure pattern characterization for trichloroethylene (Liao et 
al., 2007). The same authors also demonstrated that uncertainties in chemical-specific 
parameters only make a minor contribution to the overall variability and uncertainty.
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Figure 1 - Calculated variability and uncertainty (black) ratios for the simulated blood 
and urine concentrations for the exposure scenarios in Table 2.Variability ratio = (p90-
variability at p50-uncertainty) / (p10-variability at p50-uncertainty). Uncertainty ratio = 
(p90-uncertainty at p50-variability) / (p10-uncertainty at p50-variability).
Interpretation
Important factors that were demonstrated to determine the variation in the simulation 
results in both the exposure scenarios and different chapters of this thesis are described 
here. In accordance with Chapter 4, these factors are related to 1) the exposure phase 
of interest (i.e. uptake, steady-state or elimination), 2) the metabolic processes and 
rates involved, and 3) the range of variation in the model parameters. 
Exposure phase 
In Chapter 4 it was demonstrated that the influence of variance components is not 
fixed, but varies over time from the uptake phase, via a steady-state phase, into the 
elimination phase. In the uptake phase, it was shown that variation in the model 
predictions was dominated by interindividual variability as reflected by the human 
physiological parameters. With regard to the exposure scenarios in Table 2, the 
15-minute scenarios for acetone and 2-propanol (scenario 1a and 2a) are most 
representative for the uptake phase due to the short exposure duration. Indeed, the 
relative impact of the physiological parameters on the overall variation is larger in 
these two scenarios in comparison with the corresponding 8-h exposure scenarios (1b 
and 2b respectively). This is partly caused by the parameter body weight, that plays a 
central role in allometric scaling and consequently influences the other physiological 
parameters. But also the endogenous acetone level contributed significantly to the 
overall variation in scenario 1a in comparison with the 8-h scenario (1b), which can be 
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explained by the endogenous concentration of acetone which represents a relatively 
high amount in relation to the small amount that is taken up in the short exposure 
time.
 The steady-state phase is represented by the exposure scenarios in which 
the exposure duration is so long that metabolism and elimination occur parallel to 
absorption (scenarios 1b, 2b, 2c). In these scenarios, variation in the model predictions 
is increasingly affected by the relative importance of metabolic parameters – described 
in more detail in the next paragraph. 
 In the elimination phase, variation in model predictions is mostly driven by 
the relative importance of parameters that are related to the main elimination routes 
involved. This is best represented in the scenarios in which the exposure is terminated 
well before the endpoint of the simulation, i.e. the acrylonitrile (ACN) scenarios (3a, 
b, c). The main elimination route in these scenarios is via cell death of erythrocytes 
containing irreversibly bound ACN. This explains the increase of the relative importance 
of human physiology, to which category the life span of erythrocytes is assigned, in the 
85 days scenario (3c) – which is close to the median life span of erythrocytes of 110 
days as simulated by the model. Also, the importance of ACN to haemoglobin binding 
decreases over time as the amount of unbound ACN in blood is minimized.
Metabolic processes and rates 
Variance in model parameter related to metabolism is demonstrated as important 
source of variation in the predicted internal concentrations in the exposure scenarios. 
In chapters 4, 5 and 6 of this thesis it was demonstrated that the metabolic parameters 
maximum velocity of metabolism (Vmax) and the Michaelis-Menten constant (Km) 
underlie this. Other researchers also report these parameters as highly relevant 
(Brochot et al., 2007; Sweeney, 2003).
With the nested Monte Carlo simulation technique as applied in this thesis, an explicit 
distinction between variability and uncertainty in the variance components for the 
metabolic parameters could be made. Although this method provides insight in the 
magnitude and the ratio between uncertainty and variability, the output strongly relies 
on the criteria that are used for the definition of the two phenomena and the underlying 
data as used for the parameterisation. In this thesis it is reasoned that interindividual 
variability in metabolic parameters originates from differences in activity of metabolic 
enzymes between individuals and uncertainty originates from differences in 
experimental design (in vivo or in vitro), a limited number of measurements and other 
analytical errors. The parameter distributions applied in this thesis have been derived 
accordingly, based on published experimental data only. However, for the metabolic 
parameters of acrylonitrile only parameter distributions for uncertainty could be 
derived due to a lack of data to differentiate between uncertainty and variability in the 
metabolic rates of this chemical (see chapter 6).
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 The relative importance of the metabolic parameters Vmax and Km differs 
significantly, from <1% up to around 45% of the total predicted variation, depending 
on the exposure scenario selected. The same observations can be made from the 
analyses in Chapter 4 and 5. These results indicate that a number of factors is involved 
that increase the relative importance of the metabolic parameters in the scenarios 
from Table 2: (1) the parameter of interest, i.e. metabolite versus parent compound, 
(2) the biological medium of the analyte, i.e. blood versus urine, and (3) the exposure 
duration, i.e. five consecutive workdays versus 15 minutes. From these factors, the 
increase of exposure duration appeared to affect the relative importance of metabolic 
parameters Vmax and Km the most. This was demonstrated in scenario 2d, in which the 
internal metabolite concentration after 5 consecutive workdays was simulated. 
Variation in model parameters
The range of variation in the model parameters can play a significant role in the 
overall predicted variation by the model. This applies in particular to sensitive model 
parameters. Therefore, a thorough and transparant parameterization of the input 
parameters is highly relevant. Three important factors that determine the range of 
variation in the parameter distributions as derived for the BioNormtox model are 
highlighted on the basis of the simulations performed: 1) the definition of variance 
components in model parameters, 2) the applied method for data collection, and 3) 
the sensitivity of model parameters.
 From the results as presented in Figure 1, it can be concluded that variation 
in workplace air concentrations contributes largely to the overall predicted variation 
in the modelled internal concentrations (40% to more than 70%) in all simulated 
exposure scenarios. Therefore, the robustness of the data that were applied, as well as 
the definition of the variance components is highly relevant. The geometric standard 
deviations (GSDs) that were used to derive the distributions of the air concentration 
the 8-h scenarios were based on a solid analysis of approximately 20,000 personal 
workday air samples by (Kromhout et al., 1993). As the reported values were in line 
with the findings of other authors that performed similar studies (Buringh and Lanting, 
1991; Kumagai et al., 1996) the data were interpreted as reliable. The GSDs for the 15-
min scenarios, based on (Kumagai and Matsunaga, 1999), were calculated from a 
smaller number of measurements and were restricted to the intra-individual (within 
worker) variance component only. The arbitrary choice to apply the inter-individual 
(between worker) variance component based on variation in the workday air samples 
by Kromhout et al. (1993) has affected the approximation of real life situations. Also 
the assumption that variation in the air concentration for a single individual for an 
average concentration of 5 consecutive work days is assumed to be smaller than the 
within-worker variance component as reported by (Kromhout et al., 1993) could not 
be underpinned with empirical data. 
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 In this thesis, data from a large number of different literature sources were 
used to define parameter distributions, among others for built-in variables concerning 
human physiology. This method for data collection differs from more generic methods 
that apply default variation coefficients or reference data for human physiology, e.g. 
data by (Brown et al., 1997) or (Price, 2003). Also, these parameter distributions were 
directly used in the model simulations, in contrast to (Bayesian) methods that first 
define prior distributions based on sometimes moderate data that are subsequently 
updated by fitting or calibration on specific datasets before the actual model simulation 
is performed with posterior distributions (Bois et al., 2010; Chiu et al., 2009; Mork, 
2009).  The direct use of extensive empirical data from various literature sources for 
the definition of parameter distributions, as applied in this thesis, is a transparent 
method that could be verified and extended by other researchers. However, a side effect 
of this method may be that the data are less homogeneous and the compiled standard 
deviations may be larger in comparison with other methods for parameterization. 
This may have indirectly increased variation in the simulated results. 
 Since variation that is caused by physiological differences between individuals 
can in principle not be reduced, one way of reducing the overall predicted variation 
is by narrowing the application domain e.g. by delimiting the population of interest 
or the exercise level. As demonstrated in Chapter 5, the effect of exercise corrected 
physiological parameters on the predicted internal exposure levels was significant 
for workplace settings mainly as a result of increased uptake. Similar results were 
described by (Mork and Johanson, 2006; Reddy et al., 2003; Verner et al., 2012). This 
illustrates that delimiting parameter distributions for exercise level may significantly 
lower the predicted model variation. 
 Also, parameter importance analysis can be used to identify parameters that 
contribute significantly to the predicted output parameter. In this thesis, it has been 
demonstrated that the importance or sensitivity of input parameters varies between 
scenarios. Vice versa, parameters that have been demonstrated to be less sensitive in 
all scenarios are a number of physico-chemical properties of chemicals, such as the 
octanol-water partition coefficient, or parameters that are related to the application of 
the QSAR by (Hendriks et al., 2005) for the estimation of partitioning coefficient. The 
total impact of these sources has been identified to contribute for a maximum of 20% 
of the total variation in internal concentrations in all simulations in Chapters 4, 5 and 
6 of this thesis and less than 10% for the scenarios in Table 2, being a relatively minor 
source of variation.
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7.4 Conclusions and implications
Exposure to chemicals at the workplace can be assessed by means of several 
monitoring and modelling approaches. Irrespective of the method applied, sources of 
uncertainty and variability will influence the outcomes. Quantification of uncertainty 
and variability in the main exposure determinants for external exposure and, in 
addition, in the parameterization of human physiology, metabolism and chemical 
properties for internal exposure is essential for a reliable assessment. 
The main conclusions that can be drawn from this thesis are described below.
Variation in workplace air concentrations
Statistical regression models derived from personal air measurements at the 
workplace indicate that environmental and production factors, such as workplace 
characteristics and individual behaviour of workers, have a large influence on both 
inter- and intra-individual variation in personal air concentrations between and within 
workers in comparison to sources of measurement error, such as originating from 
the use of personal inhalable aerosol samplers (Chapter 2 and 3). Since variation in 
workplace air concentrations of chemicals also contributes largely to the predicted 
variation in internal concentrations in workers, as demonstrated in this chapter, a 
good understanding and quantification of underlying variance components for 
workplace air concentrations will improve the reliability of the assessment of internal 
exposure levels of chemicals. 
Identification of the exposure phase per scenario
The influence of sources of variability and uncertainty on the predicted variation in 
internal concentrations is not fixed, but varies over the different phases of exposure 
from the uptake phase, via a steady-state phase, into the elimination phase. In the 
uptake phase, human physiological parameters have a relatively large influence on 
the predicted internal concentrations, while metabolic parameters become more 
relevant in the steady state phase when metabolism and elimination occur parallel to 
absorption. In the elimination phase, variation in model predictions is mostly driven 
by the relative importance of parameters that introduce uncertainty and variability 
through the main elimination routes involved. 
 The timing of the exposure scenario affects the course of the various exposure 
phases, not only through the exposure level and duration, but also by the endpoint 
of the simulation. Information about the phase of exposure at the moment that the 
internal exposure assessment  is performed will provide insight in the relevant sources 
of uncertainty and variability that play a role at that time.
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Interpretation of variation in model outcomes
Nested Monte Carlo simulation as performed in this thesis allows a separate 
quantification of interindividual variability and uncertainty in the predicted model 
variation. From the perspective of risk assessment, insight in the range of variation in 
the predicted exposure is in particular relevant if this is in the same range as applicable 
exposure limits. If this is the case, than the contribution of uncertain parameters 
to the predicted variation in exposure is relevant, since the model estimation 
could be improved by reducing uncertainty, e.g. by the collection of more (precise) 
measurements for model parameters. Parameter importance analysis will indicate 
what uncertain parameters have the highest impact on the predicted variation and 
should thus be focussed on to reduce uncertainty in predicted internal concentrations. 
 The predicted range of variation due to interindividual variability indicates 
the individuals or fraction of the population that may be exposed above the exposure 
limit. Since variability that originates from human physiology can in principle not be 
reduced, reduction of variation in workplace air concentrations, e.g. by implementation 
of control measures, is a starting point. 
 If variation in the model outcomes remains too large to obtain conclusive 
results, as an alternative the scope of the study can be adjusted e.g. by narrowing 
down the population of interest or the exercise level. Clearly, these actions will also 
restrict the application domain of the model applied. 
Implications for policy makers
Insight in the impact of different sources of interindividual variability and uncertainty 
on the predicted (internal) exposure to chemicals in different workplace scenarios can 
help to set management priorities for risk assessment. 
Although not all types of uncertainty were considered in this thesis and the number 
of assessed chemicals and scenarios is limited, the following recommendations for 
policy makers can be made:
• In situations with large variation in the workplace air concentrations, the predicted 
internal concentrations are expected to be highly variable. Risk assessment 
based on model estimations of internal concentrations requires a thorough 
characterization of sources of variation in workplace air concentrations in order 
to have added value above collecting biological measurements.
• Depending on the exposure phase of the assessed scenario, different parameters 
have influence on the variation in the predicted internal exposure. Parameter 
importance analysis can pinpoint what parameters are most relevant in each 
scenario. Thanks to the Nested Monte Carlo analysis, underlying sources of 
uncertainty and variability can be identified to support the risk assessment 
process:
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 0 Analysis of the uncertainty component will indicate the level of certainty of 
the predictions. This indicates the need for additional research to obtain 
more accurate estimates.
 0 Analysis of the variability component can be used to identify sensitive 
individuals or the fraction of the population at risk. This indicates the 
relevance of implementing control measures to reduce exposure.
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Figure A-1 Cumulative probability plots for the simulated acetone in blood concentration 
(scenario by Rose et al. (1999)) at several time points. A comparison is shown between 
the metabolic constants (Vmax and Km) for acetone as used in the present paper (A) and 
alternative metabolic constants by Kumagai and Matsunaga (1995) (B). Median values 
are displayed (dashed lines) with 10th and 90th percentiles (continuous lines). Measured 
data from Rose et al. (1999) are also displayed at t= 1, 4 and 4.5 (10th, 50th and 90th 
percentiles), corrected for endogenous acetone levels.
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Figure A-2  Relationship between the blood:air partition coefficient (Kba) for acetone and 
the simulated mean concentration acetone in blood directly after exposure to 2-propanol 
(t=4) and after 16 hours from the start of the experiment (t=16). Experimental partition 
coefficients are displayed (Fiserova-Bergerova and Diaz, 1986;  Paterson and Mackay, 
1989;  Sato and Nakajima, 1979) as well as the predicted range by means of the QSAR 
by Hendriks et al. (2005) (minimum and maximum values as dashed lines, mean as 
continuous line).
Figure A-3  Relationship between the QSAR predicted blood:air partition coefficient (Kba, 
via Hendriks et al., 2005) for acetone and the simulated mean concentration acetone in 
blood directly after exposure to 2-propanol (t=4) and after 16 hours from the start of the 
experiment (t=16). The predicted range is displayed for temperature corrected (37˚C) and 
uncorrected (25˚C) physico-chemical parameters (minimum and maximum values as 
dashed lines, mean as continuous line).
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Figure A-4  Variability ratios for increased correlation between body weight on the one hand 
and adipose tissue volume, alveolar ventilation and cardiac output on the other hand (r = 
0.8) (light bars) in comparison with the reference model (dark bars) after 4 and 8h from 
the onset of exposure to 2-propanol.
Table A-1 Specification of the variability distributions in the human physiological parameters, 
including references (continued from Table 1 main text).
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Description of 
variable
Reference Population Comment
Alveolar Ventilation (Adams, 1993;  US-
EPA, 1997)
adolescent, young 
to middle aged, and 
older adult male 
and female subjects 
(n=116)
alveolar ventilation at rest (sitting); 
method of Ragas and Huijbregts 
(1998) was used to combine 
distributions of different genders.
Cardiac Output (Milnor, 1990) male and female 
subjects (16-56 years, 
n=93)
derived by analysis of reports 
from seven different laboratories; 
measurements in lying position
Body Weight (NCHS, 1987;  US-
EPA, 1997)
(US) male and 
female subjects 
18-75 years, all races 
(n=12504)
method of Ragas and Huijbregts 
(1998) was used to combine 
distributions of different genders.
Thickness of 
epidermis
(Sandby-Moller and 
Wulf, 2003)
male and female 
subjects 20-68 years 
(median 47 years, 
n=71)
value of all body sites; 
differentiation in body sites 
available for forearm dorsal, 
shoulder and buttock; 
interindividual difference is much 
smaller than that between body 
sites
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Thickness stratum 
corneum
(Sandby-Moller and 
Wulf, 2003)
male and female 
subjects 20-68 years 
(median 47 years, 
n=71)
value of all body sites; 
differentiation in body sites 
available for forearm dorsal, 
shoulder and buttock; 
interindividual difference is much 
smaller than that between body 
sites
Volume of produced 
urine
(Raman et al., 2004) (US) male and 
female subjects (40-
79 years, n=313)
method of Ragas and Huijbregts 
(1998) was used to combine 
distributions of different age 
classes and genders.
Arterial Fraction (Milnor, 1968;  
Schmid-Schoenbein 
and Ross, 1990)
adult men (40 years, 
75 kg)
according to ICRP (1975), no 
gender differences were assumed.
Cardiac output fractions to tissues
Description of 
variable
Reference Population Comment
Adipose tissue (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
male and female 
subjects with 
apparently normal 
circulation (16-76 
years, n=104)
metastudy (11 studies); value 
is weighted mean; metastudy 
mentions reference value for males 
(0.05) and females (0.085); for 
the majority our value is based 
on studies on males, but also 
one (verifiable) study with mixed 
genders was included. Because of 
this and the fact that our value lies 
relatively close to the mean of male 
and female reference value (this 
mean is 0.0675) no adaptations of 
the value were made.
Brain (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
male and female 
subjects with 
apparently normal 
cerebral circulation 
and cardiac function 
(16-79 years, n=630)
metastudy (39 studies); value is 
weighted mean; does not differ 
significantly between gender
Heart (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
male and female 
subjects with 
apparently normal 
myocardial 
circulation (20-69 
years, n=274)
metastudy (19 studies); value is 
weighted mean; women have a 
20-30% higher value than age-
matched males
Description of 
variable
Reference Population Comment
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Kidneys (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
normotensive, 
resting male and 
female subjects with 
apparently normal 
renal and cardiac 
functions (17-69 
years, n=979)
metastudy (85 studies); value is 
weighted mean; seperate studies 
indicatie a possibly slightly higher 
value for males
Liver arterial (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
young and middle 
aged male and 
female subjects 
with normal portal 
pressure (n=35)
metastudy (5 studies); value is 
weighted mean of fractions of 
blood flow through hepatic artery
Liver venous (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
healthy male and 
female subjects 
(n=237)
metastudy (11 studies); value 
is weighted mean; the studies 
are mainly on men, but a few 
(verifiable) studies on mixed 
gender are included as well. The 
metastudy formulates a reference 
value for males (0.185) and states 
that the blood flow through the 
portal vein in females should 
be approx. 2 percent higher due 
to higher blood flow to their GI 
(gastro intestinal) tract. Data 
for females are too sparse to 
illuminate any subtle differences 
with gender that may exist. Because 
of this and the fact that our value 
lies relatively close to the mean of 
male and female reference values 
(this mean is 0.195) no adaptations 
of the value were made.
Lung (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
males and females, 
some patients 
under examination 
of potential heart 
disease (n=75)
metastudy (5 studies); value is 
weighted mean; does not differ 
significantly between gender
Muscle (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
healthy male and 
female subjects (15-
75 years, n= 713)
metastudy (54 studies); value 
is weighted mean; no gender 
difference, but dependency on 
muscle volume leads to different 
fractions between males and 
females
Skeleton (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
healthy male and 
female subjects 
(n=85)
metastudy (5 studies); value is 
weighted mean
Description of 
variable
Reference Population Comment
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Skin (Leggett et al., 
1996;  Williams and 
Leggett, 1989)
healthy male 
subjects (15-60 years, 
n=146)
metastudy (10 studies); value is 
weighted mean; the metastudy 
states that there is a theoretical 
difference between males and 
females of about 1.5%, but due to 
far higher variation between the 
analyzed studies, they formulate 
one value for both males and 
females. Although the included 
studies are on males only, we 
assume the weighted mean to be 
applicable to females as well.
Tissue volume fractions of Total volume
Description of 
variable
Reference Population Comment
Adipose tissue (Stokic et al., 2002) males (n=64) and 
females (n=76), aged 
23.44 ± 1.26 years
Blood (Wadsworth, 1954;  
Yiengst and Shock, 
1962)
adult male and 
female subjects 
(n=16)
Based on two studies by Yiengst 
and Shock (1962; n=8) for the 
blood volume in males, and by 
Wadsworth (1954; n=8) for that of 
females.
Bone (Woodard and 
Holodny, 1960)
male and female 
subjects (16 - 86 
years; females: 
43.5-55.2 kg, males: 
59.6-65 kg) (n=13)
fraction is not related to age or 
gender; volume of bone from same 
study as volume of marrow
Brain (Dekaban, 1978) Male and female 
subjects (21-39 years, 
n=552) 
mean brain weight divided by mean 
bodyweight; included females from 
the same age and study as the data 
for men (Dekaban, 1978). Total 
n=552 (males:351; females: 201)
Heart (Olivetti et al., 1995;  
Snyder et al., 1975)
male and female 
subjects (16-65 years, 
n=60)
Intestines (Snyder et al., 1975) male and female 
adult subjects 
Based on the weight of the GI tract 
as reported by the ICRP (Snyder 
et al., 1975), as an average of the 
value for males and for females. 
To come to a fraction of the total 
bodyweight, the weight of the 
intestines was divided by 78.1 kg 
for males and 65.4 kg for females 
(weights according to NCHS 1987, 
US EPA 1997)
Description of 
variable
Reference Population Comment
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Kidney (Snyder et al., 1975) male and female 
subjects (20-40 
years, (n=3428)
Based on a study reported by ICRP 
(Snyder et al., 1975), on the kidney 
weight for both men and women. 
To come to a fraction of the total 
bodyweight, the weighted mean 
of the kidney weight was divided 
by 78.1 kg for males and 65.4 kg 
for females (weights according to 
NCHS 1987, US EPA 1997). n=3428 
(males: 2414; females: 1014).
Liver (Snyder et al., 1975) male and female 
subjects (18-59 years, 
n=367)
Based on a study reported by ICRP 
(Snyder et al., 1975), on the liver 
weight for both men and women. 
To come to a fraction of the total 
bodyweight, the weighted mean 
of the kidney weight was divided 
by 78.1 kg for males and 65.4 for 
females (weights according to 
NCHS 1987, US EPA 1997). n= 367 
(males: 260;  females: 107)
Lung (Snyder et al., 1975) male and female 
subjects (18-40 
years, n=516)
Based on a study reported by ICRP 
(Snyder et al., 1975), on the weight 
of lungs for both men and women. 
To come to a fraction of the total 
bodyweight, the weighted mean 
of the lungs weight was divided 
by 78.1 kg for males and 65.4 kg 
for females (weights according to 
NCHS 1987, US EPA 1997(. n= 516 
(males: 311; females: 205)
Marrow (Woodard and 
Holodny, 1960)
male and female 
subjects (16 - 86 
years; females: 
43.5-55.2 kg, males: 
59.6-65 kg; n=13)
fraction is not related to age or 
gender; volume of bone from same 
study as volume of bone
Muscle (Snyder et al., 1975) male and female 
adult subjects (n=6)
muscle weight divided by body 
weight
Skin (Snyder et al., 1975) male and female 
adult subjects
values from different studies 
reported by ICRP (Snyder et al., 
1975), not possible to identify 
possible difference between gender
Metabolic parameters for 2-propanol
Maximum velocity 
of metabolism 
(Vmax)
(Clewell et al., 2001; 
Dorne et al. 2004)
- Clewell et al.used for mean value. 
Dorne et al  (2004) was used for 
the calculation of the CV value.
Description of 
variable
Reference Population Comment
155
Supporting information for chapter 4
A
Michaelis-Menten 
constant (Km)
(Clewell et al., 2001; 
Dorne et al. 2004)
- Clewell et al.used for mean value. 
Dorne et al  (2004) was used for 
the calculation of the CV value.
Metabolic parameters for acetone
Maximum velocity 
of metabolism 
(Vmax)
(Clewell et al., 
2001;Martinez et 
al.2010)
- Clewell et al.used for mean value. 
Dorne et al  (2004) and Martinex 
et al. (2010)    were used for the 
calculation of the CV value.
Michaelis-Menten 
constant (Km)
(Clewell et al., 
2001;Martinez et 
al.2010)
- Clewell et al.used for mean value. 
Dorne et al  (2004) and Martinex 
et al. (2010)    were used for the 
calculation of the CV value.
Fractional transfer coefficients for washin-washout module
Mucosa to arterial 
blood
(Mork et al.,2009) - Based on the prior distributions.
Bronchioles to 
mucosa
(Mork et al.,2009) - Based on the prior distributions.
Description of 
variable
Reference Population Comment
Explanation:
Variability distributions as used in the model simulations are tabulated in table 1 
(main text). Minimum and maximum values for fractional parameters (derived  from 
the NHANES database, as described by Price et al. 2003) were based on ratios with 
the most likely value (derived  from literature, as shown in Table A-1). A ratio of 1.5 
was used for all parameters except for adipose tissue (ratio of 3). Distributions for 
continuous parameters (lognormal) were based on literature only, as shown in the 
table above (A-1).
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Table A-2 Tissue composition parameter values as used for the QSAR by Hendriks et al. 
(2005)
a Schmitt (2008).
Assumptions:
Values for phospholipids as reported by Schmitt (2008) were assumed to be similar to 
polar lipids. Interstitual fluids were also considered in the tissue composition values 
in table A-3. According to Schmitt  (2008) these fluids consist for 94% of water. From 
the remaining 6%, 2% was assumed lipids and 4% proteins. The percentage of red 
blood cells in blood (needed to calculate blood composition) was assumed to be 
44%, based on Davies and Morris (1995).
tissue
neutral 
lipids (%)
polar lipids 
(%)
total lipids 
(%)
proteins (%) water (%) reference
blood 0.5 1.1 1.6 16.8 80.4 a
fat 79.4 0.0 79.4 5.7 15.7 a
bone 1.7 0.3 2.0 19.3 32.8 a
brain 4.3 6.7 11.0 8.0 79.0 a
heart 4.7 5.1 9.7 16.9 73.4 a
kidney 1.3 3.8 5.1 17.3 77.6 a
intestine 4.5 2.0 6.5 13.9 79.2 a
liver 2.0 4.9 6.9 17.9 72.7 a
lung 1.5 3.6 5.0 12.5 84.0 a
muscle 0.5 0.6 1.1 17.2 78.2 a
skin 9.3 1.0 10.3 29.5 61.6 a
bone 
marrow
79.4 0.0 79.4 5.7 15.7 similar to fat 
tissue  
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Table A-3 Calculations for correction of endogenous acetone concentration in blood (as 
reported by Rose et al., 1999). Values used for the model comparison.
Reported values for acetone in blood (Rose et al. 1999) 
t xp2s Xpso xp7s 
(mg/1) (mg/1) (mg/1) 
0 2.7 3.8 4.7 Background Xp2s = 25th percentile 
1 6.8 8.5 
2 11.1 12.5 
9.6 
15.5 
Xpso = 50th percentile (median) 
Xp7s = 75th percentile 
3 17.2 18.1 21.8 
4 17.5 21.3 24.7 
4 .5 14.6 17.7 19.4 
Calculation of the standard deviation (SD) 
t SD Data were assumed normally distributed, therefore: 
0 1.5 SO= X p75-X p2s I Z p7s- Z p2s =X p75-X p2s / 2x Z p7S 
1 2.1 Zp25 = -6. 74E-01 (Z-score at 25th percentile) 
2 3.3 Zp7s = 6. 74E-01 (Z-sco re at 75th percenti le) 
3 3.4 
4 5.3 
4 .5 3.6 
Calculated values, corrected for background level of acetone 
t 
0 
1 
2 
3 
4 
4 .5 
where: 
I! SD(t . ) X cor p2s X cor pso X cor pJs 
(mg/1) (mg/ 1) (mg/1) 
0.0 0.00 0.0 0 .0 0.0 
4.7 1.45 3.7 4.7 5.7 
8.7 2.91 6.7 8 .7 10.7 
14.3 3.07 12.2 14.3 16.4 
17.5 5.13 14.0 17.5 21.0 
13.9 3.23 11.7 13.9 16.1 
ll = XpsO, tx - XpsO, t0 
Var(t1) = Var (t0+t1)- Var (t0) = sd2(t0+t1)- sd2(t0 ) 
SD(t1) = sqrt(sd 2(t0+t 1) - sd2(t0)) 
SD(t2) = sqrt(sd 2(t0+t2)- sd2(t0)) 
Data were assumed independent o~er t ime 
X cor p2s X cor pso 
(llmol/ 1) (llmol/1) 
0 .0 0.0 
64.0 80.9 
116.0 149.7 
210.5 246.1 
241.7 301.2 
201.7 239.2 
X cor pJs 
(llmo l/1) 
0 .0 
97.8 
183.5 
281.8 
360.7 
276.8 
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Syntax A-1 Additional model syntax for the IndusChemFate model for the washin-washout 
effect of polar substances, based on Mork et al. (2009) and  Mork and Johanson (2006).
Representation of washin-washout derived from Mork et al, 2009.
Parameter from 
Mork et al, 2009
Corresponding para-
meter in present study
Description
Qalv AlvVent Alveolar Ventilation
Qbromuc Qbromuc Blood flow from bronchioles to mucosa
Qmucart Qmucart Blood flow from mucosa to arterial blood
Qc CardOutp Cardiac Output
Cinh Cinh Inhaled concentration of substance in air
Cbro Cbro Concentration of substance in bronchioles
Cmuc Cmuc Concentration of substance in mucosa
Calv Calv Alveolar concentration of substance
Cart CBlungArt Concentration of substance in arterial lung blood
Pwa / Pba RCbw Blood:Water partition coefficient
Pba RCba Blood:Air partition coefficient
Pwa RCwa Water:Air partition coefficient
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Arterial blood concentration
CBlungArt = (CardOutp * CBlungVen + AlvVent * Calv + Qmucart * Cmuc) / (CardOutp 
+ AlvVent / RCba + Qmucart / RCbw)   
Where:
CBlungArt = Concentration of substance in arterial lung blood
CBlungVen = Concentration of substance in venous lung blood
AlvVent = Alveolar Ventilation 
Calv = Alveolar concentration of substance
Qmucart = Blood flow from mucosa to arterial blood
Cmuc = Concentration of substance in mucosa
RCba = Blood:Air partition coefficient
RCbw = Blood:Water partition coefficient
Concentration in alveolae
Calv = (AlvVent * Cbro + AlvVent * CBlungArt / RCba) / (AlvVent + AlvVent)
Where:
Cbro = Concentration of substance in bronchioles
Concentration in mucosa
Cmuc = (Qmucart * CBlungArt * RCwb + Qbromuc * Cbro) / (Qmucart + Qbromuc 
/ RCwa)
Where:
RCwb = Water:Blood partition coefficient
Qbromuc = Blood flow from bronchioles to mucosa 
RCwa = Water:Air partition coefficient
Concentration in bronchioles
Cbro = (AlvVent * Calv + AlvVent * Cinh + Qbromuc * Cmuc / RCwa) / (AlvVent + 
AlvVent + Qbromuc)
Where:
Cinh = Inhaled concentration of substance in air
Amount of exhaled substance or metabolite
AmntExh = AlvVent * Cbro   
Where:
AmntExh= Amount of exhaled substance
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Equation B-1 – Calculation of renal excretion in the BioNormtox model 
A kidney = Q urine * C blood kidney * F solved        
  
Where:
A kidney is the amount excreted to urine (μmol/h), 
Q urine the flow of produced urine (l/h), 
C blood kidney the concentration of a substance in blood to the kidneys (μmol/l), and 
F solved the water soluble fraction of a substance in blood.
Table B-1 – Variability distributions of the metabolic parameters for 2-propanol and acetone 
as used in the simulations.
a Lognormal distributions are presented as geometric mean (geometric standard 
deviation)
b Km and Vmax were considered as both variable and uncertain. The variability component 
is described by lognormal distributions, based on reported interindividual variation in 
the activity of the metabolic enzymes involved, i.e. ADH and Cyp2E1 for 2-propanol and 
acetone respectively (Dorne, 2004; Martinez, 2010)
Description of variable Units
Distribution 
type Specification
 a References
2-propanol
Maximum velocity of 
metabolism (Vmax) 
b
mg*hr-1*kgbw-0.75 lognormal 300 (1.34) (Clewell et al., 2001); 
(Dorne, 2004)
Michaelis-Menten 
constant (Km) 
b
mg*l-1 lognormal 10 (1.34) (Clewell et al., 2001); 
(Dorne, 2004)
acetone
Maximum velocity of 
metabolism (Vmax) b
mg*hr-
1*kgbw-0.75
lognormal 3.5 (1.34) (Clewell et al., 2001; 
Martinez, 2010)
Michaelis-Menten 
constant (Km) b
mg*l-1 lognormal 10 (1.34) (Clewell et al., 2001; 
Martinez, 2010)
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Table B-2 – Uncertainty distributions of chemical-specific and metabolic parameters for 
2-propanol and acetone as used in the simulations.
Description of 
Variable
Units
Distribution 
type Specification 
a N b References
2-propanol (IPA)
Octanol-water 
partitioning 
coefficient (Kow)
unitless lognormal 1.24 (1.12) 6 (Abernethy et al., 1988;  
Dillingham et al.1973;  Funasaki 
et al., 1986;  Hansch, 1985;  Leo 
et al., 1969) from (Mackay, 
1995)
Vapor pressure 
at 25°C
Pa lognormal 5.88E+03 (1.03) 5 (Butler and Ramchandani, 1935;  
Daubert and Danner, 1989;  
Dean, 1985;  Riddick et al., 1986; 
Stull, 1947;  Verschueren, 1983) 
from (Mackay, 1995)
Water solubility 
at 25°C
mg*l-1 lognormal 4.16E+05 (1.10) 2 (Kamlet et al., 1987;  Taft et al., 
1985) from (Mackay, 1995)
Density at 25°C g*l-1 lognormal 7.84E+02 (1.00) 3 (Butler and Ramchandani, 1935;  
Dean, 1985;  Verschueren, 1983) 
from (Mackay, 1995)
Maximum 
velocity of 
metabolism 
(Vmax) 
d
mg*hr-
1*kgbw-0.75
lognormal 300 (2.30) 1 (Clewell et al., 2001)c
Michaelis-Menten 
constant (Km) 
d
mg*l-1 lognormal 10 (2.30) 1 (Clewell et al., 2001)c
Acetone
Octanol-water 
partitioning 
coefficient (Kow)
unitless lognormal 0.53 (1.21) 6 (Hansch and Leo, 1985; Hansch 
and Hoekman, 1995; Leo et al., 
1969) from (Mackay, 1995)
Vapor pressure 
at 25°C
Pa lognormal 3.05·104 (1.02) 5 (Daubert and Danner, 1989;  
Riddick et al., 1986;  Stull, 1947) 
from (Mackay, 1995)
Water solubility 
at 25°C
mg*l-1 lognormal 6.04·105(1.25) 4 (Kamlet et al., 1987;  Taft et al., 
1985) from (Mackay, 1995)
Density at 25°C mg*m-3 or 
g*l-1
lognormal 790 (1.00) 4 (Dean, 1985;  Riddick et al., 
1986;  Stull, 1947;  Verschueren, 
1983) from (Mackay, 1995)
Maximum 
velocity of 
metabolism 
(Vmax) 
d
mg*hr-
1*kgbw-0.75
lognormal 3.5 (2.30) 2 (Clewell et al., 2001; Kumagai 
and Matsunaga, 1995)
Michaelis-Menten 
constant (Km) d
mg*l-1 lognormal 10 (2.30) 2 (Clewell et al., 2001; Kumagai 
and Matsunaga, 1995)
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a Lognormal distributions are presented as geometric mean (geometric standard deviation), 
betaPERT distributions as most likely value (minimum, maximum), beta distributions as 
alpha, beta (minimum, maximum);
b Number of observations used from literature
c Reference only used for mean value. CV analogue with metabolic parameters for acetone 
d The values for the metabolic parameters of acetone are based on Clewell et al. (2001) and 
Kumagai and Matsunaga (1995). Differences between these two studies were interpreted as 
uncertainty. The values reported by Clewell et al. (2001) were selected as the mean values 
for the uncertainty distribution for Km and Vmax. The coefficient of variation was based 
on both studies. Due to data limitations, the coefficients of variation in Km and Vmax for 
2-propanol were assumed to equal those of acetone. 
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Table B-3 – Derived multipliers for extrapolation of fractional blood flows to tissues in rest 
to light work
Model compartment Reference
% of cardiac output to tissue 
Derived multiplier 
for light work
(35 to 50 W)at rest
at light work
33W 50W
‘Slowly perfused’ tissues 1
Lumped
a 20.2 43.2 54.4
Skin: 1.8
Muscles : 2.2
d 19 -3 -
Resting muscles and skin a 11 - 5
Working muscles and skin a 11 - 45
Skin c 9 - 16
Muscles c 21 47
Brain c 13 - 8 Brain: 0.6
Bone - - - - Bone: 1
‘Rapidly perfused’ tissues 2
Lumped d - - 27
Kidney: 0.5
Heart: 1
Kidney and Heart b 46.2 32 25
a 44 - 29
Kidney c 19 - 6
Heart c 4 - 4
Liver and ‘digestive tract’
‘Digestive tract’ c 24 - 12
Liver: 0.5
Liver b 31 21 16
a 32 - 16
d 25 - 16
Other tissues
Fat tissue
a 3 - 5
Fat: 1.7a 2.9 4 4.6
d 5 - 6
Lungs - - - - Lungs: 1
a – Mork and Johanson (2006), based on Astrand (1983), b - Dankovic and Bailer (1994), 
based on Astrand (1983), c - Brown et al., (2006), d – Thomas et al. (1996), 
1. slowly perfused tissues = sum of muscles, skin, bone, brain, testes (Nestorov et al., 1998).
2. rapidly perfused tissues = sum of: kidneys, heart (Nestorov et al., 1998).
3. no data available
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Table B-4 – Comparison between calculated mean values for blood flows to tissues at light 
work (BioNormtox model) and published experimental data from Fiserova-Bergerova 
(1983)
1.Calculated flow to tissue (l/h) corrected for increased cardiac output (rest –  GM = 390 
l/h, light exercise – GM = 741 l/h and change in blood flow to tissue (multiplier). 
2. recalculated to total volume of adipose tissue, 
3. no data available
Table B-5 – Endogenous concentration of urinary acetone in the general population 
(µmol/l).
1. As calculated based on the presented data
2. Weighted mean (GM) and GSD
Compartment in 
BioNormtox model
Blood flow to 
tissue (l/h)1
Light work
Fiserova-Bergerova 
(1983)
Blood flow to tissue 
(l/h)
Light work 
Adipose 59.1 Adipose 2 36.0
Skin 65.0 Skin
300.0
Muscles 183.2 Muscles
Brain 41.4 Brain  - 3
Bone 29.6 - -
Marrow 41.4 Red marrow 12.0
Kidneys 53.2 Kidneys 66.0
Heart 35.5 Coronary arteries 30.0
Liver arterial 17.7
Splanchnic 96.0
Liver venous 53.2
Lungs 17.7  - - 
Reference n relative weight1 AM GM sd gsd
(Pezzagno et al., 1986) 15 1% 13.1 10.1 10.7 2.0
(Bales et al., 1986) 994 62% 41.3 22.1 65.4 3.1
(Wigaeus et al., 1981) 8 0,50% 24.1 3.0 191.1 7.7
(Satoh et al., 1995) 66 4% 22.4 10.7 41.3 3.4
(Wang et al., 1994) 89 6% 14.5 7.2 25.1 3.3
(Kawai et al., 1992) 343 21% 5.0 2.0 11.2 3.8
(Ghittori et al., 1996) 100 6% 13.8 11.3 9.6 1.9
sum 1615 15.1 2 3.1 2
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Figure B-1 – Cumulative probability plots of the simulated median (continuous line), 10th 
and 90th (dotted lines) concentration percentiles in blood and urine after inhalation of 
2-propanol at the level of the OEL for 8h during rest and light exercise. Corresponding BLVs 
for each scenario are also displayed.
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Table C-1 – Variability distributions for human physiological parameters at rest and during 
light work as used in the model simulations (see also Huizer et al. 2012 and Huizer et al. 
2014 for further details).
Description 
of variable
Units
Distribution 
type At rest 
a Population References 
At light 
work a
Multiplier 
(rest to 
exercise) e
Alveolar 
ventilationb 
l/h Lognormal 511 (1.27) adolescent, 
young to 
middle aged, 
and older 
adult male and 
female subjects 
(n=116)
(Adams, 
1993;  US-
EPA, 1997)
1334 (1.14) n/a
Cardiac 
output
l/h Lognormal 390 
(1.24)
male and 
female subjects 
(16-56 years, 
n=93)
(Milnor, 
1990)
591 (1.11) n/a
Body 
weight
kg Lognormal 71.4 
(1.24)
(US) male and 
female subjects 
18-75 years, all 
races (n=12504)
(NCHS, 
1987;  US-
EPA, 1997)
71.4 (1.24) d n/a
Thickness 
of 
epidermis
cm Lognormal 0.0084 
(1.22)
male and 
female subjects 
20-68 years 
(median 47 
years, n=71)
(Sandby-
Moller and 
Wulf, 2003)
0.0084 
(1.22) d
n/a
Thickness 
of stratum 
corneum
cm Lognormal 0.0015 
(1.37)
male and 
female subjects 
20-68 years 
(median 47 
years, n=71)
(Sandby-
Moller and 
Wulf, 2003)
0.0015 
(1.37) d
n/a
Volume of 
produced 
urinec
l/h Lognormal 0.091 
(1.51)
(US) male and 
female subjects 
(40-79 years, 
n=313)
(Raman et 
al., 2004)
0.091 (1.51) d n/a
Arterial 
fraction
unitless betaPERT 0.251 
(0.167, 
0.376)
adult men (40 
years, 75 kg)
(Milnor, 
1968;  
Schmid-
Schoenbein 
and Ross, 
1990)
0.251 (0.167, 
0.376) d
n/a
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Cardiac output fractions to tissues
Adipose 
tissue
unitless betaPERT 0.061 
(0.020, 
0.184)
male and 
female subjects 
with apparently 
normal 
circulation 
(16-76 years, 
n=104)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.104 
(0.035, 
0.313)
1.7
Brain unitless betaPERT 0.117 
(0.078, 
0.176)
male and 
female subjects 
with apparently 
normal cerebral 
circulation and 
cardiac function 
(16-79 years, 
n=630)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.07 (0.047, 
0.105)
0.6
Heart unitless betaPERT 0.056 
(0.037, 
0.083)
male and 
female subjects 
with apparently 
normal 
myocardial 
circulation 
(20-69 years, 
n=274)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.056 
(0.037, 
0.083)
1
Kidneys unitless betaPERT 0.177 
(0.118, 
0.265)
normotensive, 
resting male 
and female 
subjects with 
apparently 
normal renal 
and cardiac 
functions 
(17-69 years, 
n=979)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.088 
(0.059, 
0.133)
0.5
Liver 
arterial
unitless betaPERT 0.068 
(0.046, 
0.103)
young and 
middle aged 
male and 
female subjects 
with normal 
portal pressure 
(n=35)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.034 
(0.023, 
0.051)
0.5
Description 
of variable
Units
Distribution 
type At rest 
a Population References 
At light 
work a
Multiplier 
(rest to 
exercise) e
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Liver 
venous
unitless betaPERT 0.189 
(0.126, 
0.283)
healthy male 
and female 
subjects 
(n=237)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.094 
(0.063, 
0.141)
0.5
Lung unitless betaPERT 0.034 
(0.023, 
0.051)
males and 
females, some 
patients under 
examination of 
potential heart 
disease (n=75)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.034 
(0.023, 
0.051)
1
Muscle unitless betaPERT 0.142 
(0.095, 
0.214)
healthy male 
and female 
subjects (15-75 
years, n= 713)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.313 
(0.209, 
0.470)
2.2
Skeleton unitless betaPERT 0.115 
(0.077, 
0.173)
healthy male 
and female 
subjects (n=85)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.115 (0.077, 
0.173)
1
Skin unitless betaPERT 0.059 
(0.039, 
0.089)
healthy male 
subjects (15-60 
years, n=146)
(Leggett et 
al., 1996;  
Williams 
and Leggett, 
1989)
0.107 
(0.071, 
0.160)
1.8
Tissue volume fractions of total volumes
Adipose 
tissue
unitless betaPERT 0.187 
(0.062, 
0.561)
males (n=64) 
and females 
(n=76), aged 
23.44 ± 1.26 
years
(Stokic et 
al., 2002)
0.187 
(0.062, 
0.561)  d
n/a
Blood unitless betaPERT 0.071 
(0.047, 
0.106)
adult male and 
female subjects 
(n=16)
(Wadsworth, 
1954;  
Yiengst 
and Shock, 
1962)
0.071 
(0.047, 
0.106)  d
n/a
Bone unitless betaPERT 0.075 
(0.050, 
0.113)
male and 
female subjects 
(16 - 86 years; 
females: 43.5-
55.2 kg, males: 
59.6-65 kg) 
(n=13)
(Woodard 
and 
Holodny, 
1960)
0.075 
(0.050, 
0.113)  d
n/a
Description 
of variable
Units
Distribution 
type At rest 
a Population References 
At light 
work a
Multiplier 
(rest to 
exercise) e
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a Lognormal distributions are presented as geometric mean (geometric standard deviation), 
betaPERT distributions as most likely value (minimum, maximum), beta distributions as 
alpha, beta (minimum, maximum);
Brain unitless betaPERT 0.021 
(0.014, 
0.032)
Male and 
female subjects 
(21-39 years, 
n=552) 
(Dekaban, 
1978)
0.021 
(0.014, 
0.032)  d
n/a
Heart unitless betaPERT 0.005 
(0.003, 
0.008)
male and 
female subjects 
(16-65 years, 
n=60)
(Olivetti et 
al., 1995;  
Snyder et 
al., 1975)
0.005 
(0.003, 
0.008)  d
n/a
Intestines unitless betaPERT 0.016 
(0.011, 
0.024)
male and 
female adult 
subjects 
(Snyder et 
al., 1975)
0.016 
(0.011, 
0.024)  d
n/a
Kidney unitless betaPERT 0.004 
(0.003, 
0.006)
male and 
female subjects 
(20-40 years, 
(n=3428)
(Snyder et 
al., 1975)
0.004 
(0.003, 
0.006)  d
n/a
Liver unitless betaPERT 0.023 
(0.015, 
0.034)
male and 
female subjects 
(18-59 years, 
n=367)
(Snyder et 
al., 1975)
0.023 
(0.015, 
0.034)  d
n/a
Lung unitless betaPERT 0.014 
(0.009, 
0.021)
male and 
female subjects 
(18-40 years, 
n=516)
(Snyder et 
al., 1975)
0.014 
(0.009, 
0.021)  d
n/a
Marrow unitless betaPERT 0.047 
(0.031, 
0.071)
male and 
female subjects 
(16 - 86 years; 
females: 43.5-
55.2 kg, males: 
59.6-65 kg; 
n=13)
(Woodard 
and 
Holodny, 
1960)
0.047 
(0.031, 
0.071)  d
n/a
Muscle unitless betaPERT 0.400 
(0.267, 
0.600)
male and 
female adult 
subjects (n=6)
(Snyder et 
al., 1975)
0.400 
(0.267, 
0.600)  d
n/a
Skin unitless betaPERT 0.058 
(0.039, 
0.087)
male and 
female adult 
subjects
(Snyder et 
al., 1975)
0.058 
(0.039, 
0.087)  d
n/a
Fractional transfer coefficients for washin-washout module
Mucosa 
to arterial 
blood
Unitless Beta 25.26, 
8.88 (0,1)
- (Mork et 
al.,2009)
25.26, 8.88 
(0,1)  d
n/a
Bronchioles 
to mucosa
Unitless Beta 29.67, 
3.67 (0,1)
- (Mork et 
al.,2009)
29.67, 3.67 
(0,1)  d
n/a
Description 
of variable
Units
Distribution 
type At rest 
a Population References 
At light 
work a
Multiplier 
(rest to 
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b Alveolar ventilation and cardiac output were assumed to be correlated with a correlation 
coefficient of 0.8 (Levitzky, 2003). 
c Includes individuals from general population in all states of exercise, based on Raman et 
al. 2004.
d unchanged at light work compared to situation in rest
e Deterministic multiplier to convert the distributions in rest to light exercise, as described 
by Huizer et al 2014.
Table C-2 – Uncertainty distributions for the parameters as used by the model QSAR for 
blood-water partitioning.
a Lognormal distributions are presented as geometric mean (geometric standard deviation), 
betaPERT distributions as most likely value (minimum, maximum), beta distributions as 
alpha, beta (minimum, maximum);
b Deterministic multiplier to convert the distributions in rest to light exercise, as described 
by Huizer et al 2014.
c Quantitative Structure Activity Relationship
d unchanged at light work compared to situation in rest
Description of 
Variable
Units
Distribution 
type At rest 
a References
At light 
work a
Multiplier 
(rest to 
exercise) b
QSAR c for the blood-water partition coefficient
Affinity exponent 
for neutral lipids 
unitless betaPERT 1 (0.8, 1.25) (Hendriks 
et al., 2005)
1 (0.8, 
1.25)  d
n/a
Affinity exponent 
for polar lipids 
unitless betaPERT 0.94 (0.75, 
1.18)
(Hendriks 
et al., 2005)
0.94 (0.75, 
1.18)  d
n/a
Affinity exponent 
for proteins 
unitless betaPERT 0.63 (0.50, 
0.79)
(Hendriks 
et al., 2005)
0.63 (0.50, 
0.79)  d
n/a
Intercept for 
neutral lipids 
unitless betaPERT 0.04 (0.01, 
0.12)
(Hendriks 
et al., 2005)
0.04 (0.01, 
0.12)  d
n/a
Intercept for polar 
lipids 
unitless betaPERT 2.0 (0.67, 
6.0)
(Hendriks 
et al., 2005)
2.0 (0.67, 
6.0)  d
n/a
Intercept for 
proteins 
unitless betaPERT 2.9 (0.97, 
8.7)
(Hendriks 
et al., 2005)
2.9 (0.97, 
8.7)  d
n/a
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Category
Age 
group
n AM sd
Source 
database
relative weight 
in calculation
GM          
(g/dl blood)
gsd
White men 20-29 250 15,43 0,77 Scripps-Kaiser 1,00% 15,41 1,05
30-39 894 15,24 0,85 Scripps-Kaiser 3,50% 15,22 1,06
40-49 2219 15,2 0,89 Scripps-Kaiser 8,70% 15,17 1,06
50-59 3346 15,1 0,93 Scripps-Kaiser 13,00% 15,07 1,06
60-69 3073 15,02 0,95 Scripps-Kaiser 12,00% 14,99 1,07
White women 20-29 240 13,41 0,8 Scripps-Kaiser 0,90% 13,39 1,06
30-39 809 13,59 0,86 Scripps-Kaiser 3,20% 13,56 1,07
40-49 1917 13,58 0,86 Scripps-Kaiser 7,50% 13,55 1,07
50-59 2829 13,62 0,86 Scripps-Kaiser 11,00% 13,59 1,07
60-69 3006 13,63 0,88 Scripps-Kaiser 11,70% 13,6 1,07
Black men 20-29 27 14,83 0,76 Scripps-Kaiser 0,10% 14,81 1,05
30-39 87 14,76 1,02 Scripps-Kaiser 0,30% 14,72 1,07
40-49 163 14,58 1,06 Scripps-Kaiser 0,60% 14,54 1,08
50-59 157 14,46 1,08 Scripps-Kaiser 0,60% 14,42 1,08
60-69 103 14,27 0,98 Scripps-Kaiser 0,40% 14,24 1,07
Black women 20-29 17 13,26 0,75 Scripps-Kaiser 0,10% 13,24 1,06
30-39 68 12,97 0,93 Scripps-Kaiser 0,30% 12,94 1,07
40-49 120 12,88 0,91 Scripps-Kaiser 0,50% 12,85 1,07
50-59 135 12,96 0,89 Scripps-Kaiser 0,50% 12,93 1,07
60-69 90 13,03 0,91 Scripps-Kaiser 0,40% 13 1,07
White men 20-29 332 15,51 0,96 NHANES III 1,30% 15,48 1,06
30-39 389 15,29 0,95 NHANES III 1,50% 15,26 1,06
40-49 379 15,2 0,99 NHANES III 1,50% 15,17 1,07
50-59 356 15,17 1,01 NHANES III 1,40% 15,14 1,07
60-69 364 14,94 1,04 NHANES III 1,40% 14,9 1,07
White women 20-29 322 13,57 0,88 NHANES III 1,30% 13,54 1,07
30-39 402 13,66 0,86 NHANES III 1,60% 13,63 1,06
40-49 321 13,58 0,94 NHANES III 1,30% 13,55 1,07
50-59 312 13,76 0,94 NHANES III 1,20% 13,73 1,07
60-69 320 13,66 1,04 NHANES III 1,20% 13,62 1,08
Black men 20-29 403 14,84 0,96 NHANES III 1,60% 14,81 1,07
30-39 394 14,61 1,18 NHANES III 1,50% 14,56 1,08
40-49 290 14,5 1,07 NHANES III 1,10% 14,46 1,08
50-59 166 14,25 1,27 NHANES III 0,60% 14,19 1,09
60-69 137 14,19 1,02 NHANES III 0,50% 14,15 1,07
Black women 20-29 321 12,78 0,92 NHANES III 1,30% 12,75 1,07
30-39 339 12,77 1,11 NHANES III 1,30% 12,72 1,09
40-49 244 12,87 1,05 NHANES III 1,00% 12,83 1,08
50-59 146 13,07 0,95 NHANES III 0,60% 13,04 1,08
60-69 161 12,89 1,01 NHANES III 0,60% 12,85 1,08
Calculated 25648 100% 14,3 1,07
Table C-3 – Calculation of haemoglobin content in the working population (20 - 70 years), 
based on Beutler and Waalen, 2006.
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Figure C-1. Relevant pathways for biotransformation of acrylonitrile (ACN) for the 
simulation of N-2-cyanoethylvaline (CEV) in haemoglobin.
CEO – cyanoethylene oxide, GSH – glutathione,
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 Risk assessment of chemical emissions at the workplace hinges on two 
essential features: 1) exposure assessment in which exposure to a chemical is 
determined, and 2) effect assessment that focuses on the chemicals’ capacity to cause 
adverse health effects. Exposure to chemicals at the workplace can be assessed by 
means of quantification of external (ambient air) or internal (e.g. blood) concentrations 
of chemicals and/or their metabolites. Traditionally, since the 1970-ies, exposure is 
assessed by means of personal air measurements among workers in their working 
environment. More recently, internal exposure assessment gained interest, as internal 
concentrations are closer to the target organ dose and therefore considered to result 
in more precise exposure-response relations and consequently to provide greater 
precision in risk estimates. This has increased the use of human biomonitoring as 
a method to determine hazardous substances or their metabolites in body fluids 
such as blood or urine. Besides taking samples of relevant body fluids, target tissue 
dose metrics are increasingly predicted with computer models. Physiologically based 
pharmacokinetic (PBPK) or toxicokinetic (PBTK) models that simulate the absorption, 
distribution, metabolism and excretion of chemicals that enter the body based on a 
mechanistic approach are often used in this context.
Depending on the exposure assessment method applied and the exposure setting 
of interest, variation in the measured or estimated external (ambient air) or internal 
(biological media) concentration can be caused by sources of variability and/or 
uncertainty. Uncertainty is caused by a lack of knowledge and can in principle be 
reduced, such as by more precise measurements and methods. Variability can be 
found in any population as a result of physiological differences between people, 
individual behaviour, and spatial and temporal differences. Sources of variability and 
uncertainty are present in any workplace scenario and therefore influence the exposure 
assessment and subsequently the risk assessment. Quantification of parameter 
uncertainty and interindividual variability can provide insight in the underlying causes 
of the variation in exposure predictions.
 The overall aim of this thesis was to improve chemical exposure assessment 
for the workplace by quantification of sources of uncertainty and variability in various 
exposure settings. Air concentrations and internal concentrations were considered, 
based on workplace air measurements and by means of internal exposure prediction 
models. Sources of uncertainty and variability were quantified to obtain insight in their 
magnitude and relative importance. This information can be used by risk assessors 
to better interpret outcomes of model simulations for the workplace by identification 
of the fraction of the population at risk and the level of certainty of the predictions. 
Also uncertain parameters in model estimations can be identified in order to improve 
chemical exposure assessment for the workplace.
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 In Chapter 2 it was demonstrated that different types of personal inhalable 
aerosol samplers, as applied in the rubber manufacturing industry, lead to uncertainty 
because they do not provide identical measured air concentrations. Differences in 
mean workplace air concentrations as measured with the different personal samplers 
were up to a factor of two. Depending on which of the 6 tested samplers was used, 
the air concentration was either underestimated or overestimated in comparison to 
the golden standard. Statistical analyses were performed to calculate a performance 
ratio for each individual sampler, which was used to express its performance in 
relation to the golden standard. Possible confounding factors that could influence this 
performance, such as wind speed, humidity, temperature and distance to the source, 
were identified separately. The estimated performance ratios ranged within a factor of 
three on average. 
 Although most of the studied inhalable dust samplers can be used in 
accordance with measurement protocols, they appeared not to meet the described 
requirements based on their performance as calculated in this study. Consequently, 
the selection of (certified) personal air samplers can lead to an increase of uncertainty 
in the measurement results. However, in comparison with the total variance in the air 
measurements as quantified in this study, the influence of the measurement error that 
was caused by the personal inhalable dust sampler was relatively minor at 5-17%. 
 In Chapter 3 it was demonstrated how personal air samples, that were 
collected among bricklaying students and their teachers at six different vocational 
training centers for future construction workers, could be used to predict exposure 
to respirable dust and crystalline silica from working with trial mortar. An empirical 
statistical model was developed based on the measured exposure data to characterize 
relevant determinants of exposure that influenced the interindividual and intra-
individual variability in the measured exposure concentration to respirable dust. A 
simple model with factors like activities performed by the students, type of training 
center and presence of a dust extraction system explained more than 50% of the total 
variation in the measured respirable dust concentration in air. Based on the model, 
control measures to reduce exposure could be suggested, such as the reduction of dry 
sweeping and the installation of dust extraction systems.
In the next chapters sources of variation in internal concentrations were assessed by 
means of exposure prediction models.
 Chapter 4 described a method to separate parameter uncertainty and 
interindividual variability in the predictions of the generic human physiologically-
based pharmacokinetic (PBPK) model BIONORMTOX by means of nested Monte 
Carlo simulations. In this chapter, the concentration of acetone in human blood was 
simulated during and after 4 hours of exposure to 2-propanol via air. It was shown that 
the influence of interindividual variability and uncertainty  varies over time, from the 
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uptake phase, via a steady-state phase, into the elimination phase. During the uptake 
phase, interindividual variability played the most important role in predicting the 
variation of acetone concentrations in blood. After exposure ceased, the parameter 
uncertainty increased mainly due to uncertainty in the metabolic parameters of 
acetone, whereas variability remained unchanged. This study illustrates how separate 
information on uncertainty and variability can help decision makers to identify whether 
they should focus on identification of sensitive individuals or on additional research 
to obtain more accurate estimates for particular parameters in the risk assessment 
process. 
 Chapter 5  demonstrated how the BIONORMTOX model can be applied 
to evaluate coherence between occupational exposure limits (OELs) and their 
corresponding biological limit values (BLVs). Internal concentrations of 2-propanol 
and acetone were simulated after inhalation exposure at the level of their OELs. The 
fraction of workers with predicted internal concentrations lower than the BLV after 
exposure at the level of the OEL, i.e. ´false negatives´, was taken as a measure for 
incoherence. The impact of variability and uncertainty in input parameters on the 
predicted internal concentrations was separated by means of nested Monte Carlo 
simulation. Although it was demonstrated that the BLVs for 2-propanol and acetone 
were likely (i.e., with 50% certainty) to be coherent with their OEL for the majority of 
the working population (55–98%), for a fraction of the population a higher chance of 
incoherence between the OEL and the BLV was found. It was indicated that internal 
concentrations tend to decrease with increasing body weight, implying a higher 
chance of incoherence for individuals with a large body weight. However, incoherence 
does not necessarily imply adverse health effects, since OELs were originally derived 
from toxicity data and are therefore more directly linked to possible adverse health 
effects in contrast to BLVs. In order to assess the acceptability of this incoherence, a 
maximum population fraction at risk of exceeding the OEL should be specified as well 
as a minimum level of certainty in predicting this fraction. 
 In Chapter 6 a case study was presented on the application of PBPK 
modelling combined with measured biomonitoring data to backtrack the air 
concentration of acrylonitrile (ACN) during a chemical incident. The incident 
concerned the decontamination of a tank wagon, whereby a cleaning worker who was 
found unconscious in the wagon was evacuated by his colleagues. Blood levels of 
N-2-cyanoethylvaline (CEV) were measured in the 4 cleaning workers that rescued 
their colleague in the aftermath of the chemical incident at various points in time. 
Reversed dosimetry was applied combined with nested Monte Carlo simulation to 
quantify the variation in the predicted air concentrations as a result of uncertainty 
in chemical-specific and scenario related input data and variability in physiological 
parameters, based on the collected blood samples after 25 and 85 days. Uncertainty 
in the exact exposure duration at the time of the chemical accident was found to have 
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a dominant influence on the model outcomes. It was also shown that uncertainty 
can be further reduced by collecting human biomonitoring data as soon as possible 
after the incident. The collection of specific information about individual physiological 
parameters from the victims, such as body weight, may have further reduced the 
variation by 5 to 20% in this case study.  
 In Chapter 7, a number of simulations were performed to combine variability 
in external exposure concentrations with uncertainty and variability in the PBPK models 
to predict internal concentrations. The following conclusions on the importance of 
a separate quantification of uncertainty and variability in exposure modelling at the 
workplace were drawn.
• Variability in workplace air concentrations of chemicals contributes largely to 
the predicted variation in internal concentrations in workers. Without a solid 
quantification of workplace air concentrations, the added value of quantifying 
uncertainty and variability in internal exposure levels, e.g. using a PBPK model, 
is limited.
• The influence of sources of variability and uncertainty on the predicted variation 
in internal concentrations is not fixed, but varies over the different phases of 
exposure from the uptake phase, via a steady-state phase, into the elimination 
phase. The timing of the exposure scenario affects the course of the various 
exposure phases. Therefore, information about the phase of exposure at the 
moment that the internal exposure assessment is performed, is required to 
provide insight in the relevant sources of uncertainty and variability at that time.
Based on these conclusions, it was recommended to characterize sources of variation 
in workplace air concentrations thoroughly when assessing internal concentrations of 
chemicals by means of exposure models, especially in situations with large variation 
in the workplace air concentrations. Only then (PBPK) model predictions of internal 
concentrations will have added value above collecting biological measurements
Finally, it was recommended to use nested Monte Carlo simulations in combination 
with parameter importance analysis more often in the risk assessment process, to 
identify and quantify parameters that introduce uncertainty and variability. Analysis of 
the uncertainty component will indicate the level of certainty of the predictions and 
thus the need for additional research to obtain more accurate estimates. Analysis 
of the variability component can be utilised to identify sensitive individuals or the 
fraction of the population at risk and thus the relevance of implementing control 
measures to reduce exposure.
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Het beoordelen van gezondheidsrisico’s ten gevolge van het vrijkomen van 
chemische stoffen op de werkplek kent tenminste twee belangrijke aspecten: 1) de 
blootstellingsbeoordeling waarbij de hoogte van de blootstelling wordt bepaald, 
en 2) de effectbeoordeling die gericht is op het bepalen van de capaciteit van een 
chemische stof om nadelige gezondheidseffecten te veroorzaken. De blootstelling 
aan chemische stoffen op de werkplek kan worden bepaald middels het kwantificeren 
van externe (omgevingslucht) of interne (bloed, urine) concentraties van chemische 
stoffen of hun afbraakproducten, ook wel metabolieten. Volgens de klassieke aanpak 
wordt de blootstelling bepaald middels het uitvoeren van persoonsgebonden 
luchtmetingen bij medewerkers in hun werkomgeving. Recenter is de aandacht 
voor interne concentraties, die dichterbij het doelorgaan worden bepaald. Dit 
wordt verwacht te resulteren in het nauwkeuriger vaststellen van de relatie tussen 
blootstelling en respons, en zodoende tot een grotere precisie bij het uitvoeren van 
risicoschattingen. In de afgelopen jaren heeft dit geleid tot een toename van humane 
biomonitoring als methode om gevaarlijke stoffen of hun afbraakproducten vast te 
stellen in lichaamsvloeistoffen als bloed en urine. Naast het uitvoeren van metingen 
in deze lichaamsvloeistoffen worden inwendige doses in doelorganen in toenemende 
mate voorspeld met computermodellen. Het gaat hierbij vaak om zogenoemde 
farmacokinetische (PBPK) of toxicokinetische (PBTK) modellen, die gebaseerd zijn 
op de humane fysiologie. Met dit soort modellen wordt de absorptie, verspreiding 
(distributie), afbraak (metabolisme) en excretie van chemische stoffen die het lichaam 
binnentreden voorspeld, waarbij een mechanistische benadering wordt gevolgd. 
 Afhankelijk van de wijze waarop de blootstelling wordt vastgesteld en de 
context waarin dit plaatsvindt, kunnen bronnen van variabiliteit en/of onzekerheid 
een rol spelen in de gemeten of geschatte externe (lucht) of interne (biologische 
media) concentratie. Onzekerheid wordt veroorzaakt door een gebrek aan kennis en 
kan in principe worden gereduceerd, bijvoorbeeld door het uitvoeren van preciezere 
metingen of gebruik van preciezere methodes. Variabiliteit is aanwezig in iedere 
populatie ten gevolge van fysiologische verschillen tussen mensen, individueel gedrag 
en variatie in ruimte en tijd. Bronnen van variabiliteit en onzekerheid komen voor op 
iedere werkplek en oefenen zodoende invloed uit op de blootstellingsbeoordeling en 
de daaropvolgende risicobeoordeling. Het kwantificeren van parameter onzekerheid 
en interindividuele variabiliteit kan inzicht verschaffen in de onderliggende oorzaken 
van variatie in blootstellingsschattingen. 
 Dit proefschrift heeft als doel om de beoordeling van blootstelling aan 
chemische stoffen op de werkplek te verbeteren door het kwantificeren van bronnen 
van onzekerheid en variabiliteit in verschillende blootstellingssituaties. Hierbij ligt de 
nadruk op luchtconcentraties en interne concentraties van chemische stoffen, die zijn 
vastgesteld door middel van persoonsgebonden luchtmetingen op de werkplek en 
middels schattingsmodellen voor interne blootstelling.  In dit kader zijn verschillende 
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bronnen van onzekerheid en variabiliteit kwantitatief in kaart gebracht om meer 
inzicht te krijgen in hun afzonderlijke invloed op de totale variatie. Deze informatie 
kan door beleidsmakers worden aangewend om uitkomsten van modelsimulaties 
voor de werkplek beter te kunnen interpreteren middels het identificeren van de fractie 
van de populatie at risk en de mate van zekerheid dat de schatting klopt. Daarnaast 
kunnen modelparameters worden geïdentificeerd die onzekerheid in schattingen tot 
gevolg hebben, met als doel om de beoordeling van chemische blootstelling op de 
werkplek te verbeteren.
 
In Hoofdstuk 2 wordt aangetoond dat het gebruik van verschillende types meetkoppen 
voor het persoonsgebonden meten van inhaleerbaar aerosol in de rubberindustrie 
onzekerheid introduceren, doordat ze geen identieke luchtconcentraties meten. 
Verschillen in de gemiddelde luchtconcentratie, zoals gemeten met verschillende 
types meetkoppen op de werkplek, lopen op tot een factor twee. Afhankelijk van welke 
van de zes geteste meetkoppen werd gebruikt, werd de luchtconcentratie onderschat 
dan wel overschat in vergelijking met de gouden standaard. Op basis van statistische 
analyses is voor iedere meetkop een ratio berekend om de prestatie ten opzichte van 
de gouden standaard uit te drukken. Mogelijke verstorende factoren die de prestatie 
konden beïnvloeden, zoals windsnelheid, temperatuur en afstand tot de bron, zijn 
apart geïdentificeerd. De geschatte prestatie-ratio’s varieerden gemiddeld binnen een 
factor drie.   
Ondanks het feit dat de meeste van de onderzochte meetkoppen gebruikt mogen 
worden volgens bestaande meetprotocollen, bleken ze op basis van hun prestaties 
zoals berekend in dit onderzoek niet te voldoen aan de randvoorwaarden. 
Dientengevolge kan de keuze voor een (gecertificeerde) meetkop voor het uitvoeren 
van persoonsgebonden metingen leiden tot een toename van de onzekerheid in het 
meetresultaat. Echter, in vergelijking met de totale variatie in de luchtmetingen die 
binnen dit onderzoek zijn uitgevoerd, is de invloed van de meetfout door gebruik van 
de meetkop met 5 - 17% relatief klein.
In Hoofdstuk 3 is beschreven hoe persoonsgebonden metingen, zoals uitgevoerd bij 
leerlingmetselaars en hun docenten op zes verschillende opleidingscentra tijdens het 
gebruik van oefenmortel, gebruikt kunnen worden om de blootstelling aan respirabel 
stof en kristallijn silica te voorspellen. Op basis van de verzamelde meetgegevens 
is een empirisch statistisch model ontwikkeld, waarmee relevante determinanten 
van blootstelling gekarakteriseerd zijn die invloed hebben op de interindividuele en 
intra-individuele variabiliteit in de blootstelling aan respirabel stof. Een simpel model 
met factoren zoals het type uitgevoerde werkzaamheden, het type opleidingscentrum 
en de aanwezigheid van een luchtbehandelingsysteem verklaarde meer dan 50% 
van de totale variatie in de gemeten luchtconcentratie respirabel stof. Op basis van 
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dit model konden beheersmaatregelen worden geadviseerd om de blootstelling te 
verlagen, zoals het verminderen van vegen met een bezem en de installatie van een 
luchtbehandelingsysteem.
In de volgende hoofdstukken wordt ingegaan op bronnen van variatie bij het vaststellen 
van de interne concentratie met behulp van blootstellingsmodellen. 
 In Hoofdstuk 4 wordt een methode beschreven om parameter onzekerheid en 
interindividuele variabiliteit in de uitkomsten van het generieke humaan fysiologisch 
kinetisch (PBPK) model BIONORMTOX te kunnen scheiden door toepassing van 
geneste Monte Carlo simulatie. In dit hoofdstuk is de bloedconcentratie aceton 
gesimuleerd tijdens en na afloop van een 4 uur durende blootstelling aan 2-propanol 
via de lucht. Hierbij is aangetoond dat de invloed van interindividuele variabiliteit en 
onzekerheid varieert over de tijd, van de opnamefase, via de steady-state fase, naar 
de eliminatiefase. Gedurende de opnamefase speelde interindividuele variabiliteit 
de belangrijkste rol bij het voorspellen van de variatie van de acetonconcentratie in 
bloed. Nadat de blootstelling beëindigd werd, nam de parameteronzekerheid toe door 
met name de metabole parameters van aceton, terwijl de variabiliteit ongewijzigd 
bleef. Deze studie illustreert hoe het scheiden van informatie over onzekerheid en 
variabiliteit beleidsmakers kan helpen in hun besluit om zich ter ondersteuning van 
de risicobeoordeling te richten op het identificeren van gevoelige individuen of op 
het stimuleren van aanvullend onderzoek om meer accurate schattingen te verkrijgen 
voor bepaalde parameters.
 Hoofdstuk 5 demonstreert hoe het BIONORMTOX model kan worden 
ingezet om de coherentie tussen luchtgrenswaarden (OELs) en hun corresponderende 
biologische grenswaarde (BLV) te evalueren. Hiervoor werden interne concentraties 
2-propanol en aceton gesimuleerd na inhalatieblootstelling op het niveau van 
de luchtgrenswaarde (OEL). Het deel van de arbeidspopulatie waarvoor interne 
concentraties werden voorspeld onder de biologische grenswaarde (BLV) na 
inhalatieblootstelling op het niveau van de OEL, de zogenoemde ‘vals positieven’, 
werd hierbij als maat voor incoherentie genomen. De invloed van variabiliteit en 
onzekerheid in de inputparameters op de voorspelde interne concentraties werd 
gescheiden middels geneste Monte Carlo simulatie. Hoewel werd aangetoond dat de 
BLV’s voor 2-propanol en aceton met 50% zekerheid coherent waren met hun OEL 
voor het grootste deel van de arbeidspopulatie (55 – 98%), werd voor een fractie van 
de populatie een hogere kans op incoherentie tussen OEL en BLV gevonden. Er zijn 
aanwijzingen dat de interne concentraties afnemen met toename in lichaamsgewicht, 
wat impliceert dat er een grotere kans op incoherentie bestaat voor individuen met 
een hoger lichaamsgewicht. Echter, incoherentie impliceert niet noodzakelijkerwijs 
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dat nadelige gezondheidseffecten zullen optreden, aangezien OELs oorspronkelijk 
afgeleid zijn van toxiciteitsgegevens en zodoende directer gekoppeld zijn aan nadelige 
gezondheidseffecten dan de meeste BLV’s. Om antwoord te geven op de vraag of 
eventuele incoherentie aanvaardbaar is, zou zowel een maximale fractie van de 
populatie die de luchtgrenswaarde (OEL) overschrijdt moeten worden vastgesteld, 
als een minimale zekerheid dat deze fractie juist is vastgesteld. 
 In Hoofdstuk 6 wordt een case study beschreven over de toepassing van 
PBPK modellen in combinatie met gemeten biomonitoringsgegevens om de 
luchtconcentratie acrylnitril (ACN) tijdens een chemisch incident te herleiden. 
Het betreft een incident bij het decontamineren van een tankwagon, waarbij een 
bewusteloos geraakte schoonmaker door zijn collega’s wordt geëvacueerd. Bij de vier 
schoonmakers die betrokken waren bij deze evacuatie is op verschillende momenten 
na het incident de bloedconcentratie N-2-cyanoethylvaline (CEV) bepaald. Hierbij is 
zogenoemde reversed dosimetry toegepast in combinatie met geneste Monte Carlo 
simulatie om de variatie in de voorspelde luchtconcentratie te kwantificeren ten 
gevolge van onzekerheden in chemische en scenario-gerelateerde inputgegevens en 
variabiliteit in fysiologische parameters, op basis van de verzamelde bloedmetingen 
op 25 en 85 dagen na het incident. Onzekerheid in de exacte blootstellingsduur 
tijdens het incident had de grootste invloed op de modelvoorspellingen. Tevens werd 
aangetoond dat de onzekerheid in de voorspelling verder kan worden teruggebracht 
door het verzamelen van biomonitoringsgegevens zo snel als mogelijk na het incident. 
Het verzamelen van specifieke informatie over individuele fysiologische kenmerken 
van de betrokkenen, zoals hun lichaamsgewicht, kon de variatie in deze case study 
terugbrengen met 5 tot 20%.
In Hoofdstuk 7 worden de resultaten van een aantal simulaties gepresenteerd, die zijn 
uitgevoerd om de variabiliteit in externe blootstellingsconcentraties te combineren 
met onzekerheid en variabiliteit in PBPK modellen om interne concentraties te kunnen 
schatten. De volgende conclusies over het belang van het separaat kwantificeren 
van onzekerheid en variabiliteit bij het modelleren van blootstelling op de werkplek 
worden getrokken:
• Variabiliteit in de luchtconcentratie van chemische stoffen op de werkplek 
draagt in grote mate bij aan de voorspelde variatie in interne concentraties bij 
medewerkers. Zonder een degelijke, kwantitatieve karakterisatie van variabiliteit 
in de luchtconcentratie is de toegevoegde waarde van het kwantificeren van 
onzekerheid en variabiliteit in interne blootstelling, bijvoorbeeld middels PBPK 
modellen, beperkt.
• De invloed van bronnen van variabiliteit en onzekerheid op de voorspelde variatie 
in interne concentratie staat niet vast, maar varieert tussen de verschillende 
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fasen van blootstelling, van de opnamefase, via de steady-state fase naar de 
eliminatiefase. Het exacte verloop van het blootstellingsscenario, waaronder de 
duur en hoogte van de concentratie, beïnvloedt het verloop van deze verschillende 
fasen. Om inzicht te krijgen in de relevante bronnen van onzekerheid en variabiliteit 
in de interne blootstelling op een vastgesteld moment, is het zodoende essentieel 
om over informatie te beschikken over de fase van blootstelling.
Op basis van deze conclusies wordt aangeraden om bronnen van variatie in 
de luchtconcentratie op de werkplek goed te karakteriseren alvorens de interne 
concentratie van chemische stoffen vast te stellen middels blootstellingsmodellen, 
in het bijzonder wanneer grote variatie in de luchtconcentratie verwacht wordt. Alleen 
in dat geval zullen schattingen van de interne concentratie middels (PBPK) modellen 
toegevoegde waarde hebben ten opzichte van het verzamelen van biologische 
metingen.
Tenslotte wordt geadviseerd om vaker geneste Monte Carlo simulatie in combinatie 
met parameter importance analyse toe te passen bij de risicobeoordeling, om 
parameters die onzekerheid en variabiliteit introduceren te identificeren en te 
kwantificeren. Analyse van de onzekerheidscomponent geeft een indicatie van het 
niveau van zekerheid van de schatting en zodoende de noodzaak om aanvullend 
onderzoek te doen om nauwkeuriger schattingen te kunnen uitvoeren. Analyse van de 
variabiliteitscomponent kan worden ingezet om gevoelige individuen of de fractie van 
de populatie at risk te identificeren en daarmee de relevantie om beheersmaatregelen 
te implementeren om de blootstelling te reduceren.
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